data_1ust_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ust _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 121.062 0.458 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.855 ' HB2' HG22 ' A' ' 80' ' ' VAL . 72.1 mmtt -98.33 126.94 44.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.429 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 40.4 t -71.84 124.58 25.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.414 ' O ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -64.42 -26.11 68.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.289 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.07 -43.47 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.355 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 3.1 mm-40 -73.08 -46.07 53.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.337 0.589 . . . . 0.0 110.28 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.623 HD11 ' N ' ' A' ' 50' ' ' LEU . 1.4 mp -61.35 -49.85 75.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.434 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 94' ' ' ILE . 70.7 mt -62.91 -51.36 72.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.71 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.788 HG13 ' HE1' ' A' ' 103' ' ' PHE . 47.6 mt -60.14 -43.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -50.8 -43.98 58.9 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.412 0.445 . . . . 0.0 110.485 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.64 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -80.8 -55.88 3.24 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.547 176.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.743 HD22 HD21 ' A' ' 115' ' ' LEU . 24.2 tp -51.29 -31.08 20.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.326 0.651 . . . . 0.0 111.953 -171.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -75.89 -31.04 59.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.19 -51.19 5.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.64 HD21 ' O ' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -89.31 21.42 3.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.139 0.495 . . . . 0.0 111.007 -173.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.688 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -59.75 -32.09 70.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.992 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 56.2 -109.36 0.49 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.673 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 16.2 ptm180 -65.86 -34.78 78.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.189 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.719 ' O ' ' HD3' ' A' ' 114' ' ' LYS . 21.0 ptmt -175.2 -48.2 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.062 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.2 29.78 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -141.41 152.64 44.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 7.7 t -66.42 159.99 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.724 -174.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.549 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -50.29 -50.14 72.38 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.6 Cg_endo -50.85 -38.98 58.73 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.599 2.199 . . . . 0.0 112.84 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.43 81.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.756 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.407 HD13 HD11 ' A' ' 55' ' ' LEU . 18.1 mt -63.6 -41.64 98.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.244 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 94.9 mttt -60.1 -38.78 83.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 88.1 tttt -68.29 -47.69 66.95 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.121 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -50.7 -47.06 59.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.752 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 50' ' ' LEU . 67.3 mt -67.63 -40.56 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.071 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 97.3 mttt -63.31 -40.11 96.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.634 0.254 . . . . 0.0 111.664 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 4.8 mm-40 -73.59 -39.45 64.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.317 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -93.96 -41.44 9.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CD2' HD13 ' A' ' 50' ' ' LEU . 14.6 m-85 -119.87 73.51 18.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.13 -23.68 54.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.994 2.463 . . . . 0.0 113.585 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.46 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 4.1 mp -50.06 -56.42 3.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.857 0.837 . . . . 0.0 110.456 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.855 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -91.55 -32.37 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 74' ' ' LYS . . . -55.31 -41.43 79.61 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.348 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -100.92 33.2 2.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.227 0.537 . . . . 0.0 109.994 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 80' ' ' VAL . . . -88.32 145.49 25.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.078 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m -65.13 125.19 24.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.33 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m120 65.44 29.88 11.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.61 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.98 -43.42 98.85 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.321 0.581 . . . . 0.0 110.07 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -54.01 -42.35 68.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.05 -49.17 38.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -56.51 -37.81 70.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.597 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CE1' HG12 ' A' ' 51' ' ' ILE . 69.6 t80 -58.65 -41.29 85.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.181 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -61.09 -45.54 94.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -64.09 -36.16 83.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.639 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.95 99.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 51' ' ' ILE . 42.6 mm -60.73 -47.62 92.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.268 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 97.3 mttt -59.72 -42.49 93.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.963 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 tmtp? -65.61 -39.66 91.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.242 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.793 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -69.56 -40.82 77.67 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.106 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.6 m -70.26 -36.81 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.022 0.411 . . . . 0.0 111.29 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 1.5 pt-20 -67.85 -35.64 78.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.928 0.394 . . . . 0.0 110.361 175.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.874 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.84 41.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.964 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -113.38 -32.47 6.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.793 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 8.4 m-85 -121.41 158.41 28.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.161 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.59 143.6 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.431 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 67.8 mt-30 -111.5 104.2 55.86 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-O 120.971 0.415 . . . . 0.0 111.034 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 21.0 Cg_endo -62.03 -35.28 77.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.229 2.619 . . . . 0.0 112.512 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -96.04 28.99 2.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.288 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.93 174.82 34.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.51 140.27 74.77 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.706 2.271 . . . . 0.0 111.442 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 68.09 41.34 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.6 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.47 -138.64 3.9 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.658 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.85 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -85.94 134.95 33.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.694 HG13 HD23 ' A' ' 55' ' ' LEU . 39.7 t -97.99 154.0 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.719 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 44.1 tptt -144.47 133.12 22.24 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.743 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -55.35 118.8 4.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.54 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.206 0.527 . . . . 0.0 110.933 179.428 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.648 ' HB2' HG22 ' A' ' 80' ' ' VAL . 30.6 mmtm -91.49 147.0 23.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.437 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 15.3 t -70.21 -17.16 63.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.826 0.346 . . . . 0.0 111.368 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 20.9 m-85 71.49 -44.35 0.59 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.191 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.524 ' HG3' HD13 ' A' ' 52' ' ' ILE . 4.7 ttm105 -54.51 -45.55 73.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.057 0.456 . . . . 0.0 110.58 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 13.6 pt-20 -59.73 -46.01 90.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.13 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mp -62.75 -52.52 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.664 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.95 -52.14 63.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.535 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.612 HD12 ' OD2' ' A' ' 102' ' ' ASP . 74.7 mt -63.45 -41.29 92.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.57 -37.47 70.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.17 -58.62 3.12 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.421 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD22 HG13 ' A' ' 113' ' ' VAL . 32.1 tp -49.71 -32.65 13.95 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.454 0.702 . . . . 0.0 112.381 -172.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.534 HG21 ' N ' ' A' ' 57' ' ' ALA . 7.2 t -73.75 -31.75 63.49 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 110.773 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.534 ' N ' HG21 ' A' ' 56' ' ' THR . . . -88.05 -50.27 6.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HG ' ' OG ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -92.2 17.39 9.7 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.825 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 64' ' ' SER . 17.2 pttp -68.43 -29.04 67.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 58.76 -113.35 0.68 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.738 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.2 ptp85 -67.34 -27.48 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.584 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 59.3 pttt -173.29 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 114' ' ' LYS . . . -150.83 158.38 27.65 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 119.714 -1.232 . . . . 0.0 114.004 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HG ' ' HA ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -106.25 144.06 33.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.403 . . . . 0.0 111.169 -177.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -64.19 141.93 58.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.541 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.3 mtp-105 -55.43 -49.59 91.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.1 Cg_endo -58.32 -29.02 86.72 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.944 1.763 . . . . 0.0 112.107 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.02 83.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 55' ' ' LEU . 39.3 mt -62.58 -43.82 97.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.408 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 98.4 mttt -57.15 -40.69 77.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.703 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 53.4 tttp -67.97 -47.34 68.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.564 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.16 -46.02 65.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.374 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 53.4 mt -63.65 -44.28 98.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.992 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.2 mttt -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 67.2 mm-40 -69.68 -39.51 76.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.365 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -94.29 -41.45 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -123.16 77.16 51.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.618 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.03 -17.6 45.85 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.398 . . . . 0.0 112.824 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.52 ' H ' HD11 ' A' ' 79' ' ' ILE . 2.8 mp -55.71 -64.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 122.049 0.928 . . . . 0.0 110.016 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -76.16 -33.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.206 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 74' ' ' LYS . . . -51.55 -42.35 51.19 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.679 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -101.67 31.12 3.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 80' ' ' VAL . . . -74.87 148.68 39.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.711 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -47.63 80.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -113.39 34.85 4.27 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.419 ' CD1' HG11 ' A' ' 80' ' ' VAL . 46.4 t80 -54.71 -46.17 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.591 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -58.46 -47.45 83.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.836 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.58 -48.33 75.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -58.97 -45.05 91.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.245 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.419 ' O ' HG12 ' A' ' 94' ' ' ILE . 90.5 t80 -56.77 -47.11 80.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -62.13 -44.1 97.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.736 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.613 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 78.6 m-20 -66.01 -38.81 89.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.751 0.31 . . . . 0.0 110.769 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.94 88.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.383 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 113' ' ' VAL . 36.5 mm -61.73 -51.69 69.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.991 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.613 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -62.29 -41.07 98.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -173.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 46.6 tptt -71.73 -34.59 69.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.74 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -67.73 -40.37 90.02 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 95' ' ' LYS . 17.2 m -65.2 -42.13 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.166 0.483 . . . . 0.0 111.246 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -67.81 -41.25 83.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.87 -28.37 68.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.626 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.63 4.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.55 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.612 ' OD2' HD12 ' A' ' 52' ' ' ILE . 35.2 t70 -113.83 -41.99 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.027 -0.586 . . . . 0.0 109.495 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.74 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 21.1 m-85 -114.44 171.82 7.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.957 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -153.47 136.33 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 80.7 mt-30 -122.39 105.84 36.03 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 25.5 Cg_endo -62.14 -36.05 71.81 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.896 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HB2' ' HA2' ' A' ' 111' ' ' GLY . 98.9 mttt -91.76 16.37 10.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.15 -146.59 49.28 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.955 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.71 133.88 57.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.15 2.567 . . . . 0.0 112.482 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.76 30.7 18.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.108 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 107' ' ' LYS . . . -114.89 160.1 13.38 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.566 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.602 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -55.12 130.83 43.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.534 HG23 HG22 ' A' ' 94' ' ' ILE . 17.7 t -90.17 155.66 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.486 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.603 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -152.16 136.8 16.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.687 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.446 HD21 ' CG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -51.15 127.32 18.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.801 -174.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.039 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.233 0.214 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.813 ' HB2' HG22 ' A' ' 80' ' ' VAL . 71.5 mmtt -83.16 138.23 33.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 48.2 m -72.41 115.74 12.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' O ' HG13 ' A' ' 51' ' ' ILE . 8.1 m-85 -62.29 -30.45 71.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.544 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -52.5 -48.55 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.988 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 19.2 mm-40 -62.53 -46.65 87.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.173 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD11 ' N ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -60.06 -48.53 81.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.834 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.688 HG12 ' HE1' ' A' ' 90' ' ' PHE . 68.7 mt -64.29 -53.85 38.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.06 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.757 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.9 mt -60.44 -45.52 96.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.48 -39.2 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 110.504 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.42 -59.88 2.46 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.451 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.599 HD21 HD21 ' A' ' 115' ' ' LEU . 18.3 tp -46.04 -36.06 5.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.185 0.994 . . . . 0.0 112.543 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -68.78 -34.21 75.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.122 0.486 . . . . 0.0 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.55 -53.44 4.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.602 ' O ' ' HB3' ' A' ' 64' ' ' SER . 1.7 pt? -91.52 20.34 5.45 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.923 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -60.43 -19.89 57.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.683 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 43.9 mt-10 63.29 -115.13 0.46 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.982 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -73.06 -48.2 38.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.688 0.28 . . . . 0.0 111.142 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -179.18 27.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.233 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.48 125.94 0.88 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.583 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.602 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 2.3 p -113.22 133.46 55.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.7 m -57.92 135.65 56.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.936 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.577 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 35.5 ptt180 -53.92 -41.11 86.3 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 21.5 Cg_endo -57.94 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.672 1.582 . . . . 0.0 112.703 177.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.24 88.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.514 ' HG ' HD23 ' A' ' 58' ' ' LEU . 6.7 mp -59.42 -33.43 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.434 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 8.6 mtmm -56.97 -38.49 73.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.2 tttp -67.1 -52.35 42.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.099 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.42 -43.47 64.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.817 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.462 HG12 ' HB3' ' A' ' 50' ' ' LEU . 79.7 mt -65.87 -46.8 87.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.164 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.3 mttt -60.48 -43.38 97.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 111.437 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.2 mt-10 -66.46 -36.68 83.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -93.96 -33.72 13.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.823 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -130.24 76.04 78.38 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.525 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.48 -21.29 37.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.036 2.491 . . . . 0.0 112.469 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.537 ' H ' HD11 ' A' ' 79' ' ' ILE . 4.7 mp -52.37 -68.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.721 0.772 . . . . 0.0 110.52 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -73.23 -30.51 31.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.223 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -34.46 36.68 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.82 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -114.94 42.31 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.208 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.08 15.25 1.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.775 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m 69.75 -62.35 0.42 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.832 0.853 . . . . 0.0 112.468 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -98.4 29.56 3.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.035 0.445 . . . . 0.0 110.127 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.47 -46.18 80.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.472 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.24 -42.15 99.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.744 0.307 . . . . 0.0 110.847 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.95 -48.54 65.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.344 0.593 . . . . 0.0 110.166 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -61.09 -41.01 95.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.688 ' HE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -59.34 -43.85 92.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.26 -43.74 98.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -64.48 -38.23 90.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.876 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.402 ' HB3' HD13 ' A' ' 51' ' ' ILE . . . -62.21 -41.86 98.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.788 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 90' ' ' PHE . 46.4 mm -59.85 -48.99 85.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.273 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HZ2' ' HB3' ' A' ' 95' ' ' LYS . 9.9 mtpm? -57.33 -48.18 79.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.224 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 13.3 tmtt? -62.92 -41.08 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.239 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -65.72 -43.67 93.77 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.101 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 25.3 m -69.69 -35.47 65.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.365 -0.491 . . . . 0.0 111.651 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.41 ' OE2' ' HA ' ' A' ' 96' ' ' LYS . 22.4 pt-20 -74.09 -33.76 63.75 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.952 0.406 . . . . 0.0 110.804 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 96' ' ' LYS . . . -75.74 -19.0 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.343 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.66 42.31 6.91 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.78 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -117.03 -37.85 3.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.788 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 8.6 m-85 -118.14 161.65 19.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.953 171.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -142.06 130.79 22.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.515 ' OE1' ' HA ' ' A' ' 109' ' ' PRO . 83.0 mt-30 -106.39 110.43 63.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 11.2 Cg_exo -71.39 -37.04 6.08 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.005 2.47 . . . . 0.0 112.754 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -86.73 -48.85 7.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.462 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.84 170.84 37.01 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.784 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.515 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 20.9 Cg_endo -61.65 -34.03 85.07 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.029 2.486 . . . . 0.0 112.561 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.5 43.8 1.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.08 -144.61 4.17 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.1 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -74.64 137.84 42.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.87 0.367 . . . . 0.0 111.523 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG13 HD22 ' A' ' 55' ' ' LEU . 11.4 t -108.27 158.71 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.644 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -139.79 140.93 36.78 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.62 HD23 HG12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -56.34 119.78 6.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.051 -178.361 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 121.256 0.55 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.587 ' HB2' HG22 ' A' ' 80' ' ' VAL . 69.3 mmtt -84.14 122.38 28.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.52 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 4.8 m -70.16 121.09 16.86 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -58.65 -33.64 70.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.913 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -54.95 -40.07 69.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.636 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 3.4 mm-40 -69.93 -52.35 25.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.349 0.595 . . . . 0.0 110.087 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.624 HD11 ' N ' ' A' ' 50' ' ' LEU . 2.5 mp -57.17 -49.02 77.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.71 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.589 HG12 ' HE1' ' A' ' 90' ' ' PHE . 82.9 mt -63.38 -52.64 55.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.972 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.516 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.2 mt -63.76 -44.99 98.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.59 -41.07 84.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.462 0.649 . . . . 0.0 109.898 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.623 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -71.28 -53.34 10.55 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.627 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.778 HD23 HG13 ' A' ' 113' ' ' VAL . 46.0 tp -54.07 -37.77 64.56 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.662 0.785 . . . . 0.0 111.916 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -74.9 -31.11 61.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 110.647 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 -53.5 10.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.274 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.662 HD12 HD22 ' A' ' 69' ' ' LEU . 1.2 pp -89.16 30.97 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.612 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -33.67 61.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.031 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 58' ' ' LEU . 90.5 mt-10 66.63 -48.82 0.45 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 111.932 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.59 -28.26 0.1 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.231 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 26.0 pttm -168.05 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.057 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 113' ' ' VAL . . . -160.38 159.9 31.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.085 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 58' ' ' LEU . 6.7 t -124.54 162.49 23.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.83 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.971 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.8 m -64.59 159.65 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.635 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 110' ' ' ALA . 99.4 mtt180 -53.99 -48.49 93.75 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.9 Cg_endo -51.24 -41.16 59.5 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.407 2.071 . . . . 0.0 112.614 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.27 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 110.699 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.662 HD22 HD12 ' A' ' 58' ' ' LEU . 40.1 mt -63.27 -47.27 83.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.698 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HG2' ' CD2' ' A' ' 90' ' ' PHE . 25.5 mtmm -61.41 -36.5 80.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.112 0.482 . . . . 0.0 110.574 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.633 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 37.1 tttm -65.23 -50.36 66.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.271 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -53.7 -44.33 69.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.072 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.524 HD11 ' HZ ' ' A' ' 86' ' ' PHE . 68.3 mt -66.13 -41.09 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 99.5 mttt -68.21 -31.81 71.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.3 mt-10 -70.28 -47.91 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 111.182 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -94.69 -35.29 12.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.403 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -122.43 73.01 39.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 122.384 -0.198 . . . . 0.0 110.704 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.49 -23.69 57.45 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 2.78 . . . . 0.0 112.937 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 79' ' ' ILE . 4.1 mp -52.11 -59.21 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.068 0.937 . . . . 0.0 110.679 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.587 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -86.99 -34.34 7.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.582 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 74' ' ' LYS . . . -53.94 -42.4 70.07 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.297 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.1 m -102.22 32.29 3.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.085 0.469 . . . . 0.0 110.831 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 80' ' ' VAL . . . -82.73 149.62 27.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 120.96 13.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.68 33.29 13.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.22 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HZ ' HD11 ' A' ' 73' ' ' ILE . 22.6 t80 -58.16 -46.23 86.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.19 0.519 . . . . 0.0 110.309 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.96 -45.25 78.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.706 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.89 -45.9 80.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -61.45 -41.47 97.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.589 ' HE1' HG12 ' A' ' 51' ' ' ILE . 90.4 t80 -59.7 -47.33 86.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -59.3 -42.15 90.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.364 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.52 -39.35 93.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.054 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.61 96.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 113' ' ' VAL . 47.8 mm -60.98 -46.64 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.621 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 86.3 mttt -57.77 -45.74 85.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.074 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.592 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 5.3 tppp? -67.18 -41.45 85.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.747 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.638 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -65.08 -42.59 96.54 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.129 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -66.96 -31.42 53.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.065 0.433 . . . . 0.0 111.672 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -81.13 -36.57 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.093 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' LYS . . . -68.3 -33.21 73.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.874 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.35 46.33 1.08 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.528 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -124.02 -33.29 3.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 0.0 109.972 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.638 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 2.5 m-85 -135.59 160.72 37.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HG3' ' HB1' ' A' ' 116' ' ' ALA . 78.1 mt-10 -126.94 143.38 51.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -108.42 110.17 61.63 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.802 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -69.07 -39.8 7.31 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.059 2.506 . . . . 0.0 112.765 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -84.03 -47.1 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.322 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.82 -165.89 29.26 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.235 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.06 131.19 44.44 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.226 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 60.07 25.38 14.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.555 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.35 -149.95 11.62 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.941 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.971 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -64.41 150.46 46.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.481 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.778 HG13 HD23 ' A' ' 55' ' ' LEU . 44.0 t -117.68 151.41 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -140.12 137.42 34.46 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.696 HD21 ' HG ' ' A' ' 55' ' ' LEU . 2.7 mm? -56.77 121.55 10.09 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.847 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.516 ' HB1' ' HG3' ' A' ' 104' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.743 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.134 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HB2' HG22 ' A' ' 80' ' ' VAL . 72.5 mmtt -75.54 127.6 33.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 26.8 t -70.74 116.94 11.63 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.531 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 19.0 m-85 -63.53 -33.9 76.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 54.3 ttt180 -55.27 -48.47 73.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.786 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 46' ' ' SER . 24.0 tp10 -68.41 -46.59 69.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 50' ' ' LEU . 1.3 mp -54.48 -48.66 71.56 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.261 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 81.0 mt -65.6 -46.75 88.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.661 ' HA ' HD22 ' A' ' 115' ' ' LEU . 36.7 mt -61.4 -50.18 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.595 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -55.07 -40.24 70.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.202 0.525 . . . . 0.0 110.539 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.68 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -76.91 -59.69 3.11 Favored Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.844 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.844 HD21 HD23 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -55.6 -34.56 64.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.841 -171.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 4.7 t -65.79 -28.81 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.55 -49.19 7.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.68 HD21 ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.59 14.4 19.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -60.8 -26.58 67.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 57.44 -106.87 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.059 0.456 . . . . 0.0 110.466 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.6 ptp85 -69.22 -35.12 75.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.788 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 14.2 ptpt -179.61 -40.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 167.0 26.9 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -135.19 144.68 47.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.289 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -66.2 160.55 24.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.16 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.504 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 67.3 mtm180 -54.4 -52.45 69.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.7 Cg_endo -55.34 -33.22 84.54 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.271 1.981 . . . . 0.0 112.501 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . . . -63.06 -43.99 97.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.593 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.844 HD23 HD21 ' A' ' 55' ' ' LEU . 30.7 mt -67.07 -47.14 72.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.393 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 9.2 mtmp? -61.32 -39.13 89.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 63.8 tttm -67.09 -49.53 64.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 109.844 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -51.09 -44.89 61.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.76 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.441 HG22 HD22 ' A' ' 50' ' ' LEU . 65.7 mt -64.44 -43.88 97.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.948 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 90.4 mttt -63.9 -34.41 77.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.619 0.247 . . . . 0.0 111.547 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.5 mm-40 -69.91 -41.86 74.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -100.28 -33.28 10.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.9 67.51 79.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.598 0.237 . . . . 0.0 110.819 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.83 -19.73 40.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.221 2.614 . . . . 0.0 112.973 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.427 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 4.0 mp -51.37 -57.18 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 122.252 1.025 . . . . 0.0 109.865 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -85.02 -35.78 10.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.916 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.11 -40.5 59.24 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -102.42 30.09 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 110.437 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.97 145.96 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.1 m -59.49 -37.13 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.132 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -116.13 32.7 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' HD1' ' HE2' ' A' ' 47' ' ' TYR . 34.9 t80 -56.01 -48.39 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.397 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.28 -44.24 97.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.34 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.01 -46.38 78.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -62.36 -40.14 95.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.207 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -59.38 -50.65 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -61.52 -38.58 87.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.549 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -67.14 -37.28 83.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.126 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.86 97.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.493 HG22 HG23 ' A' ' 113' ' ' VAL . 45.2 mm -58.85 -51.04 76.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -43.3 89.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.752 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.667 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -68.04 -44.36 76.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 109.735 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.725 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -60.88 -45.69 96.04 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.857 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.2 m -65.81 -33.59 64.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.897 0.348 . . . . 0.0 111.871 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 1.6 pp20? -77.68 -41.32 38.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 110.657 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.35 -42.84 74.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.735 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.96 40.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.407 ' HB2' ' CA ' ' A' ' 97' ' ' GLY . 87.8 m-20 -113.03 -41.71 3.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.725 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 2.0 m-85 -132.75 169.85 16.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.102 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HG3' ' HB1' ' A' ' 116' ' ' ALA . 32.0 mt-10 -134.8 146.3 49.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.53 83.64 34.77 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.48 42.08 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.656 2.238 . . . . 0.0 112.902 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -145.8 -48.34 0.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.382 . . . . 0.0 110.167 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.22 -145.71 14.51 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.748 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.38 125.42 13.93 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.753 2.302 . . . . 0.0 112.396 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 54.02 35.0 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.105 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.79 -148.71 11.45 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.373 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.45 135.23 34.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 94' ' ' ILE . 57.5 t -93.13 132.4 37.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 1.1 tmtp? -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -72.22 112.24 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.261 0.553 . . . . 0.0 111.372 -173.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.48 ' HB1' ' HG3' ' A' ' 104' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.854 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.234 0.237 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.912 ' HB2' HG22 ' A' ' 80' ' ' VAL . 75.3 mmtt -94.14 127.91 40.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.599 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -75.24 114.69 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.47 ' HA ' HD13 ' A' ' 50' ' ' LEU . 5.4 m-85 -62.59 -32.7 73.74 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -55.82 -46.31 78.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.978 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 46' ' ' SER . 10.9 pt-20 -72.46 -39.98 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.608 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 46' ' ' SER . 66.2 mt -60.46 -51.68 68.45 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.4 mt -65.12 -42.03 93.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.792 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.688 ' HA ' HD22 ' A' ' 115' ' ' LEU . 35.6 mt -64.32 -46.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.278 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.13 -36.74 71.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 110.119 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.529 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -77.15 -59.67 3.07 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.616 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -54.08 -30.37 48.0 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.086 0.555 . . . . 0.0 112.442 -171.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.572 HG21 ' N ' ' A' ' 57' ' ' ALA . 14.7 t -67.06 -33.06 74.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.142 0.496 . . . . 0.0 110.135 175.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.572 ' N ' HG21 ' A' ' 56' ' ' THR . . . -85.23 -44.8 12.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.012 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 68' ' ' ALA . 1.1 pt? -108.68 34.11 3.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.207 -173.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -23.47 63.84 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.258 -0.276 . . . . 0.0 110.656 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 69.01 -49.51 0.59 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.667 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -162.49 -38.2 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.387 178.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.667 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 60.2 pttt -179.86 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 110.751 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 135.31 2.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.699 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -119.05 151.85 37.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.017 0.437 . . . . 0.0 109.959 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -66.38 143.19 57.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.146 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.554 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 73.4 mtm180 -53.25 -50.01 84.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.652 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.5 Cg_endo -57.55 -30.06 87.14 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.196 1.931 . . . . 0.0 112.643 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 58' ' ' LEU . . . -65.74 -44.94 84.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.599 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.529 HD22 HD23 ' A' ' 58' ' ' LEU . 69.8 mt -63.38 -42.52 98.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.305 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 85.0 mttt -57.65 -42.48 83.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.318 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.594 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 65.8 tttp -65.34 -49.82 67.94 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.197 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CE1' ' HA3' ' A' ' 54' ' ' GLY . 55.2 t80 -51.71 -45.69 63.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 69' ' ' LEU . 76.0 mt -65.13 -43.1 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.2 mttt -61.8 -42.36 98.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.1 mm-40 -64.84 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.259 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.64 -42.38 8.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.042 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -120.67 79.78 31.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.464 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.09 -22.15 68.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 112.273 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.486 ' H ' HD11 ' A' ' 79' ' ' ILE . 4.7 mp -50.39 -61.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 122.04 0.924 . . . . 0.0 110.387 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.912 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.1 t -79.85 -32.12 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.142 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.424 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -56.26 -45.83 87.51 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.701 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.2 m -100.96 33.04 2.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.791 0.329 . . . . 0.0 110.793 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 80' ' ' VAL . . . -80.1 32.69 0.27 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m 64.08 -72.65 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.56 0.744 . . . . 0.0 112.409 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 38.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 0.0 110.545 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -43.86 98.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.802 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -44.74 91.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.021 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.62 -48.05 82.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.222 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -60.97 -42.11 97.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.155 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.409 ' HZ ' ' HB2' ' A' ' 69' ' ' LEU . 90.2 t80 -61.16 -49.62 76.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 74.6 m-20 -58.89 -42.97 90.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -65.77 -42.32 90.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.851 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.77 -42.76 89.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.737 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 29.4 mm -60.52 -53.74 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.688 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 91' ' ' ASN . 99.0 mttt -58.17 -46.54 85.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.55 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 18.3 tptm -65.78 -46.17 79.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.083 -175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -70.81 -34.03 66.2 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.063 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.737 ' HB ' ' O ' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -63.77 -34.7 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.57 0.7 . . . . 0.0 111.042 -178.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 20.8 pt-20 -86.55 -36.6 18.84 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.491 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.14 71.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.225 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.75 37.8 0.75 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.554 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.38 -34.12 5.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.68 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 4.2 m-85 -127.4 161.42 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.418 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.527 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 9.6 pt-20 -144.8 129.74 18.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.922 0.391 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.539 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 70.5 mt-30 -99.21 103.51 20.7 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -60.98 -32.38 92.33 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.115 2.543 . . . . 0.0 113.234 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.44 -47.87 10.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.798 0.332 . . . . 0.0 110.962 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.8 27.41 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.8 135.99 72.26 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.525 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.77 39.99 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.204 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.94 -143.75 5.88 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.03 135.6 33.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.539 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 2.5 p -114.0 141.23 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.116 0.484 . . . . 0.0 110.821 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.2 ttpp -122.53 152.73 40.07 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.688 HD22 ' HA ' ' A' ' 52' ' ' ILE . 16.2 mt -57.75 130.37 46.12 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.61 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 104' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.915 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.447 0.641 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -91.19 131.75 36.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 40.0 t -73.12 128.87 36.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.78 -18.76 62.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.825 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -58.73 -45.6 89.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HG3' ' HB3' ' A' ' 46' ' ' SER . 2.6 mt-10 -68.16 -50.71 52.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.227 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -56.77 -55.84 29.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.328 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 94' ' ' ILE . 67.8 mt -64.92 -54.44 29.62 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -176.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.599 HG13 ' HE1' ' A' ' 103' ' ' PHE . 90.4 mt -58.51 -41.42 81.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.7 -41.99 64.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.713 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -82.77 -53.52 3.52 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.127 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.633 ' HB2' HD23 ' A' ' 69' ' ' LEU . 34.7 tp -48.25 -37.39 16.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.387 0.675 . . . . 0.0 112.012 -172.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -72.0 -32.73 67.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.663 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.16 -42.32 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -97.09 12.1 33.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.871 -0.518 . . . . 0.0 111.834 -170.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -63.08 -27.54 69.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.702 0.286 . . . . 0.0 110.515 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 59.07 -111.76 0.57 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.908 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.51 -36.42 83.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.769 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -175.41 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' N ' ' HD3' ' A' ' 62' ' ' LYS . . . -154.3 145.6 12.99 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.896 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 p -95.11 -117.13 0.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -167.36 152.61 7.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 52.8 mtp180 -54.45 -54.47 48.12 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.947 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 19.1 Cg_endo -59.55 -34.36 96.84 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.073 1.848 . . . . 0.0 112.083 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.559 ' HB2' HD13 ' A' ' 58' ' ' LEU . . . -65.11 -43.31 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.866 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 55' ' ' LEU . 44.7 mt -61.17 -45.94 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.577 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 45.5 mtmt -59.74 -34.66 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.63 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 85.0 tttt -63.84 -53.53 49.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.897 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -54.93 -43.16 73.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.98 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 69' ' ' LEU . 56.7 mt -62.57 -46.49 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.233 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 85.5 mttt -66.12 -34.12 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 111.484 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.8 mm-40 -66.07 -42.34 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.133 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.56 -44.5 7.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -119.8 71.52 15.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.69 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.79 -9.48 24.8 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.612 2.208 . . . . 0.0 113.315 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.461 ' H ' HD13 ' A' ' 79' ' ' ILE . 4.3 mp -56.48 -58.49 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.054 0.93 . . . . 0.0 109.183 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -77.94 -30.74 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.735 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.445 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -57.03 -41.96 92.75 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.091 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.0 m -92.87 28.66 2.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.774 -0.251 . . . . 0.0 111.22 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 86' ' ' PHE . . . -80.01 131.64 35.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -61.05 -39.92 91.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -102.46 26.85 7.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.464 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.49 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 31.9 t80 -59.2 -45.06 92.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.635 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.71 -47.59 79.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.66 -47.75 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.12 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -61.01 -43.27 99.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.484 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.37 -50.35 73.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.33 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.61 -36.28 82.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -66.88 -42.03 86.25 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.401 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.477 HD12 HD11 ' A' ' 51' ' ' ILE . 35.9 mm -60.12 -48.91 86.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 63.6 mttp -61.91 -43.04 99.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.252 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.582 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 23.7 tptm -68.22 -38.63 82.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.804 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -63.78 -43.28 97.94 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.194 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 27.1 m -64.82 -36.72 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.12 0.46 . . . . 0.0 111.362 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 3.1 pt-20 -76.25 -41.89 47.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 96' ' ' LYS . . . -67.14 -28.87 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.244 -177.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.11 40.5 2.62 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.359 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.428 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 37.3 m-20 -113.0 -43.6 3.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.804 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 6.1 m-85 -128.49 165.59 20.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.652 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.479 ' HG3' ' HB1' ' A' ' 116' ' ' ALA . 16.5 mt-10 -141.8 142.25 33.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.011 0.524 . . . . 0.0 109.715 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -115.21 117.71 40.88 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.46 -41.55 25.57 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.932 2.421 . . . . 0.0 112.659 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -83.64 -60.48 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.048 0.451 . . . . 0.0 110.746 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.04 -153.16 23.38 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.47 133.68 58.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.84 2.36 . . . . 0.0 112.8 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.5 28.87 18.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.21 -158.81 23.16 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.105 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.56 148.75 47.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.605 0.24 . . . . 0.0 110.512 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 94' ' ' ILE . 34.2 t -117.78 152.97 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.887 0.375 . . . . 0.0 110.276 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.445 ' N ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -157.69 153.09 26.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.515 HD12 HG12 ' A' ' 52' ' ' ILE . 1.5 mm? -53.15 134.56 38.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.018 0.437 . . . . 0.0 111.861 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.479 ' HB1' ' HG3' ' A' ' 104' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.968 174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.871 ' HB2' HG22 ' A' ' 80' ' ' VAL . 71.8 mmtt -88.87 140.62 29.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.3 m -68.48 107.36 2.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 110.279 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.453 ' O ' HG13 ' A' ' 51' ' ' ILE . 19.7 m-85 -62.61 -36.25 82.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.3 ttm105 -54.86 -43.48 73.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.87 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.74 -49.63 67.7 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD11 ' N ' ' A' ' 50' ' ' LEU . 2.4 mp -55.32 -49.59 71.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.535 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.511 HG22 HD12 ' A' ' 69' ' ' LEU . 76.1 mt -66.33 -50.67 66.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.236 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.631 ' HA ' HD23 ' A' ' 115' ' ' LEU . 39.7 mt -61.25 -47.21 94.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.526 0.203 . . . . 0.0 111.304 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' O ' ' HB1' ' A' ' 57' ' ' ALA . 35.8 mm-40 -54.25 -42.41 69.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.675 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -73.53 -56.98 5.24 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.332 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 115' ' ' LEU . 4.8 tp -58.07 -30.28 66.09 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -75.96 -32.83 59.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 53' ' ' GLU . . . -86.76 -51.01 6.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.38 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.677 ' HG ' ' N ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -76.79 -53.71 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.006 -176.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.677 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 40.3 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.749 2.42 . . . . 0.0 117.057 175.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' LEU . 51.3 mt-10 64.16 -105.73 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.27 0.628 . . . . 0.0 109.414 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -77.87 -30.28 50.79 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.711 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.634 ' HZ1' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 167.65 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.134 178.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.405 ' HA3' HD12 ' A' ' 55' ' ' LEU . . . -142.1 150.87 22.43 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -133.57 156.3 48.07 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.868 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.8 t -62.68 157.17 21.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.548 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 82.9 mtm180 -48.87 -52.41 46.58 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.076 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 6.0 Cg_endo -49.63 -38.28 45.15 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 122.977 2.452 . . . . 0.0 112.979 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.85 90.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.983 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.511 HD12 HG22 ' A' ' 51' ' ' ILE . 58.7 mt -66.16 -44.25 84.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.887 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 57.1 mtpt -59.07 -35.38 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.828 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 45.3 tttm -68.79 -50.23 52.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.333 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.1 -43.87 64.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.554 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 50' ' ' LEU . 80.6 mt -62.87 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.963 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.5 mttt -61.19 -37.4 82.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 52.4 mt-10 -67.92 -42.4 81.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.964 0.411 . . . . 0.0 111.197 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.12 -40.54 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.94 76.2 58.0 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.592 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -18.99 52.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.412 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 3.7 mp -51.96 -67.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.829 0.823 . . . . 0.0 110.29 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.871 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -74.21 -35.78 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.02 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 74' ' ' LYS . . . -53.64 -42.29 66.93 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.935 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -102.66 27.75 6.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.952 0.406 . . . . 0.0 110.34 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.97 140.24 47.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -61.77 -38.74 89.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.453 0.644 . . . . 0.0 110.468 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -102.87 22.43 13.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.421 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.481 ' CD1' HG11 ' A' ' 80' ' ' VAL . 31.7 t80 -58.38 -45.49 88.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.201 0.524 . . . . 0.0 110.877 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.47 -42.57 98.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.208 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.2 -49.41 61.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.617 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -61.93 -43.42 98.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.057 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -58.47 -47.32 84.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.487 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -62.17 -43.2 99.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.473 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -64.08 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.877 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.62 98.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.641 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' A' ' 51' ' ' ILE . 30.9 mm -61.17 -53.22 52.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.02 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.577 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 57.2 mttm -53.81 -49.71 67.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.083 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -72.22 -30.88 65.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.618 ' HA2' ' CD1' ' A' ' 103' ' ' PHE . . . -75.67 -39.3 34.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.855 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.792 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 29.6 m -69.06 -37.69 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.904 0.352 . . . . 0.0 111.317 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.1 pt-20 -66.89 -39.18 87.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.925 0.393 . . . . 0.0 110.675 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.3 36.56 5.89 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.754 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -112.67 -23.12 10.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.792 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -135.28 153.78 51.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 169.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -142.23 123.21 14.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.722 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 54.8 mt-30 -96.27 107.79 37.62 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.851 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -62.94 -34.27 71.88 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.233 1.955 . . . . 0.0 111.522 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -86.5 33.3 0.63 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.46 -138.17 19.31 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.151 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -91.04 -28.52 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.992 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.97 52.13 2.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.79 -140.76 4.02 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.234 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.868 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -80.13 142.79 34.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.722 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 6.1 p -120.43 143.15 33.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.038 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.46 143.22 47.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 52' ' ' ILE . 10.7 mt -58.12 129.46 42.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.608 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.779 0 CA-C-O 121.464 0.65 . . . . 0.0 112.243 -176.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.87 0.367 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.821 ' HB2' HG22 ' A' ' 80' ' ' VAL . 34.4 mmtm -77.88 135.49 37.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.82 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 m -72.68 116.6 13.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.243 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.91 -31.52 72.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.71 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -58.22 -42.12 85.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.439 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.79 -53.95 18.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HB3' HD12 ' A' ' 73' ' ' ILE . 2.8 mp -53.71 -53.46 51.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.822 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 51' ' ' ILE . 63.5 mt -65.59 -50.64 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.315 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.537 HG12 HD12 ' A' ' 115' ' ' LEU . 51.7 mt -62.31 -42.64 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.79 -40.75 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 110.934 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -75.34 -59.38 3.6 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.467 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.747 HD23 HG13 ' A' ' 113' ' ' VAL . 19.1 tp -46.17 -37.96 7.68 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.927 0.891 . . . . 0.0 112.401 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -72.12 -31.99 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.94 -41.44 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.764 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.497 HD21 ' O ' ' A' ' 54' ' ' GLY . 1.5 pt? -107.4 20.11 19.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.449 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -66.59 -26.14 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.482 -0.136 . . . . 0.0 110.844 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 67.92 -46.16 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -151.62 -46.08 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.22 -0.3 . . . . 0.0 110.73 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.651 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 23.4 pttm -174.63 26.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.534 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.03 133.31 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.763 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -126.27 141.22 52.0 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.391 0.277 . . . . 0.0 110.293 178.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 m -62.56 137.11 58.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.763 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 39.2 mtp180 -53.8 -49.32 89.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.146 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HA ' ' HZ2' ' A' ' 70' ' ' LYS . 17.7 Cg_endo -56.41 -34.27 94.04 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.977 1.785 . . . . 0.0 112.523 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.49 ' HB2' HD13 ' A' ' 58' ' ' LEU . . . -62.23 -45.05 95.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 55' ' ' LEU . 5.2 mp -60.59 -40.44 91.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HZ2' ' HA ' ' A' ' 67' ' ' PRO . 28.2 mtmm -61.11 -35.72 77.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.501 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.603 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 59.3 tttp -65.09 -50.3 66.68 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.913 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.22 -44.04 64.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.948 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.631 HD11 ' HZ ' ' A' ' 86' ' ' PHE . 73.1 mt -65.19 -42.8 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.824 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.1 mttt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 111.489 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.4 mm-40 -63.48 -41.8 98.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.19 -43.46 8.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.197 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -120.36 81.58 30.53 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.499 0.19 . . . . 0.0 110.882 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.01 -23.39 77.36 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.659 2.239 . . . . 0.0 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.459 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 3.5 mp -53.62 -63.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.868 0.842 . . . . 0.0 110.4 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -77.23 -33.26 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.689 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -41.52 61.62 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.551 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -104.53 30.62 5.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.766 0.317 . . . . 0.0 110.856 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 80' ' ' VAL . . . -82.71 48.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.6 t 55.79 -103.39 0.18 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.303 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -81.05 39.64 0.51 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.245 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 73' ' ' ILE . 10.8 t80 -58.57 -40.16 82.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.21 -45.02 88.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.555 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.33 -44.93 95.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.196 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -61.89 -43.3 99.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.795 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HE1' HG12 ' A' ' 51' ' ' ILE . 86.2 t80 -60.5 -50.32 74.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.075 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -59.3 -43.32 92.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.345 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -64.41 -40.72 96.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.807 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.78 93.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.15 -48.82 85.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.512 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 60.2 mtpt -58.61 -49.2 78.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.027 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 17.0 tptm -66.45 -39.71 89.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.805 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -67.67 -43.67 84.21 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.398 -175.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -64.71 -39.03 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.996 0.398 . . . . 0.0 111.687 -175.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.5 pt-20 -72.0 -40.99 68.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.55 83.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.183 0.516 . . . . 0.0 111.048 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.2 40.34 0.59 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.703 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 -37.83 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.676 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 7.6 m-85 -129.03 160.09 33.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.916 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -126.69 144.68 50.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.634 HE21 HG12 ' A' ' 98' ' ' VAL . 54.7 mt-30 -128.16 105.67 19.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.918 0.389 . . . . 0.0 111.144 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 90.5 Cg_endo -78.61 39.67 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.151 2.567 . . . . 0.0 112.708 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -148.39 -56.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.761 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.85 -144.43 7.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.88 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.14 -38.31 2.85 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.735 2.29 . . . . 0.0 113.494 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.472 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -127.74 40.81 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.59 -145.11 18.43 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.969 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.599 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -84.93 141.19 30.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.747 HG13 HD23 ' A' ' 55' ' ' LEU . 14.5 t -104.42 154.12 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.789 0.328 . . . . 0.0 110.502 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.651 ' HD2' ' HA ' ' A' ' 62' ' ' LYS . 78.0 tttt -148.58 144.54 27.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD12 HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -52.47 133.14 35.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.56 -178.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.498 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HB2' HG22 ' A' ' 80' ' ' VAL . 71.2 mmtt -88.17 120.76 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 m -67.55 121.9 16.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.118 0.485 . . . . 0.0 110.051 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -63.23 -23.59 67.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.188 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.61 -38.0 80.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.716 0.293 . . . . 0.0 110.735 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 46' ' ' SER . 4.2 mt-10 -72.18 -50.6 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mp -54.0 -52.46 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.623 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.491 HG21 ' CD2' ' A' ' 69' ' ' LEU . 69.1 mt -64.09 -53.01 48.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.293 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.499 HG13 ' HE1' ' A' ' 103' ' ' PHE . 60.4 mt -61.89 -44.62 99.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.738 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -54.52 -44.36 72.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.516 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.72 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -69.54 -63.38 3.4 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.2 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.852 HD22 HD12 ' A' ' 115' ' ' LEU . 15.0 tp -40.72 -44.83 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.444 1.097 . . . . 0.0 112.757 -175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.537 ' HA ' HD22 ' A' ' 115' ' ' LEU . 4.6 t -73.03 -26.38 61.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.512 0.672 . . . . 0.0 110.922 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 56' ' ' THR . . . -88.01 -39.62 14.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.644 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 54' ' ' GLY . 1.2 pt? -113.8 20.98 15.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.959 -0.463 . . . . 0.0 111.934 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 46.2 pttt -61.17 -31.57 71.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.737 0.304 . . . . 0.0 111.266 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 56.51 -102.63 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.113 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -65.8 -34.29 77.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.363 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.543 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 9.6 ptpp? 173.76 -37.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.821 0.448 . . . . 0.0 110.079 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.95 26.29 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.711 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -124.01 141.6 51.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.726 0.298 . . . . 0.0 111.348 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 5.7 m -63.74 148.3 49.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.372 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.8 -50.9 58.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.0 Cg_endo -50.84 -33.18 40.18 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.76 2.307 . . . . 0.0 112.865 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.433 ' CB ' HD13 ' A' ' 58' ' ' LEU . . . -65.05 -48.22 74.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.948 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.491 ' CD2' HG21 ' A' ' 51' ' ' ILE . 6.6 mp -65.56 -38.6 90.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.844 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 92.6 mttt -57.78 -39.96 78.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.58 -51.39 62.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.172 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -52.76 -44.22 66.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.847 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 69' ' ' LEU . 81.5 mt -67.56 -45.87 84.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.459 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.1 mttt -58.7 -43.32 90.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.86 0.362 . . . . 0.0 111.221 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.4 -39.68 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.818 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -94.45 -36.35 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -125.68 72.98 68.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 -23.36 42.93 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.959 2.439 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.438 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 3.1 mp -53.34 -68.06 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.542 0.687 . . . . 0.0 110.598 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -70.9 -35.41 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.88 177.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -42.14 62.58 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.8 m -107.16 38.95 1.98 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.791 0.329 . . . . 0.0 110.844 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 80' ' ' VAL . . . -82.58 13.61 3.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.82 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t 70.8 -58.91 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.808 0.843 . . . . 0.0 111.806 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -96.73 23.88 6.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -56.36 -44.88 80.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.681 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.24 -40.59 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.57 -48.7 76.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.173 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.213 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.424 ' CE1' HG12 ' A' ' 51' ' ' ILE . 82.5 t80 -62.06 -48.52 79.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.785 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -61.74 -41.6 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -60.58 -42.04 95.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.787 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.551 HG22 HG23 ' A' ' 113' ' ' VAL . 40.5 mm -60.53 -53.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' O ' HG21 ' A' ' 98' ' ' VAL . 95.4 mttt -63.62 -45.01 92.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.696 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -67.71 -38.51 83.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.145 0.498 . . . . 0.0 110.149 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.602 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -66.43 -43.49 92.41 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.17 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 26.8 m -66.34 -37.89 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.101 0.451 . . . . 0.0 111.602 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.82 -42.62 66.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.553 0.216 . . . . 0.0 110.908 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.51 93.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.98 35.88 1.09 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.31 -36.11 5.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.9 m-85 -130.64 162.09 30.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.832 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -135.49 149.01 49.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.524 ' HG3' HG12 ' A' ' 98' ' ' VAL . 47.4 mt-30 -124.69 113.34 27.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.974 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 61.4 Cg_endo -76.81 -33.83 2.7 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.954 2.436 . . . . 0.0 113.031 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.734 ' HD2' ' HB1' ' A' ' 112' ' ' ALA . 68.1 mttm -82.88 -46.62 12.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.173 -175.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.02 -174.02 45.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.729 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.51 -29.33 89.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.273 2.648 . . . . 0.0 112.639 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . -135.39 39.81 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 110.105 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.36 -56.59 0.87 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.866 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 107' ' ' LYS . . . -173.57 143.03 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.617 0.367 . . . . 0.0 110.131 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.602 HG13 HD23 ' A' ' 55' ' ' LEU . 21.4 t -99.48 150.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 0.0 110.988 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -143.31 141.54 31.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.852 HD12 HD22 ' A' ' 55' ' ' LEU . 2.7 mm? -52.84 131.02 34.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.124 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.56 174.205 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.1 pttm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.84 0.352 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -151.35 -51.39 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -66.8 147.75 52.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.291 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 41.9 0.72 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.933 0.397 . . . . 0.0 110.942 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.9 p -170.73 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.201 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t 57.15 35.91 26.85 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.082 0.553 . . . . 0.0 111.374 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.855 ' HB2' HG22 ' A' ' 80' ' ' VAL . 72.1 mmtt -98.33 126.94 44.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.429 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 40.4 t -71.84 124.58 25.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' O ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -64.42 -26.11 68.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.289 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.07 -43.47 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.355 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 3.1 mm-40 -73.08 -46.07 53.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.337 0.589 . . . . 0.0 110.28 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.623 HD11 ' N ' ' A' ' 50' ' ' LEU . 1.4 mp -61.35 -49.85 75.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.434 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 94' ' ' ILE . 70.7 mt -62.91 -51.36 72.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.71 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.788 HG13 ' HE1' ' A' ' 103' ' ' PHE . 47.6 mt -60.14 -43.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -50.8 -43.98 58.9 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.412 0.445 . . . . 0.0 110.485 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.64 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -80.8 -55.88 3.24 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.547 176.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.743 HD22 HD21 ' A' ' 115' ' ' LEU . 24.2 tp -51.29 -31.08 20.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.326 0.651 . . . . 0.0 111.953 -171.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -75.89 -31.04 59.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.19 -51.19 5.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.64 HD21 ' O ' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -89.31 21.42 3.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.139 0.495 . . . . 0.0 111.007 -173.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.688 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -59.75 -32.09 70.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.992 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 56.2 -109.36 0.49 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.673 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 16.2 ptm180 -65.86 -34.78 78.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.189 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.719 ' O ' ' HD3' ' A' ' 114' ' ' LYS . 21.0 ptmt -175.2 -48.2 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.062 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.2 29.78 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -141.41 152.64 44.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 7.7 t -66.42 159.99 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.724 -174.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.549 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -50.29 -50.14 72.38 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.6 Cg_endo -50.85 -38.98 58.73 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.599 2.199 . . . . 0.0 112.84 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.43 81.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.756 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.407 HD13 HD11 ' A' ' 55' ' ' LEU . 18.1 mt -63.6 -41.64 98.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.244 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 94.9 mttt -60.1 -38.78 83.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 88.1 tttt -68.29 -47.69 66.95 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.121 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -50.7 -47.06 59.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.752 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 50' ' ' LEU . 67.3 mt -67.63 -40.56 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.071 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 97.3 mttt -63.31 -40.11 96.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.634 0.254 . . . . 0.0 111.664 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 4.8 mm-40 -73.59 -39.45 64.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.317 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -93.96 -41.44 9.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.417 ' CD2' HD13 ' A' ' 50' ' ' LEU . 14.6 m-85 -119.87 73.51 18.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.13 -23.68 54.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.994 2.463 . . . . 0.0 113.585 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.46 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 4.1 mp -50.06 -56.42 3.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.857 0.837 . . . . 0.0 110.456 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.855 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -91.55 -32.37 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 74' ' ' LYS . . . -55.31 -41.43 79.61 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.348 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -100.92 33.2 2.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.227 0.537 . . . . 0.0 109.994 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 80' ' ' VAL . . . -88.32 145.49 25.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.078 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m -65.13 125.19 24.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.33 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m120 65.44 29.88 11.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.61 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.98 -43.42 98.85 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.321 0.581 . . . . 0.0 110.07 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -54.01 -42.35 68.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.05 -49.17 38.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -56.51 -37.81 70.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.597 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.498 ' CE1' HG12 ' A' ' 51' ' ' ILE . 69.6 t80 -58.65 -41.29 85.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.181 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -61.09 -45.54 94.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -64.09 -36.16 83.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.639 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.95 99.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 51' ' ' ILE . 42.6 mm -60.73 -47.62 92.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.268 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 97.3 mttt -59.72 -42.49 93.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.963 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 tmtp? -65.61 -39.66 91.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.242 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.793 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -69.56 -40.82 77.67 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.106 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.6 m -70.26 -36.81 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.022 0.411 . . . . 0.0 111.29 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 1.5 pt-20 -67.85 -35.64 78.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.928 0.394 . . . . 0.0 110.361 175.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.874 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.84 41.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.964 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -113.38 -32.47 6.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.793 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 8.4 m-85 -121.41 158.41 28.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.161 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.59 143.6 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.431 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 67.8 mt-30 -111.5 104.2 55.86 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-O 120.971 0.415 . . . . 0.0 111.034 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 21.0 Cg_endo -62.03 -35.28 77.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.229 2.619 . . . . 0.0 112.512 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -96.04 28.99 2.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.288 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.804 ' HA3' ' HA ' ' A' ' 126' ' ' GLU . . . 74.93 174.82 34.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.915 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.452 ' HG3' HG23 ' A' ' 129' ' ' VAL . 21.8 Cg_exo -63.51 140.27 74.77 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.706 2.271 . . . . 0.0 111.442 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 68.09 41.34 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.6 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.47 -138.64 3.9 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.658 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.85 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -85.94 134.95 33.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.694 HG13 HD23 ' A' ' 55' ' ' LEU . 39.7 t -97.99 154.0 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.719 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 44.1 tptt -144.47 133.12 22.24 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.743 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -55.35 118.8 4.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.54 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.37 129.28 34.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.206 0.527 . . . . 0.0 110.933 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.732 ' HE3' HD11 ' A' ' 115' ' ' LEU . 35.3 mmtp -131.53 -40.72 1.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.522 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.878 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.12 58.6 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -70.37 156.97 91.07 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.442 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.23 -178.61 1.47 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.583 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 63.05 37.7 11.45 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.661 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 t -132.9 55.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.126 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -111.74 44.7 1.33 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.563 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -130.2 24.62 5.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.448 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.804 ' HA ' ' HA3' ' A' ' 108' ' ' GLY . 24.3 pt-20 -100.5 -4.56 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.451 -175.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt 68.34 -74.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.223 0.609 . . . . 0.0 111.655 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -158.13 54.29 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.678 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 126' ' ' GLU . 29.9 t -82.12 58.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.441 0.639 . . . . 0.0 109.743 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.169 -176.342 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 57.79 -136.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.567 0.542 . . . . 0.0 110.898 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.84 142.96 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 44' ' ' SER . . . -76.26 -146.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.833 0.349 . . . . 0.0 110.506 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 45' ' ' LYS . 15.0 m -79.53 28.65 0.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.783 0.325 . . . . 0.0 110.981 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 42' ' ' ALA . 1.8 m -77.33 38.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.134 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.648 ' HB2' HG22 ' A' ' 80' ' ' VAL . 30.6 mmtm -91.49 147.0 23.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.437 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 15.3 t -70.21 -17.16 63.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.826 0.346 . . . . 0.0 111.368 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 20.9 m-85 71.49 -44.35 0.59 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.191 -175.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.524 ' HG3' HD13 ' A' ' 52' ' ' ILE . 4.7 ttm105 -54.51 -45.55 73.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.057 0.456 . . . . 0.0 110.58 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 13.6 pt-20 -59.73 -46.01 90.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.13 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mp -62.75 -52.52 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.664 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.95 -52.14 63.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.535 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.612 HD12 ' OD2' ' A' ' 102' ' ' ASP . 74.7 mt -63.45 -41.29 92.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.57 -37.47 70.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.17 -58.62 3.12 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.421 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD22 HG13 ' A' ' 113' ' ' VAL . 32.1 tp -49.71 -32.65 13.95 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.454 0.702 . . . . 0.0 112.381 -172.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.534 HG21 ' N ' ' A' ' 57' ' ' ALA . 7.2 t -73.75 -31.75 63.49 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 110.773 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' N ' HG21 ' A' ' 56' ' ' THR . . . -88.05 -50.27 6.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HG ' ' OG ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -92.2 17.39 9.7 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.825 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 64' ' ' SER . 17.2 pttp -68.43 -29.04 67.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 58.76 -113.35 0.68 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.738 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.2 ptp85 -67.34 -27.48 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.584 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 59.3 pttt -173.29 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 114' ' ' LYS . . . -150.83 158.38 27.65 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 119.714 -1.232 . . . . 0.0 114.004 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HG ' ' HA ' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -106.25 144.06 33.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.403 . . . . 0.0 111.169 -177.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -64.19 141.93 58.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.541 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.3 mtp-105 -55.43 -49.59 91.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.1 Cg_endo -58.32 -29.02 86.72 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.944 1.763 . . . . 0.0 112.107 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.02 83.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.42 HD23 ' HB2' ' A' ' 55' ' ' LEU . 39.3 mt -62.58 -43.82 97.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.408 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 98.4 mttt -57.15 -40.69 77.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.703 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 53.4 tttp -67.97 -47.34 68.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.564 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.16 -46.02 65.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.374 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 53.4 mt -63.65 -44.28 98.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.992 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.2 mttt -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 67.2 mm-40 -69.68 -39.51 76.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.365 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -94.29 -41.45 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -123.16 77.16 51.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.618 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.03 -17.6 45.85 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.398 . . . . 0.0 112.824 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.52 ' H ' HD11 ' A' ' 79' ' ' ILE . 2.8 mp -55.71 -64.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 122.049 0.928 . . . . 0.0 110.016 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -76.16 -33.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.206 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 74' ' ' LYS . . . -51.55 -42.35 51.19 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.679 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -101.67 31.12 3.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 80' ' ' VAL . . . -74.87 148.68 39.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.711 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -47.63 80.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -113.39 34.85 4.27 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.419 ' CD1' HG11 ' A' ' 80' ' ' VAL . 46.4 t80 -54.71 -46.17 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.591 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -58.46 -47.45 83.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.836 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.58 -48.33 75.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -58.97 -45.05 91.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.245 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.419 ' O ' HG12 ' A' ' 94' ' ' ILE . 90.5 t80 -56.77 -47.11 80.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -62.13 -44.1 97.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.736 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.613 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 78.6 m-20 -66.01 -38.81 89.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.751 0.31 . . . . 0.0 110.769 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.94 88.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.383 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 113' ' ' VAL . 36.5 mm -61.73 -51.69 69.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.991 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.613 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -62.29 -41.07 98.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -173.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 46.6 tptt -71.73 -34.59 69.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.74 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -67.73 -40.37 90.02 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 95' ' ' LYS . 17.2 m -65.2 -42.13 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.166 0.483 . . . . 0.0 111.246 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -67.81 -41.25 83.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.87 -28.37 68.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.626 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.63 4.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.55 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.612 ' OD2' HD12 ' A' ' 52' ' ' ILE . 35.2 t70 -113.83 -41.99 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.027 -0.586 . . . . 0.0 109.495 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.74 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 21.1 m-85 -114.44 171.82 7.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.957 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.603 ' HB3' ' HD3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -153.47 136.33 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 80.7 mt-30 -122.39 105.84 36.03 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.602 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 25.5 Cg_endo -62.14 -36.05 71.81 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.896 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HB2' ' HA2' ' A' ' 111' ' ' GLY . 98.9 mttt -91.76 16.37 10.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.15 -146.59 49.28 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.955 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.71 133.88 57.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.15 2.567 . . . . 0.0 112.482 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.76 30.7 18.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.108 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 107' ' ' LYS . . . -114.89 160.1 13.38 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.566 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.602 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -55.12 130.83 43.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.534 HG23 HG22 ' A' ' 94' ' ' ILE . 17.7 t -90.17 155.66 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.486 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.603 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -152.16 136.8 16.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.687 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.446 HD21 ' CG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -51.15 127.32 18.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.801 -174.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.13 127.76 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.666 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 43.7 tptt -76.16 92.63 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.884 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.9 pttm 62.23 170.63 0.13 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.513 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -60.24 -53.47 57.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -172.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.598 ' OG ' ' HE2' ' A' ' 118' ' ' LYS . 33.7 p -73.28 135.85 79.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.185 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HB3' HG22 ' A' ' 129' ' ' VAL . 1.7 Cg_endo -47.0 134.34 18.25 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.729 2.953 . . . . 0.0 113.892 -174.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -149.47 49.56 0.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.476 177.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.485 HG11 ' H ' ' A' ' 125' ' ' LYS . 32.8 t -93.98 133.39 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.064 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.619 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 2.7 mptp? -72.17 -32.67 67.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.06 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.485 ' H ' HG11 ' A' ' 123' ' ' VAL . 64.7 tttp -72.38 151.74 42.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.368 171.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.84 53.87 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.476 ' C ' ' H ' ' A' ' 129' ' ' VAL . 51.2 tptt -73.78 -48.96 27.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.225 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 75.37 -35.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.11 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 121' ' ' PRO . 99.1 t 74.82 -50.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 111.328 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.545 -0.74 . . . . 0.0 110.842 175.15 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.93 0.395 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 60.8 58.2 2.44 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.567 0.699 . . . . 0.0 109.367 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.82 144.58 54.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.929 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.19 27.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 p -156.9 -7.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.708 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -80.0 55.26 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.813 ' HB2' HG22 ' A' ' 80' ' ' VAL . 71.5 mmtt -83.16 138.23 33.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 48.2 m -72.41 115.74 12.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' O ' HG13 ' A' ' 51' ' ' ILE . 8.1 m-85 -62.29 -30.45 71.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.544 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -52.5 -48.55 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.988 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 19.2 mm-40 -62.53 -46.65 87.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.173 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD11 ' N ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -60.06 -48.53 81.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.834 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.688 HG12 ' HE1' ' A' ' 90' ' ' PHE . 68.7 mt -64.29 -53.85 38.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.06 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.757 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.9 mt -60.44 -45.52 96.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.48 -39.2 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 110.504 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.42 -59.88 2.46 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.451 175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.599 HD21 HD21 ' A' ' 115' ' ' LEU . 18.3 tp -46.04 -36.06 5.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.185 0.994 . . . . 0.0 112.543 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -68.78 -34.21 75.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.122 0.486 . . . . 0.0 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.55 -53.44 4.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.602 ' O ' ' HB3' ' A' ' 64' ' ' SER . 1.7 pt? -91.52 20.34 5.45 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.923 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -60.43 -19.89 57.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.683 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 43.9 mt-10 63.29 -115.13 0.46 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.982 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -73.06 -48.2 38.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.688 0.28 . . . . 0.0 111.142 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -179.18 27.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.233 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.48 125.94 0.88 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.583 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.602 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 2.3 p -113.22 133.46 55.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.7 m -57.92 135.65 56.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.936 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.577 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 35.5 ptt180 -53.92 -41.11 86.3 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 21.5 Cg_endo -57.94 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.672 1.582 . . . . 0.0 112.703 177.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.24 88.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.514 ' HG ' HD23 ' A' ' 58' ' ' LEU . 6.7 mp -59.42 -33.43 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.434 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 8.6 mtmm -56.97 -38.49 73.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.2 tttp -67.1 -52.35 42.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.099 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.42 -43.47 64.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.817 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.462 HG12 ' HB3' ' A' ' 50' ' ' LEU . 79.7 mt -65.87 -46.8 87.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.164 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.3 mttt -60.48 -43.38 97.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 111.437 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.2 mt-10 -66.46 -36.68 83.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -93.96 -33.72 13.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.823 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -130.24 76.04 78.38 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.525 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.48 -21.29 37.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.036 2.491 . . . . 0.0 112.469 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.537 ' H ' HD11 ' A' ' 79' ' ' ILE . 4.7 mp -52.37 -68.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.721 0.772 . . . . 0.0 110.52 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -73.23 -30.51 31.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.223 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -34.46 36.68 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.82 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -114.94 42.31 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.208 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.08 15.25 1.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.775 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m 69.75 -62.35 0.42 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.832 0.853 . . . . 0.0 112.468 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -98.4 29.56 3.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.035 0.445 . . . . 0.0 110.127 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.47 -46.18 80.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.472 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.24 -42.15 99.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.744 0.307 . . . . 0.0 110.847 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.95 -48.54 65.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.344 0.593 . . . . 0.0 110.166 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -61.09 -41.01 95.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.688 ' HE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -59.34 -43.85 92.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.26 -43.74 98.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -64.48 -38.23 90.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.876 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.402 ' HB3' HD13 ' A' ' 51' ' ' ILE . . . -62.21 -41.86 98.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.788 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 90' ' ' PHE . 46.4 mm -59.85 -48.99 85.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.273 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HZ2' ' HB3' ' A' ' 95' ' ' LYS . 9.9 mtpm? -57.33 -48.18 79.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.224 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 13.3 tmtt? -62.92 -41.08 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.239 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.788 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -65.72 -43.67 93.77 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.101 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 25.3 m -69.69 -35.47 65.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.365 -0.491 . . . . 0.0 111.651 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.41 ' OE2' ' HA ' ' A' ' 96' ' ' LYS . 22.4 pt-20 -74.09 -33.76 63.75 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.952 0.406 . . . . 0.0 110.804 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 96' ' ' LYS . . . -75.74 -19.0 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.343 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.66 42.31 6.91 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.78 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -117.03 -37.85 3.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.788 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 8.6 m-85 -118.14 161.65 19.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.953 171.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.466 ' CD ' ' HB ' ' A' ' 123' ' ' VAL . 26.3 pt-20 -142.06 130.79 22.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.515 ' OE1' ' HA ' ' A' ' 109' ' ' PRO . 83.0 mt-30 -106.39 110.43 63.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 11.2 Cg_exo -71.39 -37.04 6.08 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.005 2.47 . . . . 0.0 112.754 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -86.73 -48.85 7.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.462 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.84 170.84 37.01 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.784 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.515 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 20.9 Cg_endo -61.65 -34.03 85.07 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.029 2.486 . . . . 0.0 112.561 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.5 43.8 1.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.08 -144.61 4.17 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.1 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -74.64 137.84 42.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.87 0.367 . . . . 0.0 111.523 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG13 HD22 ' A' ' 55' ' ' LEU . 11.4 t -108.27 158.71 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.644 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -139.79 140.93 36.78 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.62 HD23 HG12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -56.34 119.78 6.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.99 134.28 38.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.051 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 123.01 19.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -68.17 -37.4 80.95 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.9 mptt -83.75 79.0 9.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.711 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 66.3 m 72.04 120.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 123.911 0.757 . . . . 0.0 112.309 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 130' ' ' SER . 23.6 Cg_exo -65.88 158.4 54.14 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.838 3.025 . . . . 0.0 112.555 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -151.61 42.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.721 0.772 . . . . 0.0 110.044 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.466 ' HB ' ' CD ' ' A' ' 104' ' ' GLU . 7.5 p -94.84 135.25 29.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.909 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 58.9 pttt 40.04 66.86 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.549 0.74 . . . . 0.0 111.993 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -70.67 51.32 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.536 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.641 ' HG3' ' HG2' ' A' ' 127' ' ' LYS . 22.3 pt-20 -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.354 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.641 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 21.0 pttm -163.46 -142.95 0.07 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.07 123.18 19.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 110.584 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.5 p -165.96 47.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 122.538 1.161 . . . . 0.0 109.512 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.465 ' HA ' ' HD2' ' A' ' 121' ' ' PRO . 48.1 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.23 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.049 0.452 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -78.69 60.32 2.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.413 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -132.53 153.05 51.33 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 134.15 53.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.851 0.357 . . . . 0.0 111.299 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.504 ' HB2' HG21 ' A' ' 80' ' ' VAL . 72.8 p 52.71 50.24 18.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.747 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -85.66 20.72 2.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 110.436 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.587 ' HB2' HG22 ' A' ' 80' ' ' VAL . 69.3 mmtt -84.14 122.38 28.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.52 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 4.8 m -70.16 121.09 16.86 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -58.65 -33.64 70.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.913 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -54.95 -40.07 69.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.636 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.52 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 3.4 mm-40 -69.93 -52.35 25.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.349 0.595 . . . . 0.0 110.087 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.624 HD11 ' N ' ' A' ' 50' ' ' LEU . 2.5 mp -57.17 -49.02 77.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.71 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.589 HG12 ' HE1' ' A' ' 90' ' ' PHE . 82.9 mt -63.38 -52.64 55.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.972 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.516 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.2 mt -63.76 -44.99 98.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.59 -41.07 84.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.462 0.649 . . . . 0.0 109.898 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.623 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -71.28 -53.34 10.55 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.627 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.778 HD23 HG13 ' A' ' 113' ' ' VAL . 46.0 tp -54.07 -37.77 64.56 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.662 0.785 . . . . 0.0 111.916 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -74.9 -31.11 61.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 110.647 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 -53.5 10.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.274 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.662 HD12 HD22 ' A' ' 69' ' ' LEU . 1.2 pp -89.16 30.97 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.612 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -33.67 61.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.031 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' A' ' 58' ' ' LEU . 90.5 mt-10 66.63 -48.82 0.45 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 111.932 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.59 -28.26 0.1 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.231 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 26.0 pttm -168.05 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.057 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 113' ' ' VAL . . . -160.38 159.9 31.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.085 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 58' ' ' LEU . 6.7 t -124.54 162.49 23.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.83 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.971 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.8 m -64.59 159.65 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.635 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 110' ' ' ALA . 99.4 mtt180 -53.99 -48.49 93.75 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.9 Cg_endo -51.24 -41.16 59.5 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.407 2.071 . . . . 0.0 112.614 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.27 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 110.699 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.662 HD22 HD12 ' A' ' 58' ' ' LEU . 40.1 mt -63.27 -47.27 83.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.698 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' HG2' ' CD2' ' A' ' 90' ' ' PHE . 25.5 mtmm -61.41 -36.5 80.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.112 0.482 . . . . 0.0 110.574 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.633 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 37.1 tttm -65.23 -50.36 66.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.271 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -53.7 -44.33 69.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.072 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.524 HD11 ' HZ ' ' A' ' 86' ' ' PHE . 68.3 mt -66.13 -41.09 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 99.5 mttt -68.21 -31.81 71.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.3 mt-10 -70.28 -47.91 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 111.182 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -94.69 -35.29 12.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.403 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -122.43 73.01 39.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 122.384 -0.198 . . . . 0.0 110.704 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.49 -23.69 57.45 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 2.78 . . . . 0.0 112.937 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 79' ' ' ILE . 4.1 mp -52.11 -59.21 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.068 0.937 . . . . 0.0 110.679 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.587 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -86.99 -34.34 7.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.582 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 74' ' ' LYS . . . -53.94 -42.4 70.07 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.297 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.1 m -102.22 32.29 3.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.085 0.469 . . . . 0.0 110.831 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 80' ' ' VAL . . . -82.73 149.62 27.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 120.96 13.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.68 33.29 13.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.22 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.524 ' HZ ' HD11 ' A' ' 73' ' ' ILE . 22.6 t80 -58.16 -46.23 86.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.19 0.519 . . . . 0.0 110.309 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.96 -45.25 78.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.706 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.89 -45.9 80.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -61.45 -41.47 97.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.589 ' HE1' HG12 ' A' ' 51' ' ' ILE . 90.4 t80 -59.7 -47.33 86.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -59.3 -42.15 90.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.364 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.52 -39.35 93.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.054 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.61 96.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 113' ' ' VAL . 47.8 mm -60.98 -46.64 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.621 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 86.3 mttt -57.77 -45.74 85.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.074 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.592 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 5.3 tppp? -67.18 -41.45 85.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.747 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.638 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -65.08 -42.59 96.54 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.129 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -66.96 -31.42 53.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.065 0.433 . . . . 0.0 111.672 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -81.13 -36.57 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.093 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 96' ' ' LYS . . . -68.3 -33.21 73.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.874 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.35 46.33 1.08 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.528 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -124.02 -33.29 3.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 0.0 109.972 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.638 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 2.5 m-85 -135.59 160.72 37.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' HG3' ' HB1' ' A' ' 116' ' ' ALA . 78.1 mt-10 -126.94 143.38 51.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -108.42 110.17 61.63 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.802 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.723 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . 19.2 Cg_exo -69.07 -39.8 7.31 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.059 2.506 . . . . 0.0 112.765 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -84.03 -47.1 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.322 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.82 -165.89 29.26 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.235 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.06 131.19 44.44 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.226 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 60.07 25.38 14.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.555 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.35 -149.95 11.62 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.941 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.971 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -64.41 150.46 46.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.481 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.778 HG13 HD23 ' A' ' 55' ' ' LEU . 44.0 t -117.68 151.41 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -140.12 137.42 34.46 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.696 HD21 ' HG ' ' A' ' 55' ' ' LEU . 2.7 mm? -56.77 121.55 10.09 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.847 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.516 ' HB1' ' HG3' ' A' ' 104' ' ' GLU . . . -90.03 122.0 32.62 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.134 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -83.38 -28.84 28.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.746 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HD3' ' HB3' ' A' ' 122' ' ' GLU . 17.8 ptpt -71.79 134.83 46.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.533 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.03 41.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 72.8 m -161.85 149.26 11.72 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.951 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.47 126.27 18.81 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.209 1.939 . . . . 0.0 111.21 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.568 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 26.8 tt0 -174.73 57.85 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.346 0.593 . . . . 0.0 109.965 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.85 129.44 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.81 45.88 0.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.336 0.588 . . . . 0.0 111.202 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.723 ' HD2' ' HA ' ' A' ' 106' ' ' PRO . 56.1 mttm -84.54 143.43 29.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 63.86 -126.46 0.5 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.62 -40.13 66.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 111.008 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -171.34 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.69 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.8 p -165.96 -32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.887 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.329 -0.844 . . . . 0.0 109.941 177.087 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 56.36 50.63 12.84 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.654 0.596 . . . . 0.0 110.504 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 56.63 -167.5 0.11 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.712 1.205 . . . . 0.0 111.446 -175.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' A' ' 44' ' ' SER . . . -70.9 147.17 49.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.401 ' HA ' HG23 ' A' ' 79' ' ' ILE . 15.2 m -78.3 35.98 0.23 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.105 0.478 . . . . 0.0 110.829 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 42' ' ' ALA . 16.6 t -87.81 38.5 0.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.546 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.765 ' HB2' HG22 ' A' ' 80' ' ' VAL . 72.5 mmtt -75.54 127.6 33.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.578 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 26.8 t -70.74 116.94 11.63 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' CZ ' HG23 ' A' ' 80' ' ' VAL . 19.0 m-85 -63.53 -33.9 76.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 54.3 ttt180 -55.27 -48.47 73.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.786 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 46' ' ' SER . 24.0 tp10 -68.41 -46.59 69.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 50' ' ' LEU . 1.3 mp -54.48 -48.66 71.56 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.261 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 81.0 mt -65.6 -46.75 88.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.661 ' HA ' HD22 ' A' ' 115' ' ' LEU . 36.7 mt -61.4 -50.18 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.595 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -55.07 -40.24 70.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.202 0.525 . . . . 0.0 110.539 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.68 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -76.91 -59.69 3.11 Favored Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.844 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.844 HD21 HD23 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -55.6 -34.56 64.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.841 -171.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 4.7 t -65.79 -28.81 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.55 -49.19 7.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.68 HD21 ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.59 14.4 19.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -60.8 -26.58 67.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 57.44 -106.87 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.059 0.456 . . . . 0.0 110.466 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.424 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.6 ptp85 -69.22 -35.12 75.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.788 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.537 ' HD2' HG23 ' A' ' 129' ' ' VAL . 14.2 ptpt -179.61 -40.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 167.0 26.9 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -135.19 144.68 47.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.289 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -66.2 160.55 24.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.16 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.504 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 67.3 mtm180 -54.4 -52.45 69.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.7 Cg_endo -55.34 -33.22 84.54 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.271 1.981 . . . . 0.0 112.501 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 58' ' ' LEU . . . -63.06 -43.99 97.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.593 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.844 HD23 HD21 ' A' ' 55' ' ' LEU . 30.7 mt -67.07 -47.14 72.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.393 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 9.2 mtmp? -61.32 -39.13 89.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 63.8 tttm -67.09 -49.53 64.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 109.844 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -51.09 -44.89 61.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.76 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.441 HG22 HD22 ' A' ' 50' ' ' LEU . 65.7 mt -64.44 -43.88 97.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.948 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 90.4 mttt -63.9 -34.41 77.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.619 0.247 . . . . 0.0 111.547 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.5 mm-40 -69.91 -41.86 74.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -100.28 -33.28 10.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.9 67.51 79.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.598 0.237 . . . . 0.0 110.819 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.83 -19.73 40.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.221 2.614 . . . . 0.0 112.973 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.427 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 4.0 mp -51.37 -57.18 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 122.252 1.025 . . . . 0.0 109.865 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -85.02 -35.78 10.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.916 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.11 -40.5 59.24 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -102.42 30.09 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 110.437 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.97 145.96 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.1 m -59.49 -37.13 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.132 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -116.13 32.7 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' HD1' ' HE2' ' A' ' 47' ' ' TYR . 34.9 t80 -56.01 -48.39 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.397 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.28 -44.24 97.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.34 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.01 -46.38 78.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -62.36 -40.14 95.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.207 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -59.38 -50.65 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -61.52 -38.58 87.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.549 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -67.14 -37.28 83.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.126 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.86 97.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.493 HG22 HG23 ' A' ' 113' ' ' VAL . 45.2 mm -58.85 -51.04 76.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -43.3 89.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.752 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.667 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -68.04 -44.36 76.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 109.735 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.725 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -60.88 -45.69 96.04 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.857 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.2 m -65.81 -33.59 64.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.897 0.348 . . . . 0.0 111.871 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 1.6 pp20? -77.68 -41.32 38.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 110.657 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.35 -42.84 74.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.735 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.96 40.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.407 ' HB2' ' CA ' ' A' ' 97' ' ' GLY . 87.8 m-20 -113.03 -41.71 3.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.725 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 2.0 m-85 -132.75 169.85 16.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.102 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HG3' ' HB1' ' A' ' 116' ' ' ALA . 32.0 mt-10 -134.8 146.3 49.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -120.53 83.64 34.77 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.547 ' HB2' ' HB ' ' A' ' 129' ' ' VAL . 85.7 Cg_endo -78.48 42.08 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.656 2.238 . . . . 0.0 112.902 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -145.8 -48.34 0.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.382 . . . . 0.0 110.167 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.22 -145.71 14.51 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.748 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.38 125.42 13.93 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.753 2.302 . . . . 0.0 112.396 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 54.02 35.0 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.105 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.79 -148.71 11.45 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.373 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.45 135.23 34.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 94' ' ' ILE . 57.5 t -93.13 132.4 37.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 1.1 tmtp? -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -72.22 112.24 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.261 0.553 . . . . 0.0 111.372 -173.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.48 ' HB1' ' HG3' ' A' ' 104' ' ' GLU . . . -68.07 132.07 46.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.854 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.14 66.0 1.2 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.095 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -165.25 -151.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.334 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 119' ' ' LYS . 13.0 mptt -87.22 -48.08 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.156 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 51.0 m -155.04 144.14 15.04 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.501 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 7.4 Cg_exo -70.19 132.15 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.024 1.816 . . . . 0.0 112.003 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -91.06 40.37 1.02 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.863 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.4 p -144.76 140.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.739 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -165.95 -59.45 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -111.3 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.662 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.79 -127.37 1.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.383 0.427 . . . . 0.0 110.302 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm 57.02 42.9 25.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.428 176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -74.16 132.22 42.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.87 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 106' ' ' PRO . 13.0 p -65.48 135.23 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.371 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.506 -177.485 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.712 0.291 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -165.85 131.94 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 64.31 107.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.838 0.711 . . . . 0.0 111.133 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.06 24.76 10.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.328 0.585 . . . . 0.0 109.873 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.2 m -167.23 -141.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.954 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m 57.83 35.56 25.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.912 ' HB2' HG22 ' A' ' 80' ' ' VAL . 75.3 mmtt -94.14 127.91 40.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.599 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -75.24 114.69 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.47 ' HA ' HD13 ' A' ' 50' ' ' LEU . 5.4 m-85 -62.59 -32.7 73.74 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -55.82 -46.31 78.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.978 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 46' ' ' SER . 10.9 pt-20 -72.46 -39.98 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.608 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 46' ' ' SER . 66.2 mt -60.46 -51.68 68.45 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.4 mt -65.12 -42.03 93.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.792 -178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.688 ' HA ' HD22 ' A' ' 115' ' ' LEU . 35.6 mt -64.32 -46.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.278 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.13 -36.74 71.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 110.119 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -77.15 -59.67 3.07 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.616 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 113' ' ' VAL . 4.0 tp -54.08 -30.37 48.0 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.086 0.555 . . . . 0.0 112.442 -171.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.572 HG21 ' N ' ' A' ' 57' ' ' ALA . 14.7 t -67.06 -33.06 74.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.142 0.496 . . . . 0.0 110.135 175.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.572 ' N ' HG21 ' A' ' 56' ' ' THR . . . -85.23 -44.8 12.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.012 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' A' ' 68' ' ' ALA . 1.1 pt? -108.68 34.11 3.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.207 -173.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -23.47 63.84 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.258 -0.276 . . . . 0.0 110.656 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 69.01 -49.51 0.59 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.667 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -162.49 -38.2 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.387 178.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.667 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 60.2 pttt -179.86 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 110.751 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 135.31 2.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.699 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -119.05 151.85 37.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.017 0.437 . . . . 0.0 109.959 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -66.38 143.19 57.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.146 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.554 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 73.4 mtm180 -53.25 -50.01 84.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.652 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.5 Cg_endo -57.55 -30.06 87.14 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.196 1.931 . . . . 0.0 112.643 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 58' ' ' LEU . . . -65.74 -44.94 84.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.599 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.529 HD22 HD23 ' A' ' 58' ' ' LEU . 69.8 mt -63.38 -42.52 98.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.305 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 85.0 mttt -57.65 -42.48 83.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.318 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.594 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 65.8 tttp -65.34 -49.82 67.94 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.197 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CE1' ' HA3' ' A' ' 54' ' ' GLY . 55.2 t80 -51.71 -45.69 63.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 69' ' ' LEU . 76.0 mt -65.13 -43.1 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.2 mttt -61.8 -42.36 98.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.1 mm-40 -64.84 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.259 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.64 -42.38 8.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.042 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -120.67 79.78 31.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.464 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.09 -22.15 68.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 112.273 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.486 ' H ' HD11 ' A' ' 79' ' ' ILE . 4.7 mp -50.39 -61.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 122.04 0.924 . . . . 0.0 110.387 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.912 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.1 t -79.85 -32.12 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.142 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.424 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -56.26 -45.83 87.51 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.701 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.2 m -100.96 33.04 2.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.791 0.329 . . . . 0.0 110.793 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 80' ' ' VAL . . . -80.1 32.69 0.27 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m 64.08 -72.65 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.56 0.744 . . . . 0.0 112.409 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 38.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 0.0 110.545 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -43.86 98.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.802 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -44.74 91.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.021 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.62 -48.05 82.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.222 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -60.97 -42.11 97.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.155 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.409 ' HZ ' ' HB2' ' A' ' 69' ' ' LEU . 90.2 t80 -61.16 -49.62 76.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 74.6 m-20 -58.89 -42.97 90.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -65.77 -42.32 90.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.851 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.77 -42.76 89.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.737 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 29.4 mm -60.52 -53.74 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.688 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 91' ' ' ASN . 99.0 mttt -58.17 -46.54 85.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.55 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 18.3 tptm -65.78 -46.17 79.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.083 -175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -70.81 -34.03 66.2 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.063 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.737 ' HB ' ' O ' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -63.77 -34.7 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.57 0.7 . . . . 0.0 111.042 -178.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 20.8 pt-20 -86.55 -36.6 18.84 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.491 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.14 71.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.225 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.698 ' HA3' ' HG3' ' A' ' 121' ' ' PRO . . . 119.75 37.8 0.75 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.554 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.38 -34.12 5.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.68 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 4.2 m-85 -127.4 161.42 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.418 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.527 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 9.6 pt-20 -144.8 129.74 18.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.922 0.391 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.539 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 70.5 mt-30 -99.21 103.51 20.7 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.757 ' HA ' HG23 ' A' ' 123' ' ' VAL . 52.3 Cg_exo -60.98 -32.38 92.33 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.115 2.543 . . . . 0.0 113.234 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.44 -47.87 10.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.798 0.332 . . . . 0.0 110.962 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.8 27.41 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.8 135.99 72.26 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.525 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.77 39.99 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.204 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.94 -143.75 5.88 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.03 135.6 33.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.539 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 2.5 p -114.0 141.23 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.116 0.484 . . . . 0.0 110.821 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.2 ttpp -122.53 152.73 40.07 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.688 HD22 ' HA ' ' A' ' 52' ' ' ILE . 16.2 mt -57.75 130.37 46.12 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.61 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 104' ' ' GLU . . . -73.43 159.94 32.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.915 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -67.53 80.63 0.17 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.469 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 118' ' ' LYS . 12.8 mptt 61.79 -114.71 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.462 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -103.99 43.52 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.807 0.336 . . . . 0.0 111.061 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 56.5 p -166.79 130.3 1.51 Allowed Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 120.932 0.396 . . . . 0.0 111.564 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.698 ' HG3' ' HA3' ' A' ' 101' ' ' GLY . 2.9 Cg_exo -77.23 137.09 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.179 2.586 . . . . 0.0 112.31 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.468 ' O ' HG12 ' A' ' 129' ' ' VAL . 48.6 mt-10 -98.85 44.49 1.03 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.152 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 106' ' ' PRO . 55.0 t -143.93 117.13 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.867 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 124' ' ' LYS . 44.8 mmtm 64.2 -50.81 0.28 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 172.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.444 ' HD3' ' HG2' ' A' ' 121' ' ' PRO . 39.5 mtpt -58.94 125.85 25.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.947 0.403 . . . . 0.0 111.919 -172.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 57.35 -150.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.936 177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.781 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -83.18 -154.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -178.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.634 ' HG2' ' HG2' ' A' ' 127' ' ' LYS . 65.7 mm-40 60.16 -134.05 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.476 0.311 . . . . 0.0 111.367 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 122' ' ' GLU . 21.7 t 60.79 53.69 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.59 0.71 . . . . 0.0 110.041 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.147 -177.502 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.93 -50.9 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.247 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' OE2' ' HB3' ' A' ' 44' ' ' SER . 88.5 tt0 -172.75 129.62 0.52 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.249 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.17 -133.59 0.14 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.844 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.64 ' HB3' HG21 ' A' ' 80' ' ' VAL . 15.9 m -80.58 41.77 0.57 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.905 0.383 . . . . 0.0 111.907 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.416 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 14.5 t -84.3 42.36 0.88 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.447 0.641 . . . . 0.0 110.101 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -91.19 131.75 36.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 40.0 t -73.12 128.87 36.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.78 -18.76 62.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.825 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -58.73 -45.6 89.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' HG3' ' HB3' ' A' ' 46' ' ' SER . 2.6 mt-10 -68.16 -50.71 52.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.227 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -56.77 -55.84 29.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.328 -175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 94' ' ' ILE . 67.8 mt -64.92 -54.44 29.62 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -176.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.599 HG13 ' HE1' ' A' ' 103' ' ' PHE . 90.4 mt -58.51 -41.42 81.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.7 -41.99 64.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.713 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -82.77 -53.52 3.52 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.127 175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.633 ' HB2' HD23 ' A' ' 69' ' ' LEU . 34.7 tp -48.25 -37.39 16.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.387 0.675 . . . . 0.0 112.012 -172.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -72.0 -32.73 67.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.663 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.16 -42.32 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -97.09 12.1 33.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.871 -0.518 . . . . 0.0 111.834 -170.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -63.08 -27.54 69.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.702 0.286 . . . . 0.0 110.515 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 59.07 -111.76 0.57 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.908 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.51 -36.42 83.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.769 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -175.41 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' N ' ' HD3' ' A' ' 62' ' ' LYS . . . -154.3 145.6 12.99 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.896 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 p -95.11 -117.13 0.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -167.36 152.61 7.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 52.8 mtp180 -54.45 -54.47 48.12 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.947 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 19.1 Cg_endo -59.55 -34.36 96.84 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.073 1.848 . . . . 0.0 112.083 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.559 ' HB2' HD13 ' A' ' 58' ' ' LEU . . . -65.11 -43.31 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.866 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.633 HD23 ' HB2' ' A' ' 55' ' ' LEU . 44.7 mt -61.17 -45.94 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.577 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 45.5 mtmt -59.74 -34.66 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.63 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 85.0 tttt -63.84 -53.53 49.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.897 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -54.93 -43.16 73.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.98 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 69' ' ' LEU . 56.7 mt -62.57 -46.49 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.233 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 85.5 mttt -66.12 -34.12 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 111.484 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.8 mm-40 -66.07 -42.34 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.133 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.56 -44.5 7.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -119.8 71.52 15.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.69 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.79 -9.48 24.8 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.612 2.208 . . . . 0.0 113.315 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.461 ' H ' HD13 ' A' ' 79' ' ' ILE . 4.3 mp -56.48 -58.49 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.054 0.93 . . . . 0.0 109.183 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.64 HG21 ' HB3' ' A' ' 43' ' ' SER . 1.0 OUTLIER -77.94 -30.74 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.735 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.445 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -57.03 -41.96 92.75 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.091 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.0 m -92.87 28.66 2.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.774 -0.251 . . . . 0.0 111.22 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 86' ' ' PHE . . . -80.01 131.64 35.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -61.05 -39.92 91.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -102.46 26.85 7.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.464 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.49 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 31.9 t80 -59.2 -45.06 92.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.635 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.71 -47.59 79.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.66 -47.75 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.12 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -61.01 -43.27 99.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.484 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.37 -50.35 73.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.33 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.61 -36.28 82.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -66.88 -42.03 86.25 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.401 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.477 HD12 HD11 ' A' ' 51' ' ' ILE . 35.9 mm -60.12 -48.91 86.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 63.6 mttp -61.91 -43.04 99.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.252 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.582 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 23.7 tptm -68.22 -38.63 82.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.804 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -63.78 -43.28 97.94 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.194 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 27.1 m -64.82 -36.72 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.12 0.46 . . . . 0.0 111.362 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 3.1 pt-20 -76.25 -41.89 47.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 96' ' ' LYS . . . -67.14 -28.87 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.244 -177.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.685 ' HA2' ' HA ' ' A' ' 119' ' ' LYS . . . 102.11 40.5 2.62 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.359 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.428 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 37.3 m-20 -113.0 -43.6 3.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.804 ' CD2' ' HA2' ' A' ' 97' ' ' GLY . 6.1 m-85 -128.49 165.59 20.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.652 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.479 ' HG3' ' HB1' ' A' ' 116' ' ' ALA . 16.5 mt-10 -141.8 142.25 33.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.011 0.524 . . . . 0.0 109.715 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -115.21 117.71 40.88 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.46 -41.55 25.57 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.932 2.421 . . . . 0.0 112.659 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -83.64 -60.48 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.048 0.451 . . . . 0.0 110.746 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.04 -153.16 23.38 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.47 133.68 58.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.84 2.36 . . . . 0.0 112.8 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.5 28.87 18.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.21 -158.81 23.16 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.105 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.56 148.75 47.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.605 0.24 . . . . 0.0 110.512 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 94' ' ' ILE . 34.2 t -117.78 152.97 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.887 0.375 . . . . 0.0 110.276 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.445 ' N ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -157.69 153.09 26.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.515 HD12 HG12 ' A' ' 52' ' ' ILE . 1.5 mm? -53.15 134.56 38.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.018 0.437 . . . . 0.0 111.861 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.479 ' HB1' ' HG3' ' A' ' 104' ' ' GLU . . . -67.43 142.51 56.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.968 174.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.472 ' HG3' ' OE2' ' A' ' 104' ' ' GLU . 41.7 mttp -60.08 -36.8 78.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.903 -177.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 118' ' ' LYS . 33.1 ttmt -165.1 159.92 18.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.685 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -63.76 -49.16 74.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.59 ' N ' ' HG2' ' A' ' 119' ' ' LYS . 67.9 m 61.06 156.28 0.11 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.376 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.47 170.19 8.55 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.539 2.159 . . . . 0.0 111.584 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.35 116.39 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.442 0.639 . . . . 0.0 111.083 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -97.85 131.93 43.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.821 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? 47.51 -135.72 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.912 0.757 . . . . 0.0 112.255 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -147.73 -52.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.681 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.24 132.65 36.56 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 127' ' ' LYS . 3.4 mptp? -80.82 57.38 3.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 111.674 -176.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.416 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.6 mt-10 -78.86 61.22 3.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 128' ' ' GLU . 65.5 t 79.16 -44.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.361 -166.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.63 172.765 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.532 ' H1 ' ' HD3' ' A' ' 39' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.57 135.09 57.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.34 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.448 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 29.1 tt0 -80.09 54.07 1.85 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.096 0.474 . . . . 0.0 110.232 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.19 -46.46 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.158 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.52 ' HA ' HG21 ' A' ' 80' ' ' VAL . 8.5 t -136.32 23.82 3.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 67.0 m -92.29 34.09 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.491 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.871 ' HB2' HG22 ' A' ' 80' ' ' VAL . 71.8 mmtt -88.87 140.62 29.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.3 m -68.48 107.36 2.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 110.279 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.453 ' O ' HG13 ' A' ' 51' ' ' ILE . 19.7 m-85 -62.61 -36.25 82.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.3 ttm105 -54.86 -43.48 73.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.87 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.74 -49.63 67.7 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD11 ' N ' ' A' ' 50' ' ' LEU . 2.4 mp -55.32 -49.59 71.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.535 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.511 HG22 HD12 ' A' ' 69' ' ' LEU . 76.1 mt -66.33 -50.67 66.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.236 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.631 ' HA ' HD23 ' A' ' 115' ' ' LEU . 39.7 mt -61.25 -47.21 94.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.526 0.203 . . . . 0.0 111.304 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' O ' ' HB1' ' A' ' 57' ' ' ALA . 35.8 mm-40 -54.25 -42.41 69.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.675 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -73.53 -56.98 5.24 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.332 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 115' ' ' LEU . 4.8 tp -58.07 -30.28 66.09 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -75.96 -32.83 59.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 53' ' ' GLU . . . -86.76 -51.01 6.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.38 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.677 ' HG ' ' N ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -76.79 -53.71 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.006 -176.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.677 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 40.3 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.749 2.42 . . . . 0.0 117.057 175.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' LEU . 51.3 mt-10 64.16 -105.73 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.27 0.628 . . . . 0.0 109.414 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -77.87 -30.28 50.79 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.711 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.634 ' HZ1' ' HB3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 167.65 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.134 178.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.405 ' HA3' HD12 ' A' ' 55' ' ' LEU . . . -142.1 150.87 22.43 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -133.57 156.3 48.07 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.868 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.8 t -62.68 157.17 21.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.548 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 82.9 mtm180 -48.87 -52.41 46.58 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.076 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 6.0 Cg_endo -49.63 -38.28 45.15 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 122.977 2.452 . . . . 0.0 112.979 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.85 90.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.983 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.511 HD12 HG22 ' A' ' 51' ' ' ILE . 58.7 mt -66.16 -44.25 84.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.887 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 57.1 mtpt -59.07 -35.38 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.828 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.515 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 45.3 tttm -68.79 -50.23 52.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.333 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.1 -43.87 64.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.554 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 50' ' ' LEU . 80.6 mt -62.87 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.963 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.5 mttt -61.19 -37.4 82.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 52.4 mt-10 -67.92 -42.4 81.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.964 0.411 . . . . 0.0 111.197 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.12 -40.54 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.94 76.2 58.0 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.592 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -18.99 52.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.412 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 3.7 mp -51.96 -67.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.829 0.823 . . . . 0.0 110.29 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.871 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -74.21 -35.78 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.02 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 74' ' ' LYS . . . -53.64 -42.29 66.93 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.935 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -102.66 27.75 6.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.952 0.406 . . . . 0.0 110.34 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.97 140.24 47.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -61.77 -38.74 89.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.453 0.644 . . . . 0.0 110.468 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -102.87 22.43 13.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.421 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.481 ' CD1' HG11 ' A' ' 80' ' ' VAL . 31.7 t80 -58.38 -45.49 88.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.201 0.524 . . . . 0.0 110.877 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.47 -42.57 98.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.208 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.2 -49.41 61.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.617 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -61.93 -43.42 98.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.057 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -58.47 -47.32 84.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.487 -178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -62.17 -43.2 99.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.473 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -64.08 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.877 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.62 98.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.641 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' A' ' 51' ' ' ILE . 30.9 mm -61.17 -53.22 52.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.02 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.577 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 57.2 mttm -53.81 -49.71 67.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.083 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -72.22 -30.88 65.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.618 ' HA2' ' CD1' ' A' ' 103' ' ' PHE . . . -75.67 -39.3 34.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.855 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.792 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 29.6 m -69.06 -37.69 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.904 0.352 . . . . 0.0 111.317 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.1 pt-20 -66.89 -39.18 87.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.925 0.393 . . . . 0.0 110.675 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.3 36.56 5.89 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.754 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -112.67 -23.12 10.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.792 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -135.28 153.78 51.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 169.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -142.23 123.21 14.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.722 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 54.8 mt-30 -96.27 107.79 37.62 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.851 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.631 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -62.94 -34.27 71.88 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.233 1.955 . . . . 0.0 111.522 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -86.5 33.3 0.63 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.46 -138.17 19.31 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.151 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -91.04 -28.52 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.992 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.97 52.13 2.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.79 -140.76 4.02 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.234 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.868 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -80.13 142.79 34.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.722 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 6.1 p -120.43 143.15 33.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.038 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.46 143.22 47.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 52' ' ' ILE . 10.7 mt -58.12 129.46 42.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.608 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.12 121.62 42.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.464 0.65 . . . . 0.0 112.243 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -137.34 36.9 2.5 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -162.72 118.13 1.82 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 113.272 -1.786 . . . . 0.0 107.929 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.4 18.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.185 0.517 . . . . 0.0 110.699 -175.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.9 m -63.63 131.57 94.91 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.17 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.76 138.21 77.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.013 1.809 . . . . 0.0 111.167 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -147.89 41.28 1.01 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.804 0.811 . . . . 0.0 110.059 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 t -95.21 51.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.683 173.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.654 ' HG3' ' HG2' ' A' ' 128' ' ' GLU . 7.9 ttpm? -117.97 -34.29 4.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.732 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 4.0 ttmp? -70.94 140.78 51.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.231 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.611 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 85.5 mt-10 67.17 51.72 0.9 Allowed 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.637 0.586 . . . . 0.0 109.921 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 73.65 132.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.349 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.654 ' HG2' ' HG3' ' A' ' 124' ' ' LYS . 83.2 mt-10 -72.29 167.76 19.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.082 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.89 114.46 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.741 -177.029 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.611 0.243 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -84.97 -168.76 2.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.541 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 57.53 50.56 10.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 110.061 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.21 -10.57 42.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 m -72.82 7.02 2.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.004 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -78.41 41.8 0.4 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.87 0.367 . . . . 0.0 111.665 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.821 ' HB2' HG22 ' A' ' 80' ' ' VAL . 34.4 mmtm -77.88 135.49 37.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.82 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 m -72.68 116.6 13.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.243 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.91 -31.52 72.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.71 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -58.22 -42.12 85.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.439 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.79 -53.95 18.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HB3' HD12 ' A' ' 73' ' ' ILE . 2.8 mp -53.71 -53.46 51.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.822 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 51' ' ' ILE . 63.5 mt -65.59 -50.64 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.315 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.537 HG12 HD12 ' A' ' 115' ' ' LEU . 51.7 mt -62.31 -42.64 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.79 -40.75 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 110.934 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -75.34 -59.38 3.6 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.467 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.747 HD23 HG13 ' A' ' 113' ' ' VAL . 19.1 tp -46.17 -37.96 7.68 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.927 0.891 . . . . 0.0 112.401 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -72.12 -31.99 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.94 -41.44 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.764 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.497 HD21 ' O ' ' A' ' 54' ' ' GLY . 1.5 pt? -107.4 20.11 19.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.449 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -66.59 -26.14 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.482 -0.136 . . . . 0.0 110.844 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 67.92 -46.16 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -151.62 -46.08 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.22 -0.3 . . . . 0.0 110.73 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.651 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 23.4 pttm -174.63 26.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.534 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.03 133.31 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.763 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.493 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -126.27 141.22 52.0 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.391 0.277 . . . . 0.0 110.293 178.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 m -62.56 137.11 58.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.763 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 39.2 mtp180 -53.8 -49.32 89.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.146 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HA ' ' HZ2' ' A' ' 70' ' ' LYS . 17.7 Cg_endo -56.41 -34.27 94.04 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.977 1.785 . . . . 0.0 112.523 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.49 ' HB2' HD13 ' A' ' 58' ' ' LEU . . . -62.23 -45.05 95.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 55' ' ' LEU . 5.2 mp -60.59 -40.44 91.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.585 ' HZ2' ' HA ' ' A' ' 67' ' ' PRO . 28.2 mtmm -61.11 -35.72 77.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.501 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.603 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 59.3 tttp -65.09 -50.3 66.68 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.913 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.22 -44.04 64.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.948 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.631 HD11 ' HZ ' ' A' ' 86' ' ' PHE . 73.1 mt -65.19 -42.8 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.824 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.1 mttt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 111.489 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.4 mm-40 -63.48 -41.8 98.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.19 -43.46 8.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.197 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -120.36 81.58 30.53 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.499 0.19 . . . . 0.0 110.882 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.01 -23.39 77.36 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.659 2.239 . . . . 0.0 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.459 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 3.5 mp -53.62 -63.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.868 0.842 . . . . 0.0 110.4 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -77.23 -33.26 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.689 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -41.52 61.62 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.551 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -104.53 30.62 5.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.766 0.317 . . . . 0.0 110.856 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 80' ' ' VAL . . . -82.71 48.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.6 t 55.79 -103.39 0.18 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.303 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -81.05 39.64 0.51 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.245 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 73' ' ' ILE . 10.8 t80 -58.57 -40.16 82.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.21 -45.02 88.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.555 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.33 -44.93 95.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.196 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -61.89 -43.3 99.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.795 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HE1' HG12 ' A' ' 51' ' ' ILE . 86.2 t80 -60.5 -50.32 74.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.075 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -59.3 -43.32 92.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.345 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -64.41 -40.72 96.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.807 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.78 93.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.15 -48.82 85.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.512 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 60.2 mtpt -58.61 -49.2 78.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.027 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 17.0 tptm -66.45 -39.71 89.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.805 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.629 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -67.67 -43.67 84.21 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.398 -175.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -64.71 -39.03 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.996 0.398 . . . . 0.0 111.687 -175.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.5 pt-20 -72.0 -40.99 68.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.55 83.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.183 0.516 . . . . 0.0 111.048 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.2 40.34 0.59 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.703 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 -37.83 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.676 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 7.6 m-85 -129.03 160.09 33.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.916 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.551 ' OE2' ' HA ' ' A' ' 121' ' ' PRO . 29.7 mm-40 -126.69 144.68 50.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.965 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.634 HE21 HG12 ' A' ' 98' ' ' VAL . 54.7 mt-30 -128.16 105.67 19.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.918 0.389 . . . . 0.0 111.144 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.599 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 90.5 Cg_endo -78.61 39.67 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.151 2.567 . . . . 0.0 112.708 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -148.39 -56.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.761 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.85 -144.43 7.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.88 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.14 -38.31 2.85 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.735 2.29 . . . . 0.0 113.494 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.472 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -127.74 40.81 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.59 -145.11 18.43 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.969 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.599 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -84.93 141.19 30.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.747 HG13 HD23 ' A' ' 55' ' ' LEU . 14.5 t -104.42 154.12 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.789 0.328 . . . . 0.0 110.502 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.651 ' HD2' ' HA ' ' A' ' 62' ' ' LYS . 78.0 tttt -148.58 144.54 27.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD12 HG12 ' A' ' 52' ' ' ILE . 0.4 OUTLIER -52.47 133.14 35.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.56 -178.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.62 130.59 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -63.41 -54.59 34.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.934 -172.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -130.75 35.41 4.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? 70.63 -52.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.031 0.832 . . . . 0.0 110.921 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 m -69.69 148.68 96.76 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.551 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 5.9 Cg_endo -49.96 135.92 36.49 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.312 2.675 . . . . 0.0 112.613 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.11 48.62 0.38 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.849 -175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.82 67.08 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.974 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.1 61.0 4.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.646 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -69.44 -17.37 63.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.794 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -165.0 156.54 15.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.466 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.01 -43.01 99.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 31.93 0.64 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.951 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -74.04 -34.93 40.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.0 0.429 . . . . 0.0 110.27 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.401 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -110.61 -46.81 3.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -156.28 143.11 18.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.242 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.59 141.59 30.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.495 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.569 ' HB3' HG21 ' A' ' 80' ' ' VAL . 13.9 m 64.08 46.23 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -85.06 41.74 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HB2' HG22 ' A' ' 80' ' ' VAL . 71.2 mmtt -88.17 120.76 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 m -67.55 121.9 16.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.118 0.485 . . . . 0.0 110.051 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -63.23 -23.59 67.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.188 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.61 -38.0 80.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.716 0.293 . . . . 0.0 110.735 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 46' ' ' SER . 4.2 mt-10 -72.18 -50.6 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.4 mp -54.0 -52.46 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.623 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.491 HG21 ' CD2' ' A' ' 69' ' ' LEU . 69.1 mt -64.09 -53.01 48.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.293 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.499 HG13 ' HE1' ' A' ' 103' ' ' PHE . 60.4 mt -61.89 -44.62 99.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.738 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -54.52 -44.36 72.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.516 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.72 ' O ' HD21 ' A' ' 58' ' ' LEU . . . -69.54 -63.38 3.4 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.2 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.852 HD22 HD12 ' A' ' 115' ' ' LEU . 15.0 tp -40.72 -44.83 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.444 1.097 . . . . 0.0 112.757 -175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.537 ' HA ' HD22 ' A' ' 115' ' ' LEU . 4.6 t -73.03 -26.38 61.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.512 0.672 . . . . 0.0 110.922 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 56' ' ' THR . . . -88.01 -39.62 14.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.644 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 54' ' ' GLY . 1.2 pt? -113.8 20.98 15.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.959 -0.463 . . . . 0.0 111.934 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 46.2 pttt -61.17 -31.57 71.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.737 0.304 . . . . 0.0 111.266 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 56.51 -102.63 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.113 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -65.8 -34.29 77.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.363 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.543 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 9.6 ptpp? 173.76 -37.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.821 0.448 . . . . 0.0 110.079 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.95 26.29 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.711 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -124.01 141.6 51.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.726 0.298 . . . . 0.0 111.348 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 5.7 m -63.74 148.3 49.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.372 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.8 -50.9 58.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.0 Cg_endo -50.84 -33.18 40.18 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.76 2.307 . . . . 0.0 112.865 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' CB ' HD13 ' A' ' 58' ' ' LEU . . . -65.05 -48.22 74.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.948 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.491 ' CD2' HG21 ' A' ' 51' ' ' ILE . 6.6 mp -65.56 -38.6 90.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.844 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 92.6 mttt -57.78 -39.96 78.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.58 -51.39 62.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.172 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -52.76 -44.22 66.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.847 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 69' ' ' LEU . 81.5 mt -67.56 -45.87 84.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.459 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.1 mttt -58.7 -43.32 90.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.86 0.362 . . . . 0.0 111.221 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.4 -39.68 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.818 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -94.45 -36.35 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -125.68 72.98 68.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 -23.36 42.93 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.959 2.439 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.438 ' CD1' ' H ' ' A' ' 79' ' ' ILE . 3.1 mp -53.34 -68.06 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.542 0.687 . . . . 0.0 110.598 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.569 HG21 ' HB3' ' A' ' 43' ' ' SER . 0.8 OUTLIER -70.9 -35.41 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.88 177.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -42.14 62.58 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.8 m -107.16 38.95 1.98 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.791 0.329 . . . . 0.0 110.844 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' HB1' ' HA ' ' A' ' 80' ' ' VAL . . . -82.58 13.61 3.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.82 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t 70.8 -58.91 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.808 0.843 . . . . 0.0 111.806 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -96.73 23.88 6.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -56.36 -44.88 80.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.681 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.24 -40.59 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.57 -48.7 76.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.173 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.213 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.424 ' CE1' HG12 ' A' ' 51' ' ' ILE . 82.5 t80 -62.06 -48.52 79.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.785 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -61.74 -41.6 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -60.58 -42.04 95.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.787 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.551 HG22 HG23 ' A' ' 113' ' ' VAL . 40.5 mm -60.53 -53.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' O ' HG21 ' A' ' 98' ' ' VAL . 95.4 mttt -63.62 -45.01 92.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.696 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.433 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -67.71 -38.51 83.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.145 0.498 . . . . 0.0 110.149 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.602 ' HA2' ' CD2' ' A' ' 103' ' ' PHE . . . -66.43 -43.49 92.41 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.17 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 26.8 m -66.34 -37.89 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.101 0.451 . . . . 0.0 111.602 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.82 -42.62 66.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.553 0.216 . . . . 0.0 110.908 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.51 93.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.98 35.88 1.09 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.31 -36.11 5.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.9 m-85 -130.64 162.09 30.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.832 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -135.49 149.01 49.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.524 ' HG3' HG12 ' A' ' 98' ' ' VAL . 47.4 mt-30 -124.69 113.34 27.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.974 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.52 ' HA ' HG23 ' A' ' 123' ' ' VAL . 61.4 Cg_endo -76.81 -33.83 2.7 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.954 2.436 . . . . 0.0 113.031 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.734 ' HD2' ' HB1' ' A' ' 112' ' ' ALA . 68.1 mttm -82.88 -46.62 12.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.173 -175.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.02 -174.02 45.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.729 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.51 -29.33 89.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.273 2.648 . . . . 0.0 112.639 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . -135.39 39.81 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 110.105 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.36 -56.59 0.87 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.866 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.734 ' HB1' ' HD2' ' A' ' 107' ' ' LYS . . . -173.57 143.03 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.617 0.367 . . . . 0.0 110.131 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.602 HG13 HD23 ' A' ' 55' ' ' LEU . 21.4 t -99.48 150.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 0.0 110.988 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -143.31 141.54 31.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.852 HD12 HD22 ' A' ' 55' ' ' LEU . 2.7 mm? -52.84 131.02 34.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.124 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.55 117.55 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.56 174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.492 ' HE3' ' HB2' ' A' ' 117' ' ' LYS . 26.3 ttmt -149.4 22.22 0.93 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.382 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 8.1 mmpt? -151.83 135.03 15.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.56 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 3.3 mppt? -75.15 -54.53 6.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.4 p -86.46 147.48 44.37 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.35 145.99 97.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.342 2.028 . . . . 0.0 111.889 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -137.82 54.89 1.8 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.514 0.673 . . . . 0.0 109.733 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 106' ' ' PRO . 32.0 t -93.62 133.78 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.433 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.09 107.14 9.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 111.572 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 48.04 45.94 19.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.358 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' ' 107' ' ' LYS . 3.8 tp10 -69.27 -46.83 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.463 0.649 . . . . 0.0 109.345 176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -163.07 29.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.819 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 54.83 42.76 30.89 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.429 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.86 132.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.284 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.741 -178.115 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 121.062 0.458 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 72.1 mmtt -98.33 126.94 44.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.466 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 40.4 t -71.84 124.58 25.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -64.42 -26.11 68.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.289 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.07 -43.47 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.355 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 3.1 mm-40 -73.08 -46.07 53.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.337 0.589 . . . . 0.0 110.28 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 HG11 ' A' ' 80' ' ' VAL . 1.4 mp -61.35 -49.85 75.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.434 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.521 HD13 HD13 ' A' ' 94' ' ' ILE . 70.7 mt -62.91 -51.36 72.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.71 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.807 HG13 ' HE1' ' A' ' 103' ' ' PHE . 47.6 mt -60.14 -43.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -50.8 -43.98 58.9 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.412 0.445 . . . . 0.0 110.485 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -80.8 -55.88 3.24 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.547 176.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.697 HD13 HD11 ' A' ' 69' ' ' LEU . 24.2 tp -51.29 -31.08 20.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.326 0.651 . . . . 0.0 111.953 -171.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -75.89 -31.04 59.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.19 -51.19 5.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -89.31 21.42 3.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.139 0.495 . . . . 0.0 111.007 -173.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -59.75 -32.09 70.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.992 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 56.2 -109.36 0.49 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.689 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 16.2 ptm180 -65.86 -34.78 78.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.189 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.737 ' O ' ' HD3' ' A' ' 114' ' ' LYS . 21.0 ptmt -175.2 -48.2 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.062 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.2 29.78 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -141.41 152.64 44.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 7.7 t -66.42 159.99 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.724 -174.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -50.29 -50.14 72.38 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.6 Cg_endo -50.85 -38.98 58.73 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.599 2.199 . . . . 0.0 112.84 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.43 81.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.756 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.697 HD11 HD13 ' A' ' 55' ' ' LEU . 18.1 mt -63.6 -41.64 98.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.244 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 94.9 mttt -60.1 -38.78 83.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 88.1 tttt -68.29 -47.69 66.95 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.121 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -50.7 -47.06 59.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.752 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.63 -40.56 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.071 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 97.3 mttt -63.31 -40.11 96.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.634 0.254 . . . . 0.0 111.664 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 4.8 mm-40 -73.59 -39.45 64.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.317 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -93.96 -41.44 9.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -119.87 73.51 18.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.13 -23.68 54.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.994 2.463 . . . . 0.0 113.585 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.855 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.1 mp -50.06 -56.42 3.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.857 0.837 . . . . 0.0 110.456 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -91.55 -32.37 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -55.31 -41.43 79.61 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.348 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -100.92 33.2 2.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.227 0.537 . . . . 0.0 109.994 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.32 145.49 25.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.078 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m -65.13 125.19 24.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.33 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 65.44 29.88 11.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.61 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.98 -43.42 98.85 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.321 0.581 . . . . 0.0 110.07 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -54.01 -42.35 68.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.05 -49.17 38.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -56.51 -37.81 70.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.597 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.501 ' CE1' HG12 ' A' ' 51' ' ' ILE . 69.6 t80 -58.65 -41.29 85.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.181 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -61.09 -45.54 94.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -64.09 -36.16 83.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.639 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.95 99.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.54 HD12 HG21 ' A' ' 113' ' ' VAL . 42.6 mm -60.73 -47.62 92.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.268 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 97.3 mttt -59.72 -42.49 93.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.963 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 tmtp? -65.61 -39.66 91.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.242 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.804 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -69.56 -40.82 77.67 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.106 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.6 m -70.26 -36.81 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.022 0.411 . . . . 0.0 111.29 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 1.5 pt-20 -67.85 -35.64 78.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.928 0.394 . . . . 0.0 110.361 175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.874 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.84 41.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.964 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -113.38 -32.47 6.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.807 ' HE1' HG13 ' A' ' 52' ' ' ILE . 8.4 m-85 -121.41 158.41 28.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.161 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.59 143.6 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 67.8 mt-30 -111.5 104.2 55.86 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-O 120.971 0.415 . . . . 0.0 111.034 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 21.0 Cg_endo -62.03 -35.28 77.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.229 2.619 . . . . 0.0 112.512 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -96.04 28.99 2.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.288 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.93 174.82 34.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.51 140.27 74.77 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.706 2.271 . . . . 0.0 111.442 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 68.09 41.34 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.6 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.47 -138.64 3.9 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.658 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.85 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -85.94 134.95 33.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.641 HG12 HD21 ' A' ' 55' ' ' LEU . 39.7 t -97.99 154.0 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.737 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 44.1 tptt -144.47 133.12 22.24 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.681 HD22 HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -55.35 118.8 4.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.54 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.206 0.527 . . . . 0.0 110.933 179.428 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 80' ' ' VAL . 30.6 mmtm -91.49 147.0 23.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 15.3 t -70.21 -17.16 63.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.826 0.346 . . . . 0.0 111.368 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 71.49 -44.35 0.59 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.191 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' HG3' HD12 ' A' ' 52' ' ' ILE . 4.7 ttm105 -54.51 -45.55 73.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.057 0.456 . . . . 0.0 110.58 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.591 ' HG3' HD13 ' A' ' 50' ' ' LEU . 13.6 pt-20 -59.73 -46.01 90.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.13 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.591 HD13 ' HG3' ' A' ' 49' ' ' GLU . 5.1 mp -62.75 -52.52 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.664 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.95 -52.14 63.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.535 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.625 HD11 ' OD2' ' A' ' 102' ' ' ASP . 74.7 mt -63.45 -41.29 92.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.57 -37.47 70.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.638 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -78.17 -58.62 3.12 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.421 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 115' ' ' LEU . 32.1 tp -49.71 -32.65 13.95 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.454 0.702 . . . . 0.0 112.381 -172.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -31.75 63.49 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 110.773 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.05 -50.27 6.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -92.2 17.39 9.7 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.825 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 17.2 pttp -68.43 -29.04 67.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 58.76 -113.35 0.68 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.738 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.611 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.2 ptp85 -67.34 -27.48 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 59.3 pttt -173.29 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 114' ' ' LYS . . . -150.83 158.38 27.65 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 119.714 -1.232 . . . . 0.0 114.004 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.432 ' OG ' ' HG ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -106.25 144.06 33.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.403 . . . . 0.0 111.169 -177.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -64.19 141.93 58.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.546 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.3 mtp-105 -55.43 -49.59 91.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.1 Cg_endo -58.32 -29.02 86.72 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.944 1.763 . . . . 0.0 112.107 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.02 83.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 55' ' ' LEU . 39.3 mt -62.58 -43.82 97.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.408 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 98.4 mttt -57.15 -40.69 77.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.703 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 53.4 tttp -67.97 -47.34 68.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.564 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.16 -46.02 65.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.374 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.411 HG23 HD23 ' A' ' 50' ' ' LEU . 53.4 mt -63.65 -44.28 98.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.2 mttt -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 67.2 mm-40 -69.68 -39.51 76.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.365 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -94.29 -41.45 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -123.16 77.16 51.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.618 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.03 -17.6 45.85 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.398 . . . . 0.0 112.824 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.743 ' H ' HD12 ' A' ' 79' ' ' ILE . 2.8 mp -55.71 -64.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 122.049 0.928 . . . . 0.0 110.016 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -76.16 -33.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.206 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -51.55 -42.35 51.19 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.679 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -101.67 31.12 3.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -74.87 148.68 39.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.711 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -47.63 80.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -113.39 34.85 4.27 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 46.4 t80 -54.71 -46.17 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.591 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -58.46 -47.45 83.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.836 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.58 -48.33 75.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -58.97 -45.05 91.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.245 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.44 ' O ' HG12 ' A' ' 94' ' ' ILE . 90.5 t80 -56.77 -47.11 80.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -62.13 -44.1 97.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.736 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.604 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 78.6 m-20 -66.01 -38.81 89.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.751 0.31 . . . . 0.0 110.769 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.94 88.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.383 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 90' ' ' PHE . 36.5 mm -61.73 -51.69 69.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.991 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.604 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -62.29 -41.07 98.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -173.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 46.6 tptt -71.73 -34.59 69.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.747 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -67.73 -40.37 90.02 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 17.2 m -65.2 -42.13 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.166 0.483 . . . . 0.0 111.246 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -67.81 -41.25 83.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.87 -28.37 68.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.626 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.63 4.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.55 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.625 ' OD2' HD11 ' A' ' 52' ' ' ILE . 35.2 t70 -113.83 -41.99 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.027 -0.586 . . . . 0.0 109.495 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.747 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 21.1 m-85 -114.44 171.82 7.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.957 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -153.47 136.33 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 80.7 mt-30 -122.39 105.84 36.03 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 25.5 Cg_endo -62.14 -36.05 71.81 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.896 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HB2' ' HA3' ' A' ' 111' ' ' GLY . 98.9 mttt -91.76 16.37 10.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.15 -146.59 49.28 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.955 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.71 133.88 57.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.15 2.567 . . . . 0.0 112.482 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.76 30.7 18.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.108 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 107' ' ' LYS . . . -114.89 160.1 13.38 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.566 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.61 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -55.12 130.83 43.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 55' ' ' LEU . 17.7 t -90.17 155.66 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.486 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.634 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -152.16 136.8 16.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.687 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -51.15 127.32 18.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.801 -174.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.039 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.233 0.214 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 71.5 mmtt -83.16 138.23 33.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.473 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 48.2 m -72.41 115.74 12.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 51' ' ' ILE . 8.1 m-85 -62.29 -30.45 71.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.544 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -52.5 -48.55 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.988 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 19.2 mm-40 -62.53 -46.65 87.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.173 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 HG11 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -60.06 -48.53 81.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.834 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.696 HG12 ' HE1' ' A' ' 90' ' ' PHE . 68.7 mt -64.29 -53.85 38.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.06 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.78 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.9 mt -60.44 -45.52 96.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.48 -39.2 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 110.504 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -80.42 -59.88 2.46 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.451 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.68 ' HB3' HD23 ' A' ' 115' ' ' LEU . 18.3 tp -46.04 -36.06 5.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.185 0.994 . . . . 0.0 112.543 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -68.78 -34.21 75.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.122 0.486 . . . . 0.0 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.55 -53.44 4.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 64' ' ' SER . 1.7 pt? -91.52 20.34 5.45 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.923 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -60.43 -19.89 57.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.683 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 43.9 mt-10 63.29 -115.13 0.46 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.982 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -73.06 -48.2 38.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.688 0.28 . . . . 0.0 111.142 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -179.18 27.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.233 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.48 125.94 0.88 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.583 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.614 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 2.3 p -113.22 133.46 55.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.7 m -57.92 135.65 56.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.936 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.585 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 35.5 ptt180 -53.92 -41.11 86.3 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 21.5 Cg_endo -57.94 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.672 1.582 . . . . 0.0 112.703 177.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.24 88.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' A' ' 58' ' ' LEU . 6.7 mp -59.42 -33.43 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.434 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HG3' ' HA ' ' A' ' 67' ' ' PRO . 8.6 mtmm -56.97 -38.49 73.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.2 tttp -67.1 -52.35 42.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.099 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.42 -43.47 64.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.817 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.45 HG12 ' HB3' ' A' ' 50' ' ' LEU . 79.7 mt -65.87 -46.8 87.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.164 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.3 mttt -60.48 -43.38 97.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 111.437 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.2 mt-10 -66.46 -36.68 83.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -93.96 -33.72 13.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.823 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -130.24 76.04 78.38 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.525 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.48 -21.29 37.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.036 2.491 . . . . 0.0 112.469 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.842 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.7 mp -52.37 -68.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.721 0.772 . . . . 0.0 110.52 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.555 HG11 HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -73.23 -30.51 31.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.223 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -34.46 36.68 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.82 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -114.94 42.31 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.208 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.08 15.25 1.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.775 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m 69.75 -62.35 0.42 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.832 0.853 . . . . 0.0 112.468 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -98.4 29.56 3.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.035 0.445 . . . . 0.0 110.127 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.47 -46.18 80.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.472 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.404 ' CB ' ' HE3' ' A' ' 70' ' ' LYS . 6.5 p-10 -62.24 -42.15 99.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.744 0.307 . . . . 0.0 110.847 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.95 -48.54 65.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.344 0.593 . . . . 0.0 110.166 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -61.09 -41.01 95.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.696 ' HE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -59.34 -43.85 92.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -61.26 -43.74 98.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -64.48 -38.23 90.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.876 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.21 -41.86 98.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.788 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 51' ' ' ILE . 46.4 mm -59.85 -48.99 85.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.273 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' NZ ' ' HB3' ' A' ' 95' ' ' LYS . 9.9 mtpm? -57.33 -48.18 79.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.224 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' OE2' ' A' ' 99' ' ' GLU . 13.3 tmtt? -62.92 -41.08 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.239 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.794 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -65.72 -43.67 93.77 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.101 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 25.3 m -69.69 -35.47 65.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.365 -0.491 . . . . 0.0 111.651 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 96' ' ' LYS . 22.4 pt-20 -74.09 -33.76 63.75 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.952 0.406 . . . . 0.0 110.804 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.74 -19.0 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.66 42.31 6.91 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.78 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -117.03 -37.85 3.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.794 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 8.6 m-85 -118.14 161.65 19.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.953 171.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -142.06 130.79 22.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HG2' HG22 ' A' ' 113' ' ' VAL . 83.0 mt-30 -106.39 110.43 63.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 11.2 Cg_exo -71.39 -37.04 6.08 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.005 2.47 . . . . 0.0 112.754 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -86.73 -48.85 7.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.462 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.84 170.84 37.01 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.784 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.551 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 20.9 Cg_endo -61.65 -34.03 85.07 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.029 2.486 . . . . 0.0 112.561 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.5 43.8 1.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.08 -144.61 4.17 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.1 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -74.64 137.84 42.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.87 0.367 . . . . 0.0 111.523 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 55' ' ' LEU . 11.4 t -108.27 158.71 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.644 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -139.79 140.93 36.78 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -56.34 119.78 6.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.051 -178.361 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 121.256 0.55 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -84.14 122.38 28.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.58 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 4.8 m -70.16 121.09 16.86 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -58.65 -33.64 70.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.913 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -54.95 -40.07 69.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.636 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 3.4 mm-40 -69.93 -52.35 25.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.349 0.595 . . . . 0.0 110.087 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 80' ' ' VAL . 2.5 mp -57.17 -49.02 77.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.71 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.543 HG12 ' HE1' ' A' ' 90' ' ' PHE . 82.9 mt -63.38 -52.64 55.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.972 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.533 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.2 mt -63.76 -44.99 98.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.59 -41.07 84.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.462 0.649 . . . . 0.0 109.898 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.636 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -71.28 -53.34 10.55 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.627 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.906 HD23 HD13 ' A' ' 115' ' ' LEU . 46.0 tp -54.07 -37.77 64.56 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.662 0.785 . . . . 0.0 111.916 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.423 ' N ' HD21 ' A' ' 115' ' ' LEU . 5.8 t -74.9 -31.11 61.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 110.647 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 -53.5 10.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.274 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.684 HD13 ' HB3' ' A' ' 64' ' ' SER . 1.2 pp -89.16 30.97 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.612 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -54.78 -33.67 61.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.031 -177.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 58' ' ' LEU . 90.5 mt-10 66.63 -48.82 0.45 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 111.932 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.59 -28.26 0.1 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.231 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 26.0 pttm -168.05 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.057 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 113' ' ' VAL . . . -160.38 159.9 31.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.085 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.684 ' HB3' HD13 ' A' ' 58' ' ' LEU . 6.7 t -124.54 162.49 23.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.83 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.987 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.8 m -64.59 159.65 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.635 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 110' ' ' ALA . 99.4 mtt180 -53.99 -48.49 93.75 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.9 Cg_endo -51.24 -41.16 59.5 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.407 2.071 . . . . 0.0 112.614 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.27 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 110.699 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.499 HD11 HD13 ' A' ' 55' ' ' LEU . 40.1 mt -63.27 -47.27 83.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.698 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 90' ' ' PHE . 25.5 mtmm -61.41 -36.5 80.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.112 0.482 . . . . 0.0 110.574 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 37.1 tttm -65.23 -50.36 66.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.271 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -53.7 -44.33 69.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.072 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -66.13 -41.09 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.46 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 99.5 mttt -68.21 -31.81 71.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.3 mt-10 -70.28 -47.91 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 111.182 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -94.69 -35.29 12.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.403 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -122.43 73.01 39.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 122.384 -0.198 . . . . 0.0 110.704 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.49 -23.69 57.45 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 2.78 . . . . 0.0 112.937 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.806 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.1 mp -52.11 -59.21 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.068 0.937 . . . . 0.0 110.679 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 50' ' ' LEU . 1.2 t -86.99 -34.34 7.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.582 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.94 -42.4 70.07 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.297 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.1 m -102.22 32.29 3.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.085 0.469 . . . . 0.0 110.831 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.73 149.62 27.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 120.96 13.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.68 33.29 13.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.22 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -58.16 -46.23 86.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.19 0.519 . . . . 0.0 110.309 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.96 -45.25 78.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.706 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.89 -45.9 80.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -61.45 -41.47 97.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.543 ' HE1' HG12 ' A' ' 51' ' ' ILE . 90.4 t80 -59.7 -47.33 86.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -59.3 -42.15 90.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.364 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.52 -39.35 93.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.054 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.61 96.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.526 HD12 HG21 ' A' ' 113' ' ' VAL . 47.8 mm -60.98 -46.64 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 86.3 mttt -57.77 -45.74 85.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.074 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 5.3 tppp? -67.18 -41.45 85.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.747 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.646 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -65.08 -42.59 96.54 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.129 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -66.96 -31.42 53.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.065 0.433 . . . . 0.0 111.672 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -81.13 -36.57 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.093 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.21 73.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.874 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.35 46.33 1.08 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.528 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.415 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 7.6 t0 -124.02 -33.29 3.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 0.0 109.972 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 2.5 m-85 -135.59 160.72 37.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.733 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 78.1 mt-10 -126.94 143.38 51.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.579 ' HG3' HG11 ' A' ' 98' ' ' VAL . 63.8 mt-30 -108.42 110.17 61.63 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.802 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -69.07 -39.8 7.31 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.059 2.506 . . . . 0.0 112.765 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -84.03 -47.1 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.322 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.82 -165.89 29.26 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.235 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.06 131.19 44.44 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.226 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 60.07 25.38 14.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.555 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.35 -149.95 11.62 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.941 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.987 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -64.41 150.46 46.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.481 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.526 HG21 HD12 ' A' ' 94' ' ' ILE . 44.0 t -117.68 151.41 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -140.12 137.42 34.46 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.906 HD13 HD23 ' A' ' 55' ' ' LEU . 2.7 mm? -56.77 121.55 10.09 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.847 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.733 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.743 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.134 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HE3' HD13 ' A' ' 79' ' ' ILE . 72.5 mmtt -75.54 127.6 33.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.593 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 26.8 t -70.74 116.94 11.63 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' HE2' ' HD1' ' A' ' 86' ' ' PHE . 19.0 m-85 -63.53 -33.9 76.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 54.3 ttt180 -55.27 -48.47 73.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.786 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 46' ' ' SER . 24.0 tp10 -68.41 -46.59 69.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.447 ' CD2' HG11 ' A' ' 80' ' ' VAL . 1.3 mp -54.48 -48.66 71.56 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.261 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 94' ' ' ILE . 81.0 mt -65.6 -46.75 88.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' HE1' ' A' ' 103' ' ' PHE . 36.7 mt -61.4 -50.18 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.595 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -55.07 -40.24 70.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.202 0.525 . . . . 0.0 110.539 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -76.91 -59.69 3.11 Favored Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.844 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.829 HD23 HD21 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -55.6 -34.56 64.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.841 -171.313 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.496 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 4.7 t -65.79 -28.81 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.55 -49.19 7.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.59 14.4 19.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -60.8 -26.58 67.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 57.44 -106.87 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.059 0.456 . . . . 0.0 110.466 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.6 ptp85 -69.22 -35.12 75.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.788 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 14.2 ptpt -179.61 -40.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 167.0 26.9 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -135.19 144.68 47.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.289 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -66.2 160.55 24.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.16 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 67.3 mtm180 -54.4 -52.45 69.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.7 Cg_endo -55.34 -33.22 84.54 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.271 1.981 . . . . 0.0 112.501 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.99 97.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.593 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.829 HD21 HD23 ' A' ' 55' ' ' LEU . 30.7 mt -67.07 -47.14 72.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.393 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 9.2 mtmp? -61.32 -39.13 89.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 63.8 tttm -67.09 -49.53 64.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 109.844 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -51.09 -44.89 61.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.76 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.44 -43.88 97.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.948 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 90.4 mttt -63.9 -34.41 77.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.619 0.247 . . . . 0.0 111.547 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.5 mm-40 -69.91 -41.86 74.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -100.28 -33.28 10.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.9 67.51 79.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.598 0.237 . . . . 0.0 110.819 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.83 -19.73 40.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.221 2.614 . . . . 0.0 112.973 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.825 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.0 mp -51.37 -57.18 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 122.252 1.025 . . . . 0.0 109.865 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 50' ' ' LEU . 1.2 t -85.02 -35.78 10.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.916 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.11 -40.5 59.24 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -102.42 30.09 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 110.437 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.97 145.96 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.1 m -59.49 -37.13 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.132 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -116.13 32.7 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.516 ' HD1' ' HE2' ' A' ' 47' ' ' TYR . 34.9 t80 -56.01 -48.39 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.397 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.28 -44.24 97.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.34 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.01 -46.38 78.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -62.36 -40.14 95.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.207 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -59.38 -50.65 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -61.52 -38.58 87.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.549 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -67.14 -37.28 83.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.126 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.86 97.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 113' ' ' VAL . 45.2 mm -58.85 -51.04 76.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -43.3 89.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.752 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.677 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -68.04 -44.36 76.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 109.735 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.726 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -60.88 -45.69 96.04 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.857 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.2 m -65.81 -33.59 64.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.897 0.348 . . . . 0.0 111.871 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 1.6 pp20? -77.68 -41.32 38.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 110.657 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.35 -42.84 74.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.735 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.96 40.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HB2' ' CA ' ' A' ' 97' ' ' GLY . 87.8 m-20 -113.03 -41.71 3.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 2.0 m-85 -132.75 169.85 16.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.102 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 32.0 mt-10 -134.8 146.3 49.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.596 ' HG3' HG11 ' A' ' 98' ' ' VAL . 88.9 mt-30 -120.53 83.64 34.77 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.48 42.08 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.656 2.238 . . . . 0.0 112.902 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -145.8 -48.34 0.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.382 . . . . 0.0 110.167 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.22 -145.71 14.51 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.748 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.38 125.42 13.93 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.753 2.302 . . . . 0.0 112.396 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 54.02 35.0 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.105 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.79 -148.71 11.45 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.373 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.45 135.23 34.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 94' ' ' ILE . 57.5 t -93.13 132.4 37.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 1.1 tmtp? -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -72.22 112.24 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.261 0.553 . . . . 0.0 111.372 -173.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.854 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.234 0.237 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 80' ' ' VAL . 75.3 mmtt -94.14 127.91 40.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -75.24 114.69 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.573 ' HA ' HD12 ' A' ' 50' ' ' LEU . 5.4 m-85 -62.59 -32.7 73.74 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -55.82 -46.31 78.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.978 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 46' ' ' SER . 10.9 pt-20 -72.46 -39.98 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.608 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 47' ' ' TYR . 66.2 mt -60.46 -51.68 68.45 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 69' ' ' LEU . 65.4 mt -65.12 -42.03 93.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.792 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.774 ' HA ' HD21 ' A' ' 115' ' ' LEU . 35.6 mt -64.32 -46.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.278 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.13 -36.74 71.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 110.119 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -77.15 -59.67 3.07 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.616 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD23 HD23 ' A' ' 115' ' ' LEU . 4.0 tp -54.08 -30.37 48.0 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.086 0.555 . . . . 0.0 112.442 -171.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -67.06 -33.06 74.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.142 0.496 . . . . 0.0 110.135 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.23 -44.8 12.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.012 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.81 HD21 HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -108.68 34.11 3.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.207 -173.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -23.47 63.84 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.258 -0.276 . . . . 0.0 110.656 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 69.01 -49.51 0.59 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -162.49 -38.2 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.387 178.185 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.702 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 60.2 pttt -179.86 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 110.751 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 135.31 2.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.699 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -119.05 151.85 37.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.017 0.437 . . . . 0.0 109.959 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -66.38 143.19 57.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.146 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.567 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 73.4 mtm180 -53.25 -50.01 84.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.652 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.5 Cg_endo -57.55 -30.06 87.14 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.196 1.931 . . . . 0.0 112.643 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.94 84.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.599 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.81 HD23 HD21 ' A' ' 58' ' ' LEU . 69.8 mt -63.38 -42.52 98.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.305 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 85.0 mttt -57.65 -42.48 83.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.318 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 65.8 tttp -65.34 -49.82 67.94 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.197 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 55.2 t80 -51.71 -45.69 63.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 69' ' ' LEU . 76.0 mt -65.13 -43.1 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.2 mttt -61.8 -42.36 98.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.1 mm-40 -64.84 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.259 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.64 -42.38 8.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.042 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -120.67 79.78 31.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.464 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.09 -22.15 68.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 112.273 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.838 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.7 mp -50.39 -61.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 122.04 0.924 . . . . 0.0 110.387 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 45' ' ' LYS . 1.1 t -79.85 -32.12 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.142 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.442 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -56.26 -45.83 87.51 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.701 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.2 m -100.96 33.04 2.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.791 0.329 . . . . 0.0 110.793 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 80' ' ' VAL . . . -80.1 32.69 0.27 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m 64.08 -72.65 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.56 0.744 . . . . 0.0 112.409 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -101.2 38.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 0.0 110.545 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -43.86 98.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.802 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -44.74 91.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.021 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.62 -48.05 82.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.222 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -60.97 -42.11 97.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.155 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 90.2 t80 -61.16 -49.62 76.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 74.6 m-20 -58.89 -42.97 90.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -65.77 -42.32 90.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.851 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.77 -42.76 89.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.749 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 29.4 mm -60.52 -53.74 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.688 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 91' ' ' ASN . 99.0 mttt -58.17 -46.54 85.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.55 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 18.3 tptm -65.78 -46.17 79.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.083 -175.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.54 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -70.81 -34.03 66.2 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.063 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.749 ' HB ' ' O ' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -63.77 -34.7 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.57 0.7 . . . . 0.0 111.042 -178.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 20.8 pt-20 -86.55 -36.6 18.84 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.491 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.14 71.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.225 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.75 37.8 0.75 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.554 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.38 -34.12 5.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 4.2 m-85 -127.4 161.42 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.418 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 9.6 pt-20 -144.8 129.74 18.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.922 0.391 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.58 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 70.5 mt-30 -99.21 103.51 20.7 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -60.98 -32.38 92.33 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.115 2.543 . . . . 0.0 113.234 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.44 -47.87 10.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.798 0.332 . . . . 0.0 110.962 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.8 27.41 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.8 135.99 72.26 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.525 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.77 39.99 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.204 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.94 -143.75 5.88 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.03 135.6 33.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.58 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 2.5 p -114.0 141.23 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.116 0.484 . . . . 0.0 110.821 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.2 ttpp -122.53 152.73 40.07 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.774 HD21 ' HA ' ' A' ' 52' ' ' ILE . 16.2 mt -57.75 130.37 46.12 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.61 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.915 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.447 0.641 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -91.19 131.75 36.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.452 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 40.0 t -73.12 128.87 36.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.78 -18.76 62.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.825 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -58.73 -45.6 89.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 46' ' ' SER . 2.6 mt-10 -68.16 -50.71 52.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.227 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD23 HG11 ' A' ' 80' ' ' VAL . 4.7 mp -56.77 -55.84 29.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.328 -175.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 69' ' ' LEU . 67.8 mt -64.92 -54.44 29.62 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -176.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.617 HG13 ' HE1' ' A' ' 103' ' ' PHE . 90.4 mt -58.51 -41.42 81.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.7 -41.99 64.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.77 -53.52 3.52 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.127 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.635 HD11 ' HA ' ' A' ' 114' ' ' LYS . 34.7 tp -48.25 -37.39 16.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.387 0.675 . . . . 0.0 112.012 -172.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -72.0 -32.73 67.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.663 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.16 -42.32 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.09 12.1 33.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.871 -0.518 . . . . 0.0 111.834 -170.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -63.08 -27.54 69.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.702 0.286 . . . . 0.0 110.515 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 59.07 -111.76 0.57 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.908 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.51 -36.42 83.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.769 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.498 ' HD3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -175.41 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.498 ' N ' ' HD3' ' A' ' 62' ' ' LYS . . . -154.3 145.6 12.99 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.896 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 p -95.11 -117.13 0.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -167.36 152.61 7.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 52.8 mtp180 -54.45 -54.47 48.12 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.947 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 19.1 Cg_endo -59.55 -34.36 96.84 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.073 1.848 . . . . 0.0 112.083 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.31 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.866 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.47 HD11 HD13 ' A' ' 55' ' ' LEU . 44.7 mt -61.17 -45.94 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.577 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 45.5 mtmt -59.74 -34.66 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.647 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 85.0 tttt -63.84 -53.53 49.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.897 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -54.93 -43.16 73.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.98 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 69' ' ' LEU . 56.7 mt -62.57 -46.49 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.233 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 85.5 mttt -66.12 -34.12 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 111.484 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.8 mm-40 -66.07 -42.34 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.133 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.56 -44.5 7.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -119.8 71.52 15.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.69 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.79 -9.48 24.8 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.612 2.208 . . . . 0.0 113.315 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.826 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.3 mp -56.48 -58.49 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.054 0.93 . . . . 0.0 109.183 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -77.94 -30.74 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.735 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -57.03 -41.96 92.75 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.091 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.0 m -92.87 28.66 2.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.774 -0.251 . . . . 0.0 111.22 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -80.01 131.64 35.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -61.05 -39.92 91.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -102.46 26.85 7.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.464 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.769 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 31.9 t80 -59.2 -45.06 92.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.635 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.71 -47.59 79.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.66 -47.75 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.12 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -61.01 -43.27 99.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.484 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.37 -50.35 73.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.33 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.61 -36.28 82.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -66.88 -42.03 86.25 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.401 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 HG21 ' A' ' 113' ' ' VAL . 35.9 mm -60.12 -48.91 86.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 63.6 mttp -61.91 -43.04 99.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.252 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 23.7 tptm -68.22 -38.63 82.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.812 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -63.78 -43.28 97.94 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.194 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 27.1 m -64.82 -36.72 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.12 0.46 . . . . 0.0 111.362 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -76.25 -41.89 47.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.87 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.244 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.11 40.5 2.62 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.359 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -113.0 -43.6 3.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.812 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 6.1 m-85 -128.49 165.59 20.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.652 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -141.8 142.25 33.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.011 0.524 . . . . 0.0 109.715 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -115.21 117.71 40.88 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.46 -41.55 25.57 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.932 2.421 . . . . 0.0 112.659 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -83.64 -60.48 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.048 0.451 . . . . 0.0 110.746 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.04 -153.16 23.38 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.47 133.68 58.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.84 2.36 . . . . 0.0 112.8 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.5 28.87 18.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.21 -158.81 23.16 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.105 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.56 148.75 47.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.605 0.24 . . . . 0.0 110.512 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.653 HG21 HD12 ' A' ' 94' ' ' ILE . 34.2 t -117.78 152.97 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.887 0.375 . . . . 0.0 110.276 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.635 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -157.69 153.09 26.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.563 HD22 HD23 ' A' ' 55' ' ' LEU . 1.5 mm? -53.15 134.56 38.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.018 0.437 . . . . 0.0 111.861 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.968 174.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 80' ' ' VAL . 71.8 mmtt -88.87 140.62 29.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.3 m -68.48 107.36 2.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 110.279 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 51' ' ' ILE . 19.7 m-85 -62.61 -36.25 82.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.3 ttm105 -54.86 -43.48 73.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.87 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.74 -49.63 67.7 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.503 ' HB3' HG12 ' A' ' 73' ' ' ILE . 2.4 mp -55.32 -49.59 71.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.535 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.83 HG23 HD13 ' A' ' 69' ' ' LEU . 76.1 mt -66.33 -50.67 66.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.236 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.7 ' HA ' HD21 ' A' ' 115' ' ' LEU . 39.7 mt -61.25 -47.21 94.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.526 0.203 . . . . 0.0 111.304 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -54.25 -42.41 69.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.675 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.667 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -73.53 -56.98 5.24 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.332 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD23 HD23 ' A' ' 115' ' ' LEU . 4.8 tp -58.07 -30.28 66.09 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -75.96 -32.83 59.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.76 -51.01 6.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.38 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.698 ' HG ' ' N ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -76.79 -53.71 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.006 -176.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.698 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 40.3 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.749 2.42 . . . . 0.0 117.057 175.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' LEU . 51.3 mt-10 64.16 -105.73 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.27 0.628 . . . . 0.0 109.414 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -77.87 -30.28 50.79 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.711 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 167.65 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.134 178.046 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . -142.1 150.87 22.43 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -133.57 156.3 48.07 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.863 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.8 t -62.68 157.17 21.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 82.9 mtm180 -48.87 -52.41 46.58 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.076 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 6.0 Cg_endo -49.63 -38.28 45.15 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 122.977 2.452 . . . . 0.0 112.979 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.85 90.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.983 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.83 HD13 HG23 ' A' ' 51' ' ' ILE . 58.7 mt -66.16 -44.25 84.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.887 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 57.1 mtpt -59.07 -35.38 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.828 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 45.3 tttm -68.79 -50.23 52.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.333 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.1 -43.87 64.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.554 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' A' ' 50' ' ' LEU . 80.6 mt -62.87 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.963 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.5 mttt -61.19 -37.4 82.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 52.4 mt-10 -67.92 -42.4 81.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.964 0.411 . . . . 0.0 111.197 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.12 -40.54 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.94 76.2 58.0 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.592 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -18.99 52.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.779 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.7 mp -51.96 -67.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.829 0.823 . . . . 0.0 110.29 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 86' ' ' PHE . 1.2 t -74.21 -35.78 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.02 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.64 -42.29 66.93 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.935 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -102.66 27.75 6.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.952 0.406 . . . . 0.0 110.34 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -72.97 140.24 47.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -61.77 -38.74 89.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.453 0.644 . . . . 0.0 110.468 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -102.87 22.43 13.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.421 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 31.7 t80 -58.38 -45.49 88.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.201 0.524 . . . . 0.0 110.877 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.47 -42.57 98.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.208 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.2 -49.41 61.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.617 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -61.93 -43.42 98.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.057 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.42 ' O ' HG12 ' A' ' 94' ' ' ILE . 87.7 t80 -58.47 -47.32 84.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.487 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -62.17 -43.2 99.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.473 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -64.08 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.877 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.62 98.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.641 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 51' ' ' ILE . 30.9 mm -61.17 -53.22 52.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.02 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 57.2 mttm -53.81 -49.71 67.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.083 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -72.22 -30.88 65.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.631 ' HA3' ' CD1' ' A' ' 103' ' ' PHE . . . -75.67 -39.3 34.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.855 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 29.6 m -69.06 -37.69 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.904 0.352 . . . . 0.0 111.317 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.1 pt-20 -66.89 -39.18 87.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.925 0.393 . . . . 0.0 110.675 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.3 36.56 5.89 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.754 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -112.67 -23.12 10.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.8 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -135.28 153.78 51.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 169.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 34.6 mm-40 -142.23 123.21 14.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.768 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 54.8 mt-30 -96.27 107.79 37.62 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.851 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -62.94 -34.27 71.88 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.233 1.955 . . . . 0.0 111.522 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -86.5 33.3 0.63 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.46 -138.17 19.31 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.151 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -91.04 -28.52 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.992 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.97 52.13 2.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.79 -140.76 4.02 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.234 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.863 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -80.13 142.79 34.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.768 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 6.1 p -120.43 143.15 33.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.038 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -119.46 143.22 47.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.7 HD21 ' HA ' ' A' ' 52' ' ' ILE . 10.7 mt -58.12 129.46 42.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.608 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.779 0 CA-C-O 121.464 0.65 . . . . 0.0 112.243 -176.9 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.87 0.367 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' HG21 ' A' ' 80' ' ' VAL . 34.4 mmtm -77.88 135.49 37.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.82 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 m -72.68 116.6 13.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.243 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.91 -31.52 72.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.71 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -58.22 -42.12 85.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.439 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.79 -53.95 18.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 80' ' ' VAL . 2.8 mp -53.71 -53.46 51.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.822 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.412 HG12 ' HE1' ' A' ' 90' ' ' PHE . 63.5 mt -65.59 -50.64 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.315 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.498 HG23 HD21 ' A' ' 115' ' ' LEU . 51.7 mt -62.31 -42.64 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.79 -40.75 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 110.934 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -75.34 -59.38 3.6 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.467 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.891 HD23 HD22 ' A' ' 115' ' ' LEU . 19.1 tp -46.17 -37.96 7.68 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.927 0.891 . . . . 0.0 112.401 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -72.12 -31.99 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.94 -41.44 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.764 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 54' ' ' GLY . 1.5 pt? -107.4 20.11 19.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.449 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -66.59 -26.14 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.482 -0.136 . . . . 0.0 110.844 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 67.92 -46.16 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -151.62 -46.08 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.22 -0.3 . . . . 0.0 110.73 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 23.4 pttm -174.63 26.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.534 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.03 133.31 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.763 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.503 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -126.27 141.22 52.0 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.391 0.277 . . . . 0.0 110.293 178.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 m -62.56 137.11 58.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.763 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.557 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 39.2 mtp180 -53.8 -49.32 89.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.146 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 17.7 Cg_endo -56.41 -34.27 94.04 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.977 1.785 . . . . 0.0 112.523 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.05 95.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 58' ' ' LEU . 5.2 mp -60.59 -40.44 91.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -61.11 -35.72 77.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.501 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 59.3 tttp -65.09 -50.3 66.68 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.913 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.22 -44.04 64.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.948 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.1 mt -65.19 -42.8 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.824 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 111.489 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.4 mm-40 -63.48 -41.8 98.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.19 -43.46 8.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.197 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -120.36 81.58 30.53 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.499 0.19 . . . . 0.0 110.882 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.01 -23.39 77.36 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.659 2.239 . . . . 0.0 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.852 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.5 mp -53.62 -63.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.868 0.842 . . . . 0.0 110.4 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 50' ' ' LEU . 1.2 t -77.23 -33.26 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.689 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -41.52 61.62 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.551 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -104.53 30.62 5.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.766 0.317 . . . . 0.0 110.856 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 80' ' ' VAL . . . -82.71 48.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.6 t 55.79 -103.39 0.18 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.303 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -81.05 39.64 0.51 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.245 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.412 ' CD1' HG13 ' A' ' 80' ' ' VAL . 10.8 t80 -58.57 -40.16 82.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.21 -45.02 88.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.555 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.33 -44.93 95.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.196 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -61.89 -43.3 99.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.795 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.412 ' HE1' HG12 ' A' ' 51' ' ' ILE . 86.2 t80 -60.5 -50.32 74.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.075 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -59.3 -43.32 92.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.345 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -64.41 -40.72 96.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.807 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.78 93.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.15 -48.82 85.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.512 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 60.2 mtpt -58.61 -49.2 78.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.027 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 17.0 tptm -66.45 -39.71 89.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.805 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.633 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -67.67 -43.67 84.21 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.398 -175.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -64.71 -39.03 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.996 0.398 . . . . 0.0 111.687 -175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.5 pt-20 -72.0 -40.99 68.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.55 83.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.183 0.516 . . . . 0.0 111.048 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.2 40.34 0.59 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.703 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 -37.83 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.68 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 7.6 m-85 -129.03 160.09 33.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.916 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -126.69 144.68 50.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.57 HE21 HG11 ' A' ' 98' ' ' VAL . 54.7 mt-30 -128.16 105.67 19.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.918 0.389 . . . . 0.0 111.144 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 90.5 Cg_endo -78.61 39.67 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.151 2.567 . . . . 0.0 112.708 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -148.39 -56.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.761 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.85 -144.43 7.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.88 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.14 -38.31 2.85 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.735 2.29 . . . . 0.0 113.494 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.486 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -127.74 40.81 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.59 -145.11 18.43 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.969 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.616 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -84.93 141.19 30.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.64 HG12 HD21 ' A' ' 55' ' ' LEU . 14.5 t -104.42 154.12 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.789 0.328 . . . . 0.0 110.502 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 62' ' ' LYS . 78.0 tttt -148.58 144.54 27.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.891 HD22 HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -52.47 133.14 35.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.56 -178.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.498 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HE3' HD13 ' A' ' 79' ' ' ILE . 71.2 mmtt -88.17 120.76 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 m -67.55 121.9 16.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.118 0.485 . . . . 0.0 110.051 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -63.23 -23.59 67.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.188 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.61 -38.0 80.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.716 0.293 . . . . 0.0 110.735 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 46' ' ' SER . 4.2 mt-10 -72.18 -50.6 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' CD2' HG11 ' A' ' 80' ' ' VAL . 2.4 mp -54.0 -52.46 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.623 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD13 HD13 ' A' ' 94' ' ' ILE . 69.1 mt -64.09 -53.01 48.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.293 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.514 HG13 ' HE1' ' A' ' 103' ' ' PHE . 60.4 mt -61.89 -44.62 99.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.738 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -54.52 -44.36 72.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.516 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 58' ' ' LEU . . . -69.54 -63.38 3.4 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.2 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.877 ' HG ' HD22 ' A' ' 115' ' ' LEU . 15.0 tp -40.72 -44.83 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.444 1.097 . . . . 0.0 112.757 -175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.443 ' N ' HD21 ' A' ' 115' ' ' LEU . 4.6 t -73.03 -26.38 61.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.512 0.672 . . . . 0.0 110.922 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.01 -39.62 14.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.644 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 54' ' ' GLY . 1.2 pt? -113.8 20.98 15.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.959 -0.463 . . . . 0.0 111.934 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 46.2 pttt -61.17 -31.57 71.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.737 0.304 . . . . 0.0 111.266 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 56.51 -102.63 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.113 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -65.8 -34.29 77.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.363 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.577 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 9.6 ptpp? 173.76 -37.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.821 0.448 . . . . 0.0 110.079 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.95 26.29 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.711 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -124.01 141.6 51.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.726 0.298 . . . . 0.0 111.348 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 5.7 m -63.74 148.3 49.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.372 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.566 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.8 -50.9 58.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.0 Cg_endo -50.84 -33.18 40.18 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.76 2.307 . . . . 0.0 112.865 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.05 -48.22 74.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.948 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 73' ' ' ILE . 6.6 mp -65.56 -38.6 90.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.844 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 92.6 mttt -57.78 -39.96 78.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.58 -51.39 62.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.172 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -52.76 -44.22 66.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.847 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 69' ' ' LEU . 81.5 mt -67.56 -45.87 84.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.459 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.1 mttt -58.7 -43.32 90.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.86 0.362 . . . . 0.0 111.221 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.4 -39.68 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.818 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -94.45 -36.35 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -125.68 72.98 68.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 -23.36 42.93 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.959 2.439 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.1 mp -53.34 -68.06 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.542 0.687 . . . . 0.0 110.598 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG11 ' CD2' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -70.9 -35.41 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.88 177.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -42.14 62.58 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.8 m -107.16 38.95 1.98 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.791 0.329 . . . . 0.0 110.844 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.61 3.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.82 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t 70.8 -58.91 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.808 0.843 . . . . 0.0 111.806 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -96.73 23.88 6.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CD1' HG13 ' A' ' 80' ' ' VAL . 20.6 t80 -56.36 -44.88 80.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.681 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.24 -40.59 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.57 -48.7 76.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.173 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.213 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 51' ' ' ILE . 82.5 t80 -62.06 -48.52 79.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.785 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -61.74 -41.6 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -60.58 -42.04 95.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.787 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.815 HD12 HG21 ' A' ' 113' ' ' VAL . 40.5 mm -60.53 -53.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.62 -45.01 92.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.696 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -67.71 -38.51 83.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.145 0.498 . . . . 0.0 110.149 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.608 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -66.43 -43.49 92.41 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.17 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 26.8 m -66.34 -37.89 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.101 0.451 . . . . 0.0 111.602 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.82 -42.62 66.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.553 0.216 . . . . 0.0 110.908 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.51 93.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.98 35.88 1.09 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.31 -36.11 5.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.9 m-85 -130.64 162.09 30.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.832 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -135.49 149.01 49.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.552 ' HG3' HG11 ' A' ' 98' ' ' VAL . 47.4 mt-30 -124.69 113.34 27.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.974 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 61.4 Cg_endo -76.81 -33.83 2.7 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.954 2.436 . . . . 0.0 113.031 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.88 -46.62 12.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.173 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.02 -174.02 45.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.729 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.51 -29.33 89.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.273 2.648 . . . . 0.0 112.639 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . -135.39 39.81 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 110.105 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.36 -56.59 0.87 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.866 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -173.57 143.03 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.617 0.367 . . . . 0.0 110.131 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.815 HG21 HD12 ' A' ' 94' ' ' ILE . 21.4 t -99.48 150.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 0.0 110.988 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -143.31 141.54 31.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.877 HD22 ' HG ' ' A' ' 55' ' ' LEU . 2.7 mm? -52.84 131.02 34.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.124 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.56 174.205 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.1 pttm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.84 0.352 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -151.35 -51.39 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -66.8 147.75 52.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.291 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 41.9 0.72 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.933 0.397 . . . . 0.0 110.942 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.9 p -170.73 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.201 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t 57.15 35.91 26.85 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.082 0.553 . . . . 0.0 111.374 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 72.1 mmtt -98.33 126.94 44.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.466 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 40.4 t -71.84 124.58 25.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -64.42 -26.11 68.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.289 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.07 -43.47 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.355 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 3.1 mm-40 -73.08 -46.07 53.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.337 0.589 . . . . 0.0 110.28 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 HG11 ' A' ' 80' ' ' VAL . 1.4 mp -61.35 -49.85 75.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.434 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.521 HD13 HD13 ' A' ' 94' ' ' ILE . 70.7 mt -62.91 -51.36 72.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.71 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.807 HG13 ' HE1' ' A' ' 103' ' ' PHE . 47.6 mt -60.14 -43.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -50.8 -43.98 58.9 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.412 0.445 . . . . 0.0 110.485 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -80.8 -55.88 3.24 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.547 176.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.697 HD13 HD11 ' A' ' 69' ' ' LEU . 24.2 tp -51.29 -31.08 20.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.326 0.651 . . . . 0.0 111.953 -171.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -75.89 -31.04 59.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.19 -51.19 5.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -89.31 21.42 3.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.139 0.495 . . . . 0.0 111.007 -173.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -59.75 -32.09 70.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.992 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 56.2 -109.36 0.49 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.689 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 16.2 ptm180 -65.86 -34.78 78.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.189 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.737 ' O ' ' HD3' ' A' ' 114' ' ' LYS . 21.0 ptmt -175.2 -48.2 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.062 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.2 29.78 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -141.41 152.64 44.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 7.7 t -66.42 159.99 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.724 -174.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -50.29 -50.14 72.38 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.6 Cg_endo -50.85 -38.98 58.73 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.599 2.199 . . . . 0.0 112.84 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.43 81.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.756 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.697 HD11 HD13 ' A' ' 55' ' ' LEU . 18.1 mt -63.6 -41.64 98.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.244 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 94.9 mttt -60.1 -38.78 83.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 88.1 tttt -68.29 -47.69 66.95 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.121 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -50.7 -47.06 59.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.752 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.63 -40.56 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.071 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 97.3 mttt -63.31 -40.11 96.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.634 0.254 . . . . 0.0 111.664 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 4.8 mm-40 -73.59 -39.45 64.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.317 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -93.96 -41.44 9.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -119.87 73.51 18.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.13 -23.68 54.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.994 2.463 . . . . 0.0 113.585 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.855 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.1 mp -50.06 -56.42 3.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.857 0.837 . . . . 0.0 110.456 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -91.55 -32.37 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -55.31 -41.43 79.61 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.348 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -100.92 33.2 2.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.227 0.537 . . . . 0.0 109.994 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.32 145.49 25.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.078 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m -65.13 125.19 24.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.33 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 65.44 29.88 11.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.61 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.98 -43.42 98.85 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.321 0.581 . . . . 0.0 110.07 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -54.01 -42.35 68.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.05 -49.17 38.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -56.51 -37.81 70.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.597 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.501 ' CE1' HG12 ' A' ' 51' ' ' ILE . 69.6 t80 -58.65 -41.29 85.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.181 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -61.09 -45.54 94.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -64.09 -36.16 83.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.639 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.95 99.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.54 HD12 HG21 ' A' ' 113' ' ' VAL . 42.6 mm -60.73 -47.62 92.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.268 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 97.3 mttt -59.72 -42.49 93.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.963 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 tmtp? -65.61 -39.66 91.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.242 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.804 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -69.56 -40.82 77.67 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.106 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.6 m -70.26 -36.81 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.022 0.411 . . . . 0.0 111.29 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 1.5 pt-20 -67.85 -35.64 78.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.928 0.394 . . . . 0.0 110.361 175.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.874 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.84 41.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.964 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -113.38 -32.47 6.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.807 ' HE1' HG13 ' A' ' 52' ' ' ILE . 8.4 m-85 -121.41 158.41 28.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.161 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.59 143.6 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 67.8 mt-30 -111.5 104.2 55.86 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-O 120.971 0.415 . . . . 0.0 111.034 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 21.0 Cg_endo -62.03 -35.28 77.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.229 2.619 . . . . 0.0 112.512 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -96.04 28.99 2.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.288 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.834 ' HA2' ' HA ' ' A' ' 126' ' ' GLU . . . 74.93 174.82 34.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.915 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 129' ' ' VAL . 21.8 Cg_exo -63.51 140.27 74.77 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.706 2.271 . . . . 0.0 111.442 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 68.09 41.34 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.6 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.47 -138.64 3.9 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.658 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.85 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -85.94 134.95 33.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.641 HG12 HD21 ' A' ' 55' ' ' LEU . 39.7 t -97.99 154.0 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.737 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 44.1 tptt -144.47 133.12 22.24 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.77 HD12 ' HE3' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -55.35 118.8 4.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.54 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.37 129.28 34.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.206 0.527 . . . . 0.0 110.933 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.77 ' HE3' HD12 ' A' ' 115' ' ' LEU . 35.3 mmtp -131.53 -40.72 1.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.522 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.878 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.12 58.6 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -70.37 156.97 91.07 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.442 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.23 -178.61 1.47 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.583 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 63.05 37.7 11.45 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.661 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 t -132.9 55.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.126 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -111.74 44.7 1.33 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.563 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -130.2 24.62 5.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.448 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.834 ' HA ' ' HA2' ' A' ' 108' ' ' GLY . 24.3 pt-20 -100.5 -4.56 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.451 -175.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt 68.34 -74.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.223 0.609 . . . . 0.0 111.655 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -158.13 54.29 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.678 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 109' ' ' PRO . 29.9 t -82.12 58.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.441 0.639 . . . . 0.0 109.743 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.169 -176.342 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 57.79 -136.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.567 0.542 . . . . 0.0 110.898 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.84 142.96 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.26 -146.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.833 0.349 . . . . 0.0 110.506 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -79.53 28.65 0.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.783 0.325 . . . . 0.0 110.981 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m -77.33 38.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.134 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 80' ' ' VAL . 30.6 mmtm -91.49 147.0 23.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 15.3 t -70.21 -17.16 63.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.826 0.346 . . . . 0.0 111.368 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 71.49 -44.35 0.59 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.191 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' HG3' HD12 ' A' ' 52' ' ' ILE . 4.7 ttm105 -54.51 -45.55 73.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.057 0.456 . . . . 0.0 110.58 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.591 ' HG3' HD13 ' A' ' 50' ' ' LEU . 13.6 pt-20 -59.73 -46.01 90.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.13 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.591 HD13 ' HG3' ' A' ' 49' ' ' GLU . 5.1 mp -62.75 -52.52 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.664 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.95 -52.14 63.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.535 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.625 HD11 ' OD2' ' A' ' 102' ' ' ASP . 74.7 mt -63.45 -41.29 92.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.57 -37.47 70.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.638 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -78.17 -58.62 3.12 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.421 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 115' ' ' LEU . 32.1 tp -49.71 -32.65 13.95 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.454 0.702 . . . . 0.0 112.381 -172.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -31.75 63.49 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 110.773 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.05 -50.27 6.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -92.2 17.39 9.7 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.825 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 17.2 pttp -68.43 -29.04 67.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 58.76 -113.35 0.68 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.738 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.611 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.2 ptp85 -67.34 -27.48 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 59.3 pttt -173.29 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 114' ' ' LYS . . . -150.83 158.38 27.65 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 119.714 -1.232 . . . . 0.0 114.004 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.432 ' OG ' ' HG ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -106.25 144.06 33.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.403 . . . . 0.0 111.169 -177.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -64.19 141.93 58.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.3 mtp-105 -55.43 -49.59 91.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.1 Cg_endo -58.32 -29.02 86.72 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.944 1.763 . . . . 0.0 112.107 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.02 83.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 55' ' ' LEU . 39.3 mt -62.58 -43.82 97.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.408 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 98.4 mttt -57.15 -40.69 77.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.703 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 53.4 tttp -67.97 -47.34 68.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.564 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.16 -46.02 65.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.374 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.411 HG23 HD23 ' A' ' 50' ' ' LEU . 53.4 mt -63.65 -44.28 98.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.2 mttt -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 67.2 mm-40 -69.68 -39.51 76.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.365 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -94.29 -41.45 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -123.16 77.16 51.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.618 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.03 -17.6 45.85 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.398 . . . . 0.0 112.824 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.743 ' H ' HD12 ' A' ' 79' ' ' ILE . 2.8 mp -55.71 -64.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 122.049 0.928 . . . . 0.0 110.016 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -76.16 -33.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.206 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -51.55 -42.35 51.19 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.679 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -101.67 31.12 3.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -74.87 148.68 39.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.711 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -47.63 80.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -113.39 34.85 4.27 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 46.4 t80 -54.71 -46.17 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.591 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -58.46 -47.45 83.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.836 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.58 -48.33 75.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -58.97 -45.05 91.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.245 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.44 ' O ' HG12 ' A' ' 94' ' ' ILE . 90.5 t80 -56.77 -47.11 80.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -62.13 -44.1 97.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.736 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.604 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 78.6 m-20 -66.01 -38.81 89.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.751 0.31 . . . . 0.0 110.769 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.94 88.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.383 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 90' ' ' PHE . 36.5 mm -61.73 -51.69 69.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.991 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.604 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -62.29 -41.07 98.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -173.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 46.6 tptt -71.73 -34.59 69.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.747 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -67.73 -40.37 90.02 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 17.2 m -65.2 -42.13 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.166 0.483 . . . . 0.0 111.246 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -67.81 -41.25 83.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.87 -28.37 68.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.626 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.63 4.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.55 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.625 ' OD2' HD11 ' A' ' 52' ' ' ILE . 35.2 t70 -113.83 -41.99 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.027 -0.586 . . . . 0.0 109.495 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.747 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 21.1 m-85 -114.44 171.82 7.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.957 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -153.47 136.33 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 80.7 mt-30 -122.39 105.84 36.03 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 25.5 Cg_endo -62.14 -36.05 71.81 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.896 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HB2' ' HA3' ' A' ' 111' ' ' GLY . 98.9 mttt -91.76 16.37 10.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.15 -146.59 49.28 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.955 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.71 133.88 57.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.15 2.567 . . . . 0.0 112.482 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.76 30.7 18.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.108 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 107' ' ' LYS . . . -114.89 160.1 13.38 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.566 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.61 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -55.12 130.83 43.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 55' ' ' LEU . 17.7 t -90.17 155.66 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.486 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.634 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -152.16 136.8 16.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.687 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -51.15 127.32 18.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.801 -174.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.13 127.76 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 43.7 tptt -76.16 92.63 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.884 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.9 pttm 62.23 170.63 0.13 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.513 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -60.24 -53.47 57.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -172.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.595 ' OG ' ' HE2' ' A' ' 118' ' ' LYS . 33.7 p -73.28 135.85 79.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.185 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -47.0 134.34 18.25 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.729 2.953 . . . . 0.0 113.892 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -149.47 49.56 0.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.476 177.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 32.8 t -93.98 133.39 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.064 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 2.7 mptp? -72.17 -32.67 67.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.06 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -72.38 151.74 42.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.368 171.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.84 53.87 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 129' ' ' VAL . 51.2 tptt -73.78 -48.96 27.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.225 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 75.37 -35.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.11 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 127' ' ' LYS . 99.1 t 74.82 -50.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 111.328 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.545 -0.74 . . . . 0.0 110.842 175.15 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.93 0.395 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 60.8 58.2 2.44 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.567 0.699 . . . . 0.0 109.367 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.82 144.58 54.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.929 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.19 27.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HG22 ' A' ' 79' ' ' ILE . 8.2 p -156.9 -7.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.708 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -80.0 55.26 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 71.5 mmtt -83.16 138.23 33.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.473 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 48.2 m -72.41 115.74 12.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 51' ' ' ILE . 8.1 m-85 -62.29 -30.45 71.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.544 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -52.5 -48.55 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.988 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 19.2 mm-40 -62.53 -46.65 87.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.173 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 HG11 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -60.06 -48.53 81.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.834 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.696 HG12 ' HE1' ' A' ' 90' ' ' PHE . 68.7 mt -64.29 -53.85 38.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.06 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.78 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.9 mt -60.44 -45.52 96.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.48 -39.2 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 110.504 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -80.42 -59.88 2.46 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.451 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.68 ' HB3' HD23 ' A' ' 115' ' ' LEU . 18.3 tp -46.04 -36.06 5.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.185 0.994 . . . . 0.0 112.543 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -68.78 -34.21 75.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.122 0.486 . . . . 0.0 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.55 -53.44 4.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 64' ' ' SER . 1.7 pt? -91.52 20.34 5.45 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.923 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -60.43 -19.89 57.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.683 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 43.9 mt-10 63.29 -115.13 0.46 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.982 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -73.06 -48.2 38.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.688 0.28 . . . . 0.0 111.142 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -179.18 27.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.233 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.48 125.94 0.88 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.583 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.614 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 2.3 p -113.22 133.46 55.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.7 m -57.92 135.65 56.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.936 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.585 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 35.5 ptt180 -53.92 -41.11 86.3 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 21.5 Cg_endo -57.94 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.672 1.582 . . . . 0.0 112.703 177.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.24 88.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' A' ' 58' ' ' LEU . 6.7 mp -59.42 -33.43 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.434 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HG3' ' HA ' ' A' ' 67' ' ' PRO . 8.6 mtmm -56.97 -38.49 73.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.2 tttp -67.1 -52.35 42.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.099 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.42 -43.47 64.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.817 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.45 HG12 ' HB3' ' A' ' 50' ' ' LEU . 79.7 mt -65.87 -46.8 87.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.164 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.3 mttt -60.48 -43.38 97.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 111.437 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.2 mt-10 -66.46 -36.68 83.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -93.96 -33.72 13.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.823 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -130.24 76.04 78.38 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.525 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.48 -21.29 37.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.036 2.491 . . . . 0.0 112.469 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.842 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.7 mp -52.37 -68.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.721 0.772 . . . . 0.0 110.52 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.555 HG11 HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -73.23 -30.51 31.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.223 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -34.46 36.68 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.82 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -114.94 42.31 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.208 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.08 15.25 1.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.775 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m 69.75 -62.35 0.42 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.832 0.853 . . . . 0.0 112.468 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -98.4 29.56 3.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.035 0.445 . . . . 0.0 110.127 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.47 -46.18 80.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.472 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.404 ' CB ' ' HE3' ' A' ' 70' ' ' LYS . 6.5 p-10 -62.24 -42.15 99.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.744 0.307 . . . . 0.0 110.847 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.95 -48.54 65.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.344 0.593 . . . . 0.0 110.166 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -61.09 -41.01 95.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.696 ' HE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -59.34 -43.85 92.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -61.26 -43.74 98.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -64.48 -38.23 90.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.876 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.21 -41.86 98.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.788 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 51' ' ' ILE . 46.4 mm -59.85 -48.99 85.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.273 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' NZ ' ' HB3' ' A' ' 95' ' ' LYS . 9.9 mtpm? -57.33 -48.18 79.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.224 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' OE2' ' A' ' 99' ' ' GLU . 13.3 tmtt? -62.92 -41.08 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.239 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.794 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -65.72 -43.67 93.77 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.101 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 25.3 m -69.69 -35.47 65.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.365 -0.491 . . . . 0.0 111.651 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 96' ' ' LYS . 22.4 pt-20 -74.09 -33.76 63.75 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.952 0.406 . . . . 0.0 110.804 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.74 -19.0 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.66 42.31 6.91 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.78 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -117.03 -37.85 3.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.794 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 8.6 m-85 -118.14 161.65 19.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.953 171.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' CD ' ' HB ' ' A' ' 123' ' ' VAL . 26.3 pt-20 -142.06 130.79 22.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HG2' HG22 ' A' ' 113' ' ' VAL . 83.0 mt-30 -106.39 110.43 63.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 11.2 Cg_exo -71.39 -37.04 6.08 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.005 2.47 . . . . 0.0 112.754 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -86.73 -48.85 7.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.462 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.84 170.84 37.01 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.784 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.551 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 20.9 Cg_endo -61.65 -34.03 85.07 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.029 2.486 . . . . 0.0 112.561 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.5 43.8 1.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.08 -144.61 4.17 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.1 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -74.64 137.84 42.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.87 0.367 . . . . 0.0 111.523 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 55' ' ' LEU . 11.4 t -108.27 158.71 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.644 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -139.79 140.93 36.78 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -56.34 119.78 6.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.99 134.28 38.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.051 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 123.01 19.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 21.2 tptt -68.17 -37.4 80.95 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.9 mptt -83.75 79.0 9.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.711 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 66.3 m 72.04 120.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 123.911 0.757 . . . . 0.0 112.309 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 130' ' ' SER . 23.6 Cg_exo -65.88 158.4 54.14 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.838 3.025 . . . . 0.0 112.555 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -151.61 42.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.721 0.772 . . . . 0.0 110.044 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.477 ' HB ' ' CD ' ' A' ' 104' ' ' GLU . 7.5 p -94.84 135.25 29.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.909 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HG2' HG22 ' A' ' 123' ' ' VAL . 58.9 pttt 40.04 66.86 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.549 0.74 . . . . 0.0 111.993 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -70.67 51.32 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.536 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.652 ' HG3' ' HG2' ' A' ' 127' ' ' LYS . 22.3 pt-20 -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.354 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.652 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 21.0 pttm -163.46 -142.95 0.07 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.07 123.18 19.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 110.584 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.5 p -165.96 47.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 122.538 1.161 . . . . 0.0 109.512 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 121' ' ' PRO . 48.1 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.23 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.049 0.452 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -78.69 60.32 2.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.413 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -132.53 153.05 51.33 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 134.15 53.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.851 0.357 . . . . 0.0 111.299 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.512 ' HA ' HG22 ' A' ' 79' ' ' ILE . 72.8 p 52.71 50.24 18.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.747 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -85.66 20.72 2.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 110.436 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -84.14 122.38 28.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.58 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 4.8 m -70.16 121.09 16.86 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -58.65 -33.64 70.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.913 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -54.95 -40.07 69.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.636 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 3.4 mm-40 -69.93 -52.35 25.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.349 0.595 . . . . 0.0 110.087 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 80' ' ' VAL . 2.5 mp -57.17 -49.02 77.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.71 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.543 HG12 ' HE1' ' A' ' 90' ' ' PHE . 82.9 mt -63.38 -52.64 55.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.972 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.533 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.2 mt -63.76 -44.99 98.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.59 -41.07 84.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.462 0.649 . . . . 0.0 109.898 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.636 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -71.28 -53.34 10.55 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.627 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.906 HD23 HD13 ' A' ' 115' ' ' LEU . 46.0 tp -54.07 -37.77 64.56 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.662 0.785 . . . . 0.0 111.916 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.423 ' N ' HD21 ' A' ' 115' ' ' LEU . 5.8 t -74.9 -31.11 61.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 110.647 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 -53.5 10.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.274 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.684 HD13 ' HB3' ' A' ' 64' ' ' SER . 1.2 pp -89.16 30.97 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.612 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -54.78 -33.67 61.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.031 -177.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 58' ' ' LEU . 90.5 mt-10 66.63 -48.82 0.45 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 111.932 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.59 -28.26 0.1 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.231 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 26.0 pttm -168.05 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.057 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 113' ' ' VAL . . . -160.38 159.9 31.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.085 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.684 ' HB3' HD13 ' A' ' 58' ' ' LEU . 6.7 t -124.54 162.49 23.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.83 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.987 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.8 m -64.59 159.65 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.635 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 110' ' ' ALA . 99.4 mtt180 -53.99 -48.49 93.75 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.9 Cg_endo -51.24 -41.16 59.5 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.407 2.071 . . . . 0.0 112.614 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.27 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 110.699 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.499 HD11 HD13 ' A' ' 55' ' ' LEU . 40.1 mt -63.27 -47.27 83.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.698 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 90' ' ' PHE . 25.5 mtmm -61.41 -36.5 80.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.112 0.482 . . . . 0.0 110.574 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 37.1 tttm -65.23 -50.36 66.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.271 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -53.7 -44.33 69.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.072 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -66.13 -41.09 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.46 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 99.5 mttt -68.21 -31.81 71.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.3 mt-10 -70.28 -47.91 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 111.182 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -94.69 -35.29 12.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.403 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -122.43 73.01 39.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 122.384 -0.198 . . . . 0.0 110.704 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.49 -23.69 57.45 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 2.78 . . . . 0.0 112.937 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.806 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.1 mp -52.11 -59.21 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.068 0.937 . . . . 0.0 110.679 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 50' ' ' LEU . 1.2 t -86.99 -34.34 7.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.582 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.94 -42.4 70.07 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.297 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.1 m -102.22 32.29 3.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.085 0.469 . . . . 0.0 110.831 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.73 149.62 27.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 120.96 13.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.68 33.29 13.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.22 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -58.16 -46.23 86.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.19 0.519 . . . . 0.0 110.309 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.96 -45.25 78.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.706 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.89 -45.9 80.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -61.45 -41.47 97.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.543 ' HE1' HG12 ' A' ' 51' ' ' ILE . 90.4 t80 -59.7 -47.33 86.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -59.3 -42.15 90.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.364 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.52 -39.35 93.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.054 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.61 96.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.526 HD12 HG21 ' A' ' 113' ' ' VAL . 47.8 mm -60.98 -46.64 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 86.3 mttt -57.77 -45.74 85.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.074 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 5.3 tppp? -67.18 -41.45 85.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.747 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.646 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -65.08 -42.59 96.54 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.129 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -66.96 -31.42 53.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.065 0.433 . . . . 0.0 111.672 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -81.13 -36.57 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.093 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.21 73.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.874 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.35 46.33 1.08 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.528 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.415 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 7.6 t0 -124.02 -33.29 3.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 0.0 109.972 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 2.5 m-85 -135.59 160.72 37.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.733 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 78.1 mt-10 -126.94 143.38 51.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.579 ' HG3' HG11 ' A' ' 98' ' ' VAL . 63.8 mt-30 -108.42 110.17 61.63 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.802 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.642 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . 19.2 Cg_exo -69.07 -39.8 7.31 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.059 2.506 . . . . 0.0 112.765 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -84.03 -47.1 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.322 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.645 ' HA2' HG22 ' A' ' 129' ' ' VAL . . . 148.82 -165.89 29.26 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.235 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.06 131.19 44.44 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.226 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 60.07 25.38 14.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.555 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.35 -149.95 11.62 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.941 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.987 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -64.41 150.46 46.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.481 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.526 HG21 HD12 ' A' ' 94' ' ' ILE . 44.0 t -117.68 151.41 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -140.12 137.42 34.46 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.906 HD13 HD23 ' A' ' 55' ' ' LEU . 2.7 mm? -56.77 121.55 10.09 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.847 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.733 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . . . -90.03 122.0 32.62 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.134 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -83.38 -28.84 28.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.746 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.606 ' HD3' ' HB3' ' A' ' 122' ' ' GLU . 17.8 ptpt -71.79 134.83 46.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.533 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.03 41.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 72.8 m -161.85 149.26 11.72 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.951 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.47 126.27 18.81 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.209 1.939 . . . . 0.0 111.21 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.606 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 26.8 tt0 -174.73 57.85 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.346 0.593 . . . . 0.0 109.965 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.85 129.44 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.81 45.88 0.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.336 0.588 . . . . 0.0 111.202 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.642 ' HD2' ' HA ' ' A' ' 106' ' ' PRO . 56.1 mttm -84.54 143.43 29.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 63.86 -126.46 0.5 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.62 -40.13 66.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 111.008 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -171.34 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.69 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.645 HG22 ' HA2' ' A' ' 108' ' ' GLY . 14.8 p -165.96 -32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.887 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.329 -0.844 . . . . 0.0 109.941 177.087 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 56.36 50.63 12.84 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.654 0.596 . . . . 0.0 110.504 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 56.63 -167.5 0.11 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.712 1.205 . . . . 0.0 111.446 -175.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 44' ' ' SER . . . -70.9 147.17 49.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -78.3 35.98 0.23 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.105 0.478 . . . . 0.0 110.829 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 42' ' ' ALA . 16.6 t -87.81 38.5 0.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.546 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HE3' HD13 ' A' ' 79' ' ' ILE . 72.5 mmtt -75.54 127.6 33.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.593 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 26.8 t -70.74 116.94 11.63 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' HE2' ' HD1' ' A' ' 86' ' ' PHE . 19.0 m-85 -63.53 -33.9 76.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 54.3 ttt180 -55.27 -48.47 73.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.786 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 46' ' ' SER . 24.0 tp10 -68.41 -46.59 69.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.447 ' CD2' HG11 ' A' ' 80' ' ' VAL . 1.3 mp -54.48 -48.66 71.56 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.261 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 94' ' ' ILE . 81.0 mt -65.6 -46.75 88.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' HE1' ' A' ' 103' ' ' PHE . 36.7 mt -61.4 -50.18 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.595 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -55.07 -40.24 70.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.202 0.525 . . . . 0.0 110.539 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -76.91 -59.69 3.11 Favored Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.844 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.829 HD23 HD21 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -55.6 -34.56 64.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.841 -171.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.496 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 4.7 t -65.79 -28.81 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.55 -49.19 7.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.59 14.4 19.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -60.8 -26.58 67.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 57.44 -106.87 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.059 0.456 . . . . 0.0 110.466 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.6 ptp85 -69.22 -35.12 75.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.788 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HD2' HG21 ' A' ' 129' ' ' VAL . 14.2 ptpt -179.61 -40.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 167.0 26.9 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -135.19 144.68 47.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.289 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -66.2 160.55 24.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.16 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 67.3 mtm180 -54.4 -52.45 69.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.7 Cg_endo -55.34 -33.22 84.54 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.271 1.981 . . . . 0.0 112.501 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.99 97.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.593 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.829 HD21 HD23 ' A' ' 55' ' ' LEU . 30.7 mt -67.07 -47.14 72.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.393 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 9.2 mtmp? -61.32 -39.13 89.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 63.8 tttm -67.09 -49.53 64.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 109.844 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -51.09 -44.89 61.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.76 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.44 -43.88 97.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.948 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 90.4 mttt -63.9 -34.41 77.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.619 0.247 . . . . 0.0 111.547 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.5 mm-40 -69.91 -41.86 74.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -100.28 -33.28 10.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.9 67.51 79.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.598 0.237 . . . . 0.0 110.819 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.83 -19.73 40.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.221 2.614 . . . . 0.0 112.973 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.825 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.0 mp -51.37 -57.18 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 122.252 1.025 . . . . 0.0 109.865 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 50' ' ' LEU . 1.2 t -85.02 -35.78 10.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.916 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.11 -40.5 59.24 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -102.42 30.09 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 110.437 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.97 145.96 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.1 m -59.49 -37.13 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.132 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -116.13 32.7 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.516 ' HD1' ' HE2' ' A' ' 47' ' ' TYR . 34.9 t80 -56.01 -48.39 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.397 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.28 -44.24 97.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.34 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.01 -46.38 78.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -62.36 -40.14 95.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.207 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -59.38 -50.65 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -61.52 -38.58 87.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.549 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -67.14 -37.28 83.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.126 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.86 97.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 113' ' ' VAL . 45.2 mm -58.85 -51.04 76.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -43.3 89.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.752 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.677 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -68.04 -44.36 76.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 109.735 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.726 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -60.88 -45.69 96.04 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.857 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.2 m -65.81 -33.59 64.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.897 0.348 . . . . 0.0 111.871 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 1.6 pp20? -77.68 -41.32 38.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 110.657 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.35 -42.84 74.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.735 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.96 40.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HB2' ' CA ' ' A' ' 97' ' ' GLY . 87.8 m-20 -113.03 -41.71 3.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 2.0 m-85 -132.75 169.85 16.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.102 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 32.0 mt-10 -134.8 146.3 49.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.596 ' HG3' HG11 ' A' ' 98' ' ' VAL . 88.9 mt-30 -120.53 83.64 34.77 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.586 ' HB2' ' HB ' ' A' ' 129' ' ' VAL . 85.7 Cg_endo -78.48 42.08 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.656 2.238 . . . . 0.0 112.902 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -145.8 -48.34 0.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.382 . . . . 0.0 110.167 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.22 -145.71 14.51 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.748 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.38 125.42 13.93 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.753 2.302 . . . . 0.0 112.396 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 54.02 35.0 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.105 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.79 -148.71 11.45 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.373 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.45 135.23 34.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 94' ' ' ILE . 57.5 t -93.13 132.4 37.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 1.1 tmtp? -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -72.22 112.24 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.261 0.553 . . . . 0.0 111.372 -173.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . . . -68.07 132.07 46.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.854 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.14 66.0 1.2 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.095 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -165.25 -151.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.334 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 119' ' ' LYS . 13.0 mptt -87.22 -48.08 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.156 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 51.0 m -155.04 144.14 15.04 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.509 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 7.4 Cg_exo -70.19 132.15 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.024 1.816 . . . . 0.0 112.003 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -91.06 40.37 1.02 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.863 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 127' ' ' LYS . 13.4 p -144.76 140.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.739 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -165.95 -59.45 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -111.3 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.662 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.79 -127.37 1.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.383 0.427 . . . . 0.0 110.302 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.636 ' HB2' HG23 ' A' ' 123' ' ' VAL . 47.8 mmtm 57.02 42.9 25.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.428 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -74.16 132.22 42.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.87 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 106' ' ' PRO . 13.0 p -65.48 135.23 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.371 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.506 -177.485 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.712 0.291 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -165.85 131.94 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 64.31 107.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.838 0.711 . . . . 0.0 111.133 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.06 24.76 10.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.328 0.585 . . . . 0.0 109.873 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.2 m -167.23 -141.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.954 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m 57.83 35.56 25.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 80' ' ' VAL . 75.3 mmtt -94.14 127.91 40.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -75.24 114.69 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.573 ' HA ' HD12 ' A' ' 50' ' ' LEU . 5.4 m-85 -62.59 -32.7 73.74 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -55.82 -46.31 78.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.978 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 46' ' ' SER . 10.9 pt-20 -72.46 -39.98 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.608 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 47' ' ' TYR . 66.2 mt -60.46 -51.68 68.45 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 69' ' ' LEU . 65.4 mt -65.12 -42.03 93.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.792 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.774 ' HA ' HD21 ' A' ' 115' ' ' LEU . 35.6 mt -64.32 -46.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.278 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.13 -36.74 71.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 110.119 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -77.15 -59.67 3.07 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.616 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD23 HD23 ' A' ' 115' ' ' LEU . 4.0 tp -54.08 -30.37 48.0 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.086 0.555 . . . . 0.0 112.442 -171.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -67.06 -33.06 74.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.142 0.496 . . . . 0.0 110.135 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.23 -44.8 12.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.012 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.81 HD21 HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -108.68 34.11 3.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.207 -173.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -23.47 63.84 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.258 -0.276 . . . . 0.0 110.656 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 69.01 -49.51 0.59 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -162.49 -38.2 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.387 178.185 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.702 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 60.2 pttt -179.86 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 110.751 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 135.31 2.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.699 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -119.05 151.85 37.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.017 0.437 . . . . 0.0 109.959 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -66.38 143.19 57.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.146 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 73.4 mtm180 -53.25 -50.01 84.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.652 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.5 Cg_endo -57.55 -30.06 87.14 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.196 1.931 . . . . 0.0 112.643 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.94 84.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.599 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.81 HD23 HD21 ' A' ' 58' ' ' LEU . 69.8 mt -63.38 -42.52 98.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.305 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 85.0 mttt -57.65 -42.48 83.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.318 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 65.8 tttp -65.34 -49.82 67.94 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.197 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 55.2 t80 -51.71 -45.69 63.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 69' ' ' LEU . 76.0 mt -65.13 -43.1 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.2 mttt -61.8 -42.36 98.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.1 mm-40 -64.84 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.259 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.64 -42.38 8.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.042 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -120.67 79.78 31.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.464 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.09 -22.15 68.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 112.273 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.838 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.7 mp -50.39 -61.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 122.04 0.924 . . . . 0.0 110.387 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 45' ' ' LYS . 1.1 t -79.85 -32.12 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.142 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.442 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -56.26 -45.83 87.51 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.701 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.2 m -100.96 33.04 2.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.791 0.329 . . . . 0.0 110.793 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 80' ' ' VAL . . . -80.1 32.69 0.27 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m 64.08 -72.65 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.56 0.744 . . . . 0.0 112.409 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -101.2 38.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 0.0 110.545 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -43.86 98.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.802 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -44.74 91.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.021 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.62 -48.05 82.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.222 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -60.97 -42.11 97.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.155 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 90.2 t80 -61.16 -49.62 76.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 74.6 m-20 -58.89 -42.97 90.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -65.77 -42.32 90.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.851 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.77 -42.76 89.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.749 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 29.4 mm -60.52 -53.74 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.688 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 91' ' ' ASN . 99.0 mttt -58.17 -46.54 85.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.55 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 18.3 tptm -65.78 -46.17 79.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.083 -175.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.54 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -70.81 -34.03 66.2 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.063 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.749 ' HB ' ' O ' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -63.77 -34.7 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.57 0.7 . . . . 0.0 111.042 -178.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 20.8 pt-20 -86.55 -36.6 18.84 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.491 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.14 71.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.225 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.71 ' HA2' ' HG3' ' A' ' 121' ' ' PRO . . . 119.75 37.8 0.75 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.554 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.38 -34.12 5.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 4.2 m-85 -127.4 161.42 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.418 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 9.6 pt-20 -144.8 129.74 18.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.922 0.391 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.58 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 70.5 mt-30 -99.21 103.51 20.7 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -60.98 -32.38 92.33 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.115 2.543 . . . . 0.0 113.234 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.44 -47.87 10.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.798 0.332 . . . . 0.0 110.962 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.8 27.41 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.8 135.99 72.26 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.525 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.77 39.99 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.204 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.94 -143.75 5.88 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.03 135.6 33.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.58 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 2.5 p -114.0 141.23 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.116 0.484 . . . . 0.0 110.821 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.2 ttpp -122.53 152.73 40.07 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.774 HD21 ' HA ' ' A' ' 52' ' ' ILE . 16.2 mt -57.75 130.37 46.12 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.61 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.43 159.94 32.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.915 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -67.53 80.63 0.17 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.469 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 118' ' ' LYS . 12.8 mptt 61.79 -114.71 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.462 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -103.99 43.52 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.807 0.336 . . . . 0.0 111.061 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 56.5 p -166.79 130.3 1.51 Allowed Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 120.932 0.396 . . . . 0.0 111.564 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.71 ' HG3' ' HA2' ' A' ' 101' ' ' GLY . 2.9 Cg_exo -77.23 137.09 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.179 2.586 . . . . 0.0 112.31 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 129' ' ' VAL . 48.6 mt-10 -98.85 44.49 1.03 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.152 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 105' ' ' GLN . 55.0 t -143.93 117.13 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.867 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 64.2 -50.81 0.28 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 172.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 121' ' ' PRO . 39.5 mtpt -58.94 125.85 25.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.947 0.403 . . . . 0.0 111.919 -172.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . 84.9 mt-10 57.35 -150.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.936 177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.863 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -83.18 -154.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -178.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.658 ' HG2' ' HG2' ' A' ' 127' ' ' LYS . 65.7 mm-40 60.16 -134.05 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.476 0.311 . . . . 0.0 111.367 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 122' ' ' GLU . 21.7 t 60.79 53.69 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.59 0.71 . . . . 0.0 110.041 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.147 -177.502 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.93 -50.9 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.247 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' OE2' ' HB3' ' A' ' 44' ' ' SER . 88.5 tt0 -172.75 129.62 0.52 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.249 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.17 -133.59 0.14 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.844 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 m -80.58 41.77 0.57 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.905 0.383 . . . . 0.0 111.907 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 14.5 t -84.3 42.36 0.88 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.447 0.641 . . . . 0.0 110.101 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -91.19 131.75 36.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.452 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 40.0 t -73.12 128.87 36.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.78 -18.76 62.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.825 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -58.73 -45.6 89.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 46' ' ' SER . 2.6 mt-10 -68.16 -50.71 52.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.227 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD23 HG11 ' A' ' 80' ' ' VAL . 4.7 mp -56.77 -55.84 29.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.328 -175.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 69' ' ' LEU . 67.8 mt -64.92 -54.44 29.62 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -176.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.617 HG13 ' HE1' ' A' ' 103' ' ' PHE . 90.4 mt -58.51 -41.42 81.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.7 -41.99 64.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.77 -53.52 3.52 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.127 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.635 HD11 ' HA ' ' A' ' 114' ' ' LYS . 34.7 tp -48.25 -37.39 16.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.387 0.675 . . . . 0.0 112.012 -172.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -72.0 -32.73 67.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.663 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.16 -42.32 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.09 12.1 33.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.871 -0.518 . . . . 0.0 111.834 -170.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -63.08 -27.54 69.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.702 0.286 . . . . 0.0 110.515 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 59.07 -111.76 0.57 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.908 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.51 -36.42 83.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.769 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.498 ' HD3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -175.41 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.498 ' N ' ' HD3' ' A' ' 62' ' ' LYS . . . -154.3 145.6 12.99 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.896 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 p -95.11 -117.13 0.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -167.36 152.61 7.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 52.8 mtp180 -54.45 -54.47 48.12 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.947 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 19.1 Cg_endo -59.55 -34.36 96.84 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.073 1.848 . . . . 0.0 112.083 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.31 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.866 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.47 HD11 HD13 ' A' ' 55' ' ' LEU . 44.7 mt -61.17 -45.94 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.577 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 45.5 mtmt -59.74 -34.66 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.647 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 85.0 tttt -63.84 -53.53 49.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.897 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -54.93 -43.16 73.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.98 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 69' ' ' LEU . 56.7 mt -62.57 -46.49 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.233 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 85.5 mttt -66.12 -34.12 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 111.484 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.8 mm-40 -66.07 -42.34 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.133 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.56 -44.5 7.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -119.8 71.52 15.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.69 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.79 -9.48 24.8 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.612 2.208 . . . . 0.0 113.315 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.826 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.3 mp -56.48 -58.49 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.054 0.93 . . . . 0.0 109.183 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -77.94 -30.74 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.735 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -57.03 -41.96 92.75 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.091 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.0 m -92.87 28.66 2.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.774 -0.251 . . . . 0.0 111.22 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -80.01 131.64 35.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -61.05 -39.92 91.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -102.46 26.85 7.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.464 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.769 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 31.9 t80 -59.2 -45.06 92.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.635 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.71 -47.59 79.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.66 -47.75 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.12 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -61.01 -43.27 99.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.484 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.37 -50.35 73.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.33 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.61 -36.28 82.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -66.88 -42.03 86.25 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.401 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 HG21 ' A' ' 113' ' ' VAL . 35.9 mm -60.12 -48.91 86.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 63.6 mttp -61.91 -43.04 99.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.252 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 23.7 tptm -68.22 -38.63 82.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.812 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -63.78 -43.28 97.94 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.194 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 27.1 m -64.82 -36.72 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.12 0.46 . . . . 0.0 111.362 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -76.25 -41.89 47.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.87 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.244 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.689 ' HA3' ' HA ' ' A' ' 119' ' ' LYS . . . 102.11 40.5 2.62 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.359 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -113.0 -43.6 3.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.812 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 6.1 m-85 -128.49 165.59 20.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.652 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' OE2' ' HG3' ' A' ' 117' ' ' LYS . 16.5 mt-10 -141.8 142.25 33.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.011 0.524 . . . . 0.0 109.715 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -115.21 117.71 40.88 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.46 -41.55 25.57 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.932 2.421 . . . . 0.0 112.659 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -83.64 -60.48 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.048 0.451 . . . . 0.0 110.746 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.04 -153.16 23.38 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.47 133.68 58.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.84 2.36 . . . . 0.0 112.8 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.5 28.87 18.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.21 -158.81 23.16 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.105 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.56 148.75 47.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.605 0.24 . . . . 0.0 110.512 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.653 HG21 HD12 ' A' ' 94' ' ' ILE . 34.2 t -117.78 152.97 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.887 0.375 . . . . 0.0 110.276 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.635 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -157.69 153.09 26.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.563 HD22 HD23 ' A' ' 55' ' ' LEU . 1.5 mm? -53.15 134.56 38.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.018 0.437 . . . . 0.0 111.861 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.43 142.51 56.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.968 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HG3' ' OE2' ' A' ' 104' ' ' GLU . 41.7 mttp -60.08 -36.8 78.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.903 -177.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . 33.1 ttmt -165.1 159.92 18.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.689 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -63.76 -49.16 74.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.625 ' H ' ' HG2' ' A' ' 119' ' ' LYS . 67.9 m 61.06 156.28 0.11 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.376 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.47 170.19 8.55 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.539 2.159 . . . . 0.0 111.584 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.35 116.39 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.442 0.639 . . . . 0.0 111.083 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -97.85 131.93 43.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.821 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? 47.51 -135.72 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.912 0.757 . . . . 0.0 112.255 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -147.73 -52.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.681 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.24 132.65 36.56 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HG3' ' HB3' ' A' ' 99' ' ' GLU . 3.4 mptp? -80.82 57.38 3.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 111.674 -176.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.425 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.6 mt-10 -78.86 61.22 3.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 128' ' ' GLU . 65.5 t 79.16 -44.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.361 -166.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.63 172.765 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.57 135.09 57.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.34 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 29.1 tt0 -80.09 54.07 1.85 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.096 0.474 . . . . 0.0 110.232 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.19 -46.46 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.158 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -136.32 23.82 3.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.501 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 67.0 m -92.29 34.09 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.491 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 80' ' ' VAL . 71.8 mmtt -88.87 140.62 29.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.3 m -68.48 107.36 2.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 110.279 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 51' ' ' ILE . 19.7 m-85 -62.61 -36.25 82.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.3 ttm105 -54.86 -43.48 73.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.87 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.74 -49.63 67.7 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.503 ' HB3' HG12 ' A' ' 73' ' ' ILE . 2.4 mp -55.32 -49.59 71.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.535 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.83 HG23 HD13 ' A' ' 69' ' ' LEU . 76.1 mt -66.33 -50.67 66.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.236 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.7 ' HA ' HD21 ' A' ' 115' ' ' LEU . 39.7 mt -61.25 -47.21 94.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.526 0.203 . . . . 0.0 111.304 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -54.25 -42.41 69.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.675 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.667 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -73.53 -56.98 5.24 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.332 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD23 HD23 ' A' ' 115' ' ' LEU . 4.8 tp -58.07 -30.28 66.09 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -75.96 -32.83 59.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.76 -51.01 6.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.38 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.698 ' HG ' ' N ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -76.79 -53.71 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.006 -176.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.698 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 40.3 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.749 2.42 . . . . 0.0 117.057 175.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' LEU . 51.3 mt-10 64.16 -105.73 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.27 0.628 . . . . 0.0 109.414 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -77.87 -30.28 50.79 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.711 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 167.65 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.134 178.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . -142.1 150.87 22.43 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -133.57 156.3 48.07 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.863 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.8 t -62.68 157.17 21.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 82.9 mtm180 -48.87 -52.41 46.58 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.076 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 6.0 Cg_endo -49.63 -38.28 45.15 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 122.977 2.452 . . . . 0.0 112.979 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.85 90.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.983 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.83 HD13 HG23 ' A' ' 51' ' ' ILE . 58.7 mt -66.16 -44.25 84.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.887 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 57.1 mtpt -59.07 -35.38 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.828 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 45.3 tttm -68.79 -50.23 52.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.333 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.1 -43.87 64.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.554 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' A' ' 50' ' ' LEU . 80.6 mt -62.87 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.963 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.5 mttt -61.19 -37.4 82.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 52.4 mt-10 -67.92 -42.4 81.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.964 0.411 . . . . 0.0 111.197 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.12 -40.54 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.94 76.2 58.0 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.592 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -18.99 52.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.779 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.7 mp -51.96 -67.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.829 0.823 . . . . 0.0 110.29 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 86' ' ' PHE . 1.2 t -74.21 -35.78 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.02 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.64 -42.29 66.93 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.935 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -102.66 27.75 6.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.952 0.406 . . . . 0.0 110.34 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -72.97 140.24 47.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -61.77 -38.74 89.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.453 0.644 . . . . 0.0 110.468 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -102.87 22.43 13.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.421 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 31.7 t80 -58.38 -45.49 88.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.201 0.524 . . . . 0.0 110.877 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.47 -42.57 98.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.208 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.2 -49.41 61.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.617 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -61.93 -43.42 98.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.057 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.42 ' O ' HG12 ' A' ' 94' ' ' ILE . 87.7 t80 -58.47 -47.32 84.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.487 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -62.17 -43.2 99.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.473 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -64.08 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.877 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.62 98.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.641 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 51' ' ' ILE . 30.9 mm -61.17 -53.22 52.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.02 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 57.2 mttm -53.81 -49.71 67.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.083 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -72.22 -30.88 65.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.631 ' HA3' ' CD1' ' A' ' 103' ' ' PHE . . . -75.67 -39.3 34.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.855 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 29.6 m -69.06 -37.69 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.904 0.352 . . . . 0.0 111.317 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.1 pt-20 -66.89 -39.18 87.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.925 0.393 . . . . 0.0 110.675 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.3 36.56 5.89 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.754 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -112.67 -23.12 10.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.8 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -135.28 153.78 51.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 169.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 34.6 mm-40 -142.23 123.21 14.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.768 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 54.8 mt-30 -96.27 107.79 37.62 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.851 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -62.94 -34.27 71.88 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.233 1.955 . . . . 0.0 111.522 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -86.5 33.3 0.63 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.46 -138.17 19.31 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.151 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -91.04 -28.52 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.992 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.97 52.13 2.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.79 -140.76 4.02 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.234 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.863 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -80.13 142.79 34.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.768 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 6.1 p -120.43 143.15 33.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.038 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -119.46 143.22 47.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.7 HD21 ' HA ' ' A' ' 52' ' ' ILE . 10.7 mt -58.12 129.46 42.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.608 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.12 121.62 42.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.464 0.65 . . . . 0.0 112.243 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -137.34 36.9 2.5 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -162.72 118.13 1.82 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 113.272 -1.786 . . . . 0.0 107.929 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.4 18.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.185 0.517 . . . . 0.0 110.699 -175.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 73.9 m -63.63 131.57 94.91 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.17 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 120' ' ' SER . 21.4 Cg_exo -60.76 138.21 77.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.013 1.809 . . . . 0.0 111.167 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -147.89 41.28 1.01 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.804 0.811 . . . . 0.0 110.059 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 106' ' ' PRO . 4.4 t -95.21 51.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.683 173.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.673 ' HG3' ' HG2' ' A' ' 128' ' ' GLU . 7.9 ttpm? -117.97 -34.29 4.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.732 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.628 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 4.0 ttmp? -70.94 140.78 51.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.231 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.628 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 85.5 mt-10 67.17 51.72 0.9 Allowed 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.637 0.586 . . . . 0.0 109.921 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 73.65 132.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.349 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.673 ' HG2' ' HG3' ' A' ' 124' ' ' LYS . 83.2 mt-10 -72.29 167.76 19.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.082 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.89 114.46 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.741 -177.029 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.611 0.243 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -84.97 -168.76 2.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.541 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 57.53 50.56 10.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 110.061 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.21 -10.57 42.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 m -72.82 7.02 2.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.004 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -78.41 41.8 0.4 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.87 0.367 . . . . 0.0 111.665 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' HG21 ' A' ' 80' ' ' VAL . 34.4 mmtm -77.88 135.49 37.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.82 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 m -72.68 116.6 13.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.243 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.91 -31.52 72.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.71 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -58.22 -42.12 85.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.439 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.79 -53.95 18.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 80' ' ' VAL . 2.8 mp -53.71 -53.46 51.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.822 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.412 HG12 ' HE1' ' A' ' 90' ' ' PHE . 63.5 mt -65.59 -50.64 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.315 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.498 HG23 HD21 ' A' ' 115' ' ' LEU . 51.7 mt -62.31 -42.64 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.79 -40.75 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 110.934 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -75.34 -59.38 3.6 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.467 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.891 HD23 HD22 ' A' ' 115' ' ' LEU . 19.1 tp -46.17 -37.96 7.68 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.927 0.891 . . . . 0.0 112.401 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -72.12 -31.99 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.94 -41.44 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.764 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 54' ' ' GLY . 1.5 pt? -107.4 20.11 19.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.449 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -66.59 -26.14 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.482 -0.136 . . . . 0.0 110.844 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 67.92 -46.16 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -151.62 -46.08 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.22 -0.3 . . . . 0.0 110.73 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 23.4 pttm -174.63 26.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.534 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.03 133.31 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.763 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.503 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -126.27 141.22 52.0 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.391 0.277 . . . . 0.0 110.293 178.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 m -62.56 137.11 58.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.763 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.557 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 39.2 mtp180 -53.8 -49.32 89.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.146 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 17.7 Cg_endo -56.41 -34.27 94.04 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.977 1.785 . . . . 0.0 112.523 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.05 95.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 58' ' ' LEU . 5.2 mp -60.59 -40.44 91.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -61.11 -35.72 77.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.501 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 59.3 tttp -65.09 -50.3 66.68 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.913 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.22 -44.04 64.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.948 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.1 mt -65.19 -42.8 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.824 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 111.489 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.4 mm-40 -63.48 -41.8 98.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.19 -43.46 8.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.197 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -120.36 81.58 30.53 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.499 0.19 . . . . 0.0 110.882 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.01 -23.39 77.36 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.659 2.239 . . . . 0.0 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.852 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.5 mp -53.62 -63.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.868 0.842 . . . . 0.0 110.4 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 50' ' ' LEU . 1.2 t -77.23 -33.26 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.689 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -41.52 61.62 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.551 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -104.53 30.62 5.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.766 0.317 . . . . 0.0 110.856 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 80' ' ' VAL . . . -82.71 48.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.6 t 55.79 -103.39 0.18 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.303 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -81.05 39.64 0.51 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.245 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.412 ' CD1' HG13 ' A' ' 80' ' ' VAL . 10.8 t80 -58.57 -40.16 82.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.21 -45.02 88.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.555 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.33 -44.93 95.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.196 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -61.89 -43.3 99.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.795 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.412 ' HE1' HG12 ' A' ' 51' ' ' ILE . 86.2 t80 -60.5 -50.32 74.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.075 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -59.3 -43.32 92.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.345 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -64.41 -40.72 96.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.807 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.78 93.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.15 -48.82 85.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.512 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 60.2 mtpt -58.61 -49.2 78.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.027 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 17.0 tptm -66.45 -39.71 89.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.805 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.633 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -67.67 -43.67 84.21 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.398 -175.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -64.71 -39.03 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.996 0.398 . . . . 0.0 111.687 -175.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.5 pt-20 -72.0 -40.99 68.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.55 83.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.183 0.516 . . . . 0.0 111.048 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.2 40.34 0.59 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.703 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 -37.83 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.68 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 7.6 m-85 -129.03 160.09 33.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.916 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 121' ' ' PRO . 29.7 mm-40 -126.69 144.68 50.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.965 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.57 HE21 HG11 ' A' ' 98' ' ' VAL . 54.7 mt-30 -128.16 105.67 19.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.918 0.389 . . . . 0.0 111.144 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 90.5 Cg_endo -78.61 39.67 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.151 2.567 . . . . 0.0 112.708 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -148.39 -56.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.761 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.85 -144.43 7.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.88 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.14 -38.31 2.85 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.735 2.29 . . . . 0.0 113.494 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.486 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -127.74 40.81 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.59 -145.11 18.43 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.969 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.616 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -84.93 141.19 30.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.64 HG12 HD21 ' A' ' 55' ' ' LEU . 14.5 t -104.42 154.12 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.789 0.328 . . . . 0.0 110.502 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 62' ' ' LYS . 78.0 tttt -148.58 144.54 27.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.891 HD22 HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -52.47 133.14 35.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.56 -178.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.62 130.59 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -63.41 -54.59 34.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.934 -172.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 2.8 mmmp? -130.75 35.41 4.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 1.6 mptm? 70.63 -52.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.031 0.832 . . . . 0.0 110.921 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 m -69.69 148.68 96.76 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.549 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 5.9 Cg_endo -49.96 135.92 36.49 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.312 2.675 . . . . 0.0 112.613 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.11 48.62 0.38 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.849 -175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.82 67.08 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.974 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.1 61.0 4.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.646 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -69.44 -17.37 63.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.794 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -165.0 156.54 15.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.466 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.01 -43.01 99.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 31.93 0.64 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.951 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -74.04 -34.93 40.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.0 0.429 . . . . 0.0 110.27 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.401 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -110.61 -46.81 3.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -156.28 143.11 18.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.242 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.59 141.59 30.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.495 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.469 ' HA ' HG22 ' A' ' 79' ' ' ILE . 13.9 m 64.08 46.23 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -85.06 41.74 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HE3' HD13 ' A' ' 79' ' ' ILE . 71.2 mmtt -88.17 120.76 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 m -67.55 121.9 16.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.118 0.485 . . . . 0.0 110.051 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -63.23 -23.59 67.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.188 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.61 -38.0 80.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.716 0.293 . . . . 0.0 110.735 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 46' ' ' SER . 4.2 mt-10 -72.18 -50.6 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' CD2' HG11 ' A' ' 80' ' ' VAL . 2.4 mp -54.0 -52.46 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.623 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD13 HD13 ' A' ' 94' ' ' ILE . 69.1 mt -64.09 -53.01 48.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.293 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.514 HG13 ' HE1' ' A' ' 103' ' ' PHE . 60.4 mt -61.89 -44.62 99.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.738 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -54.52 -44.36 72.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.516 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 58' ' ' LEU . . . -69.54 -63.38 3.4 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.2 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.877 ' HG ' HD22 ' A' ' 115' ' ' LEU . 15.0 tp -40.72 -44.83 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.444 1.097 . . . . 0.0 112.757 -175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.443 ' N ' HD21 ' A' ' 115' ' ' LEU . 4.6 t -73.03 -26.38 61.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.512 0.672 . . . . 0.0 110.922 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.01 -39.62 14.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.644 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 54' ' ' GLY . 1.2 pt? -113.8 20.98 15.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.959 -0.463 . . . . 0.0 111.934 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 46.2 pttt -61.17 -31.57 71.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.737 0.304 . . . . 0.0 111.266 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 56.51 -102.63 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.113 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -65.8 -34.29 77.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.363 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.577 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 9.6 ptpp? 173.76 -37.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.821 0.448 . . . . 0.0 110.079 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.95 26.29 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.711 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -124.01 141.6 51.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.726 0.298 . . . . 0.0 111.348 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 5.7 m -63.74 148.3 49.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.372 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.566 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.8 -50.9 58.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.0 Cg_endo -50.84 -33.18 40.18 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.76 2.307 . . . . 0.0 112.865 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.05 -48.22 74.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.948 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 73' ' ' ILE . 6.6 mp -65.56 -38.6 90.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.844 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 92.6 mttt -57.78 -39.96 78.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.58 -51.39 62.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.172 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -52.76 -44.22 66.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.847 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 69' ' ' LEU . 81.5 mt -67.56 -45.87 84.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.459 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.1 mttt -58.7 -43.32 90.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.86 0.362 . . . . 0.0 111.221 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.4 -39.68 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.818 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -94.45 -36.35 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -125.68 72.98 68.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 -23.36 42.93 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.959 2.439 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.1 mp -53.34 -68.06 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.542 0.687 . . . . 0.0 110.598 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG11 ' CD2' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -70.9 -35.41 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.88 177.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -42.14 62.58 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.8 m -107.16 38.95 1.98 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.791 0.329 . . . . 0.0 110.844 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.61 3.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.82 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t 70.8 -58.91 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.808 0.843 . . . . 0.0 111.806 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -96.73 23.88 6.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CD1' HG13 ' A' ' 80' ' ' VAL . 20.6 t80 -56.36 -44.88 80.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.681 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.24 -40.59 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.57 -48.7 76.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.173 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.213 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 51' ' ' ILE . 82.5 t80 -62.06 -48.52 79.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.785 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -61.74 -41.6 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -60.58 -42.04 95.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.787 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.815 HD12 HG21 ' A' ' 113' ' ' VAL . 40.5 mm -60.53 -53.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.62 -45.01 92.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.696 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -67.71 -38.51 83.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.145 0.498 . . . . 0.0 110.149 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.608 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -66.43 -43.49 92.41 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.17 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 26.8 m -66.34 -37.89 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.101 0.451 . . . . 0.0 111.602 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.82 -42.62 66.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.553 0.216 . . . . 0.0 110.908 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.51 93.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.98 35.88 1.09 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.31 -36.11 5.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.9 m-85 -130.64 162.09 30.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.832 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -135.49 149.01 49.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.552 ' HG3' HG11 ' A' ' 98' ' ' VAL . 47.4 mt-30 -124.69 113.34 27.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.974 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 61.4 Cg_endo -76.81 -33.83 2.7 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.954 2.436 . . . . 0.0 113.031 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.88 -46.62 12.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.173 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.02 -174.02 45.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.729 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.51 -29.33 89.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.273 2.648 . . . . 0.0 112.639 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . -135.39 39.81 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 110.105 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.36 -56.59 0.87 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.866 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -173.57 143.03 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.617 0.367 . . . . 0.0 110.131 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.815 HG21 HD12 ' A' ' 94' ' ' ILE . 21.4 t -99.48 150.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 0.0 110.988 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -143.31 141.54 31.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.877 HD22 ' HG ' ' A' ' 55' ' ' LEU . 2.7 mm? -52.84 131.02 34.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.124 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.55 117.55 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.56 174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 117' ' ' LYS . 26.3 ttmt -149.4 22.22 0.93 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.382 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 8.1 mmpt? -151.83 135.03 15.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.56 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 3.3 mppt? -75.15 -54.53 6.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 13.4 p -86.46 147.48 44.37 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 120' ' ' SER . 28.2 Cg_exo -60.35 145.99 97.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.342 2.028 . . . . 0.0 111.889 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -137.82 54.89 1.8 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.514 0.673 . . . . 0.0 109.733 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.62 133.78 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.433 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.09 107.14 9.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 111.572 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 48.04 45.94 19.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.358 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.27 -46.83 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.463 0.649 . . . . 0.0 109.345 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -163.07 29.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.819 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 54.83 42.76 30.89 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.429 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.86 132.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.284 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.741 -178.115 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 121.062 0.458 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 72.1 mmtt -98.33 126.94 44.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.466 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 40.4 t -71.84 124.58 25.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -64.42 -26.11 68.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.289 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.07 -43.47 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.355 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 3.1 mm-40 -73.08 -46.07 53.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.337 0.589 . . . . 0.0 110.28 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 HG11 ' A' ' 80' ' ' VAL . 1.4 mp -61.35 -49.85 75.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.434 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.521 HD13 HD13 ' A' ' 94' ' ' ILE . 70.7 mt -62.91 -51.36 72.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.71 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.807 HG13 ' HE1' ' A' ' 103' ' ' PHE . 47.6 mt -60.14 -43.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -50.8 -43.98 58.9 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.412 0.445 . . . . 0.0 110.485 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -80.8 -55.88 3.24 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.547 176.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.697 HD13 HD11 ' A' ' 69' ' ' LEU . 24.2 tp -51.29 -31.08 20.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.326 0.651 . . . . 0.0 111.953 -171.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -75.89 -31.04 59.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.19 -51.19 5.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -89.31 21.42 3.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.139 0.495 . . . . 0.0 111.007 -173.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -59.75 -32.09 70.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.992 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 56.2 -109.36 0.49 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.689 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 16.2 ptm180 -65.86 -34.78 78.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.189 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.737 ' O ' ' HD3' ' A' ' 114' ' ' LYS . 21.0 ptmt -175.2 -48.2 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.062 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.2 29.78 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -141.41 152.64 44.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 7.7 t -66.42 159.99 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.724 -174.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.556 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -50.29 -50.14 72.38 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.6 Cg_endo -50.85 -38.98 58.73 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.599 2.199 . . . . 0.0 112.84 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.43 81.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.756 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.697 HD11 HD13 ' A' ' 55' ' ' LEU . 18.1 mt -63.6 -41.64 98.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.244 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 94.9 mttt -60.1 -38.78 83.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 88.1 tttt -68.29 -47.69 66.95 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.121 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -50.7 -47.06 59.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.752 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.63 -40.56 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.071 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 97.3 mttt -63.31 -40.11 96.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.634 0.254 . . . . 0.0 111.664 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 4.8 mm-40 -73.59 -39.45 64.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.317 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -93.96 -41.44 9.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -119.87 73.51 18.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.13 -23.68 54.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.994 2.463 . . . . 0.0 113.585 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.855 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.1 mp -50.06 -56.42 3.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.857 0.837 . . . . 0.0 110.456 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -91.55 -32.37 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -55.31 -41.43 79.61 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.348 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -100.92 33.2 2.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.227 0.537 . . . . 0.0 109.994 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.32 145.49 25.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.078 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m -65.13 125.19 24.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.33 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m120 65.44 29.88 11.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.61 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.98 -43.42 98.85 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.321 0.581 . . . . 0.0 110.07 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -54.01 -42.35 68.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.05 -49.17 38.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -56.51 -37.81 70.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.597 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.501 ' CE1' HG12 ' A' ' 51' ' ' ILE . 69.6 t80 -58.65 -41.29 85.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.181 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -61.09 -45.54 94.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -64.09 -36.16 83.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.639 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.95 99.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.54 HD12 HG21 ' A' ' 113' ' ' VAL . 42.6 mm -60.73 -47.62 92.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.268 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 97.3 mttt -59.72 -42.49 93.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.963 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 tmtp? -65.61 -39.66 91.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.242 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.804 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -69.56 -40.82 77.67 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.106 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.6 m -70.26 -36.81 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.022 0.411 . . . . 0.0 111.29 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 1.5 pt-20 -67.85 -35.64 78.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.928 0.394 . . . . 0.0 110.361 175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.874 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.84 41.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.964 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -113.38 -32.47 6.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.807 ' HE1' HG13 ' A' ' 52' ' ' ILE . 8.4 m-85 -121.41 158.41 28.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.161 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.59 143.6 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 67.8 mt-30 -111.5 104.2 55.86 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-O 120.971 0.415 . . . . 0.0 111.034 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 21.0 Cg_endo -62.03 -35.28 77.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.229 2.619 . . . . 0.0 112.512 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -96.04 28.99 2.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.288 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.93 174.82 34.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -63.51 140.27 74.77 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.706 2.271 . . . . 0.0 111.442 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 68.09 41.34 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.6 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.47 -138.64 3.9 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.658 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.85 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -85.94 134.95 33.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.641 HG12 HD21 ' A' ' 55' ' ' LEU . 39.7 t -97.99 154.0 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.737 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 44.1 tptt -144.47 133.12 22.24 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.681 HD22 HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -55.35 118.8 4.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.54 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 121.206 0.527 . . . . 0.0 110.933 179.428 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.164 0.507 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 80' ' ' VAL . 30.6 mmtm -91.49 147.0 23.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 15.3 t -70.21 -17.16 63.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.826 0.346 . . . . 0.0 111.368 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 71.49 -44.35 0.59 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.191 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' HG3' HD12 ' A' ' 52' ' ' ILE . 4.7 ttm105 -54.51 -45.55 73.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.057 0.456 . . . . 0.0 110.58 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.591 ' HG3' HD13 ' A' ' 50' ' ' LEU . 13.6 pt-20 -59.73 -46.01 90.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.13 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.591 HD13 ' HG3' ' A' ' 49' ' ' GLU . 5.1 mp -62.75 -52.52 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.664 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.95 -52.14 63.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.535 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.625 HD11 ' OD2' ' A' ' 102' ' ' ASP . 74.7 mt -63.45 -41.29 92.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.57 -37.47 70.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.638 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -78.17 -58.62 3.12 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.421 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 115' ' ' LEU . 32.1 tp -49.71 -32.65 13.95 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.454 0.702 . . . . 0.0 112.381 -172.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -31.75 63.49 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 110.773 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.05 -50.27 6.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -92.2 17.39 9.7 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.825 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 17.2 pttp -68.43 -29.04 67.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 58.76 -113.35 0.68 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.738 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.611 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.2 ptp85 -67.34 -27.48 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 59.3 pttt -173.29 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 114' ' ' LYS . . . -150.83 158.38 27.65 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 119.714 -1.232 . . . . 0.0 114.004 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.432 ' OG ' ' HG ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -106.25 144.06 33.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.403 . . . . 0.0 111.169 -177.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -64.19 141.93 58.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.546 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.3 mtp-105 -55.43 -49.59 91.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.1 Cg_endo -58.32 -29.02 86.72 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.944 1.763 . . . . 0.0 112.107 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.02 83.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 55' ' ' LEU . 39.3 mt -62.58 -43.82 97.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.408 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 98.4 mttt -57.15 -40.69 77.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.703 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 53.4 tttp -67.97 -47.34 68.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.564 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.16 -46.02 65.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.374 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.411 HG23 HD23 ' A' ' 50' ' ' LEU . 53.4 mt -63.65 -44.28 98.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.2 mttt -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 67.2 mm-40 -69.68 -39.51 76.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.365 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -94.29 -41.45 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -123.16 77.16 51.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.618 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.03 -17.6 45.85 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.398 . . . . 0.0 112.824 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.743 ' H ' HD12 ' A' ' 79' ' ' ILE . 2.8 mp -55.71 -64.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 122.049 0.928 . . . . 0.0 110.016 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -76.16 -33.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.206 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -51.55 -42.35 51.19 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.679 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -101.67 31.12 3.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -74.87 148.68 39.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.711 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -47.63 80.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -113.39 34.85 4.27 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 46.4 t80 -54.71 -46.17 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.591 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -58.46 -47.45 83.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.836 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.58 -48.33 75.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -58.97 -45.05 91.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.245 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.44 ' O ' HG12 ' A' ' 94' ' ' ILE . 90.5 t80 -56.77 -47.11 80.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -62.13 -44.1 97.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.736 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.604 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 78.6 m-20 -66.01 -38.81 89.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.751 0.31 . . . . 0.0 110.769 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.94 88.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.383 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 90' ' ' PHE . 36.5 mm -61.73 -51.69 69.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.991 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.604 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -62.29 -41.07 98.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -173.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 46.6 tptt -71.73 -34.59 69.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.747 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -67.73 -40.37 90.02 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 17.2 m -65.2 -42.13 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.166 0.483 . . . . 0.0 111.246 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -67.81 -41.25 83.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.87 -28.37 68.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.626 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.63 4.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.55 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.625 ' OD2' HD11 ' A' ' 52' ' ' ILE . 35.2 t70 -113.83 -41.99 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.027 -0.586 . . . . 0.0 109.495 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.747 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 21.1 m-85 -114.44 171.82 7.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.957 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -153.47 136.33 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 80.7 mt-30 -122.39 105.84 36.03 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 25.5 Cg_endo -62.14 -36.05 71.81 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.896 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HB2' ' HA3' ' A' ' 111' ' ' GLY . 98.9 mttt -91.76 16.37 10.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.15 -146.59 49.28 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.955 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.71 133.88 57.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.15 2.567 . . . . 0.0 112.482 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.76 30.7 18.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.108 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 107' ' ' LYS . . . -114.89 160.1 13.38 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.566 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.61 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -55.12 130.83 43.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 55' ' ' LEU . 17.7 t -90.17 155.66 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.486 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.634 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -152.16 136.8 16.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.687 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -51.15 127.32 18.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.801 -174.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.039 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.233 0.214 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 71.5 mmtt -83.16 138.23 33.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.473 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 48.2 m -72.41 115.74 12.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 51' ' ' ILE . 8.1 m-85 -62.29 -30.45 71.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.544 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -52.5 -48.55 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.988 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 19.2 mm-40 -62.53 -46.65 87.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.173 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 HG11 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -60.06 -48.53 81.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.834 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.696 HG12 ' HE1' ' A' ' 90' ' ' PHE . 68.7 mt -64.29 -53.85 38.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.06 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.78 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.9 mt -60.44 -45.52 96.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.48 -39.2 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 110.504 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -80.42 -59.88 2.46 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.451 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.68 ' HB3' HD23 ' A' ' 115' ' ' LEU . 18.3 tp -46.04 -36.06 5.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.185 0.994 . . . . 0.0 112.543 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -68.78 -34.21 75.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.122 0.486 . . . . 0.0 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.55 -53.44 4.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 64' ' ' SER . 1.7 pt? -91.52 20.34 5.45 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.923 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -60.43 -19.89 57.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.683 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 43.9 mt-10 63.29 -115.13 0.46 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.982 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -73.06 -48.2 38.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.688 0.28 . . . . 0.0 111.142 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -179.18 27.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.233 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.48 125.94 0.88 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.583 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.614 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 2.3 p -113.22 133.46 55.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.7 m -57.92 135.65 56.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.936 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.585 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 35.5 ptt180 -53.92 -41.11 86.3 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 21.5 Cg_endo -57.94 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.672 1.582 . . . . 0.0 112.703 177.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.24 88.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' A' ' 58' ' ' LEU . 6.7 mp -59.42 -33.43 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.434 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HG3' ' HA ' ' A' ' 67' ' ' PRO . 8.6 mtmm -56.97 -38.49 73.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.2 tttp -67.1 -52.35 42.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.099 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.42 -43.47 64.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.817 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.45 HG12 ' HB3' ' A' ' 50' ' ' LEU . 79.7 mt -65.87 -46.8 87.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.164 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.3 mttt -60.48 -43.38 97.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 111.437 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.2 mt-10 -66.46 -36.68 83.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -93.96 -33.72 13.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.823 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -130.24 76.04 78.38 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.525 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.48 -21.29 37.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.036 2.491 . . . . 0.0 112.469 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.842 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.7 mp -52.37 -68.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.721 0.772 . . . . 0.0 110.52 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.555 HG11 HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -73.23 -30.51 31.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.223 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -34.46 36.68 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.82 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -114.94 42.31 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.208 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.08 15.25 1.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.775 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m 69.75 -62.35 0.42 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.832 0.853 . . . . 0.0 112.468 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -98.4 29.56 3.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.035 0.445 . . . . 0.0 110.127 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.47 -46.18 80.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.472 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.404 ' CB ' ' HE3' ' A' ' 70' ' ' LYS . 6.5 p-10 -62.24 -42.15 99.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.744 0.307 . . . . 0.0 110.847 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.95 -48.54 65.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.344 0.593 . . . . 0.0 110.166 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -61.09 -41.01 95.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.696 ' HE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -59.34 -43.85 92.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.26 -43.74 98.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -64.48 -38.23 90.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.876 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.21 -41.86 98.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.788 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 51' ' ' ILE . 46.4 mm -59.85 -48.99 85.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.273 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' NZ ' ' HB3' ' A' ' 95' ' ' LYS . 9.9 mtpm? -57.33 -48.18 79.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.224 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' OE2' ' A' ' 99' ' ' GLU . 13.3 tmtt? -62.92 -41.08 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.239 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.794 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -65.72 -43.67 93.77 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.101 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 25.3 m -69.69 -35.47 65.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.365 -0.491 . . . . 0.0 111.651 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 96' ' ' LYS . 22.4 pt-20 -74.09 -33.76 63.75 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.952 0.406 . . . . 0.0 110.804 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.74 -19.0 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.66 42.31 6.91 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.78 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -117.03 -37.85 3.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.794 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 8.6 m-85 -118.14 161.65 19.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.953 171.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -142.06 130.79 22.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HG2' HG22 ' A' ' 113' ' ' VAL . 83.0 mt-30 -106.39 110.43 63.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 11.2 Cg_exo -71.39 -37.04 6.08 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.005 2.47 . . . . 0.0 112.754 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -86.73 -48.85 7.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.462 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.84 170.84 37.01 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.784 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.551 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 20.9 Cg_endo -61.65 -34.03 85.07 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.029 2.486 . . . . 0.0 112.561 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.5 43.8 1.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.08 -144.61 4.17 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.1 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -74.64 137.84 42.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.87 0.367 . . . . 0.0 111.523 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 55' ' ' LEU . 11.4 t -108.27 158.71 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.644 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -139.79 140.93 36.78 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -56.34 119.78 6.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.649 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.051 -178.361 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 121.256 0.55 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -84.14 122.38 28.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.58 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 4.8 m -70.16 121.09 16.86 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -58.65 -33.64 70.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.913 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -54.95 -40.07 69.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.636 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 3.4 mm-40 -69.93 -52.35 25.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.349 0.595 . . . . 0.0 110.087 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 80' ' ' VAL . 2.5 mp -57.17 -49.02 77.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.71 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.543 HG12 ' HE1' ' A' ' 90' ' ' PHE . 82.9 mt -63.38 -52.64 55.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.972 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.533 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.2 mt -63.76 -44.99 98.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.59 -41.07 84.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.462 0.649 . . . . 0.0 109.898 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.636 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -71.28 -53.34 10.55 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.627 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.906 HD23 HD13 ' A' ' 115' ' ' LEU . 46.0 tp -54.07 -37.77 64.56 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.662 0.785 . . . . 0.0 111.916 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.423 ' N ' HD21 ' A' ' 115' ' ' LEU . 5.8 t -74.9 -31.11 61.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 110.647 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 -53.5 10.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.274 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.684 HD13 ' HB3' ' A' ' 64' ' ' SER . 1.2 pp -89.16 30.97 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.612 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -54.78 -33.67 61.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.031 -177.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 58' ' ' LEU . 90.5 mt-10 66.63 -48.82 0.45 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 111.932 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.59 -28.26 0.1 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.231 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 26.0 pttm -168.05 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.057 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 113' ' ' VAL . . . -160.38 159.9 31.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.085 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.684 ' HB3' HD13 ' A' ' 58' ' ' LEU . 6.7 t -124.54 162.49 23.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.83 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.987 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.8 m -64.59 159.65 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.635 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 110' ' ' ALA . 99.4 mtt180 -53.99 -48.49 93.75 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.9 Cg_endo -51.24 -41.16 59.5 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.407 2.071 . . . . 0.0 112.614 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.27 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 110.699 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.499 HD11 HD13 ' A' ' 55' ' ' LEU . 40.1 mt -63.27 -47.27 83.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.698 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 90' ' ' PHE . 25.5 mtmm -61.41 -36.5 80.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.112 0.482 . . . . 0.0 110.574 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 37.1 tttm -65.23 -50.36 66.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.271 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -53.7 -44.33 69.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.072 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -66.13 -41.09 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.46 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 99.5 mttt -68.21 -31.81 71.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.3 mt-10 -70.28 -47.91 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 111.182 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -94.69 -35.29 12.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.403 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -122.43 73.01 39.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 122.384 -0.198 . . . . 0.0 110.704 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.49 -23.69 57.45 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 2.78 . . . . 0.0 112.937 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.806 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.1 mp -52.11 -59.21 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.068 0.937 . . . . 0.0 110.679 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 50' ' ' LEU . 1.2 t -86.99 -34.34 7.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.582 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.94 -42.4 70.07 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.297 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.1 m -102.22 32.29 3.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.085 0.469 . . . . 0.0 110.831 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.73 149.62 27.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 120.96 13.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.68 33.29 13.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.22 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -58.16 -46.23 86.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.19 0.519 . . . . 0.0 110.309 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.96 -45.25 78.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.706 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.89 -45.9 80.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -61.45 -41.47 97.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.543 ' HE1' HG12 ' A' ' 51' ' ' ILE . 90.4 t80 -59.7 -47.33 86.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -59.3 -42.15 90.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.364 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.52 -39.35 93.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.054 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.61 96.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.526 HD12 HG21 ' A' ' 113' ' ' VAL . 47.8 mm -60.98 -46.64 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 86.3 mttt -57.77 -45.74 85.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.074 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 5.3 tppp? -67.18 -41.45 85.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.747 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.646 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -65.08 -42.59 96.54 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.129 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -66.96 -31.42 53.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.065 0.433 . . . . 0.0 111.672 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -81.13 -36.57 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.093 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.21 73.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.874 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.35 46.33 1.08 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.528 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.415 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 7.6 t0 -124.02 -33.29 3.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 0.0 109.972 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 2.5 m-85 -135.59 160.72 37.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.733 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 78.1 mt-10 -126.94 143.38 51.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.579 ' HG3' HG11 ' A' ' 98' ' ' VAL . 63.8 mt-30 -108.42 110.17 61.63 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.802 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -69.07 -39.8 7.31 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.059 2.506 . . . . 0.0 112.765 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -84.03 -47.1 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.322 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.82 -165.89 29.26 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.235 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.06 131.19 44.44 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.226 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 60.07 25.38 14.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.555 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.35 -149.95 11.62 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.941 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.987 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -64.41 150.46 46.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.481 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.526 HG21 HD12 ' A' ' 94' ' ' ILE . 44.0 t -117.68 151.41 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -140.12 137.42 34.46 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.906 HD13 HD23 ' A' ' 55' ' ' LEU . 2.7 mm? -56.77 121.55 10.09 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.847 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.733 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.743 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.134 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 121.116 0.484 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HE3' HD13 ' A' ' 79' ' ' ILE . 72.5 mmtt -75.54 127.6 33.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.593 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 26.8 t -70.74 116.94 11.63 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' HE2' ' HD1' ' A' ' 86' ' ' PHE . 19.0 m-85 -63.53 -33.9 76.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 54.3 ttt180 -55.27 -48.47 73.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.786 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 46' ' ' SER . 24.0 tp10 -68.41 -46.59 69.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.447 ' CD2' HG11 ' A' ' 80' ' ' VAL . 1.3 mp -54.48 -48.66 71.56 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.261 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 94' ' ' ILE . 81.0 mt -65.6 -46.75 88.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' HE1' ' A' ' 103' ' ' PHE . 36.7 mt -61.4 -50.18 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.595 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -55.07 -40.24 70.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.202 0.525 . . . . 0.0 110.539 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -76.91 -59.69 3.11 Favored Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.844 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.829 HD23 HD21 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -55.6 -34.56 64.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.841 -171.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.496 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 4.7 t -65.79 -28.81 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.55 -49.19 7.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.59 14.4 19.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -60.8 -26.58 67.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 57.44 -106.87 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.059 0.456 . . . . 0.0 110.466 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.6 ptp85 -69.22 -35.12 75.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.788 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 14.2 ptpt -179.61 -40.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 167.0 26.9 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -135.19 144.68 47.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.289 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -66.2 160.55 24.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.16 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 67.3 mtm180 -54.4 -52.45 69.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.7 Cg_endo -55.34 -33.22 84.54 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.271 1.981 . . . . 0.0 112.501 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.99 97.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.593 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.829 HD21 HD23 ' A' ' 55' ' ' LEU . 30.7 mt -67.07 -47.14 72.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.393 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 9.2 mtmp? -61.32 -39.13 89.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 63.8 tttm -67.09 -49.53 64.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 109.844 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -51.09 -44.89 61.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.76 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.44 -43.88 97.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.948 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 90.4 mttt -63.9 -34.41 77.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.619 0.247 . . . . 0.0 111.547 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.5 mm-40 -69.91 -41.86 74.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -100.28 -33.28 10.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.9 67.51 79.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.598 0.237 . . . . 0.0 110.819 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.83 -19.73 40.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.221 2.614 . . . . 0.0 112.973 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.825 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.0 mp -51.37 -57.18 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 122.252 1.025 . . . . 0.0 109.865 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 50' ' ' LEU . 1.2 t -85.02 -35.78 10.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.916 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.11 -40.5 59.24 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -102.42 30.09 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 110.437 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.97 145.96 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.1 m -59.49 -37.13 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.132 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -116.13 32.7 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.516 ' HD1' ' HE2' ' A' ' 47' ' ' TYR . 34.9 t80 -56.01 -48.39 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.397 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.28 -44.24 97.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.34 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.01 -46.38 78.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -62.36 -40.14 95.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.207 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -59.38 -50.65 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -61.52 -38.58 87.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.549 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -67.14 -37.28 83.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.126 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.86 97.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 113' ' ' VAL . 45.2 mm -58.85 -51.04 76.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -43.3 89.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.752 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.677 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -68.04 -44.36 76.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 109.735 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.726 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -60.88 -45.69 96.04 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.857 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.2 m -65.81 -33.59 64.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.897 0.348 . . . . 0.0 111.871 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 1.6 pp20? -77.68 -41.32 38.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 110.657 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.35 -42.84 74.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.735 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.96 40.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HB2' ' CA ' ' A' ' 97' ' ' GLY . 87.8 m-20 -113.03 -41.71 3.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 2.0 m-85 -132.75 169.85 16.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.102 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 32.0 mt-10 -134.8 146.3 49.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.596 ' HG3' HG11 ' A' ' 98' ' ' VAL . 88.9 mt-30 -120.53 83.64 34.77 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.48 42.08 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.656 2.238 . . . . 0.0 112.902 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -145.8 -48.34 0.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.382 . . . . 0.0 110.167 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.22 -145.71 14.51 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.748 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.38 125.42 13.93 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.753 2.302 . . . . 0.0 112.396 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 54.02 35.0 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.105 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.79 -148.71 11.45 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.373 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.45 135.23 34.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 94' ' ' ILE . 57.5 t -93.13 132.4 37.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 1.1 tmtp? -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -72.22 112.24 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.261 0.553 . . . . 0.0 111.372 -173.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.624 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.854 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.234 0.237 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 80' ' ' VAL . 75.3 mmtt -94.14 127.91 40.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -75.24 114.69 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.573 ' HA ' HD12 ' A' ' 50' ' ' LEU . 5.4 m-85 -62.59 -32.7 73.74 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -55.82 -46.31 78.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.978 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 46' ' ' SER . 10.9 pt-20 -72.46 -39.98 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.608 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 47' ' ' TYR . 66.2 mt -60.46 -51.68 68.45 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 69' ' ' LEU . 65.4 mt -65.12 -42.03 93.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.792 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.774 ' HA ' HD21 ' A' ' 115' ' ' LEU . 35.6 mt -64.32 -46.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.278 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.13 -36.74 71.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 110.119 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -77.15 -59.67 3.07 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.616 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD23 HD23 ' A' ' 115' ' ' LEU . 4.0 tp -54.08 -30.37 48.0 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.086 0.555 . . . . 0.0 112.442 -171.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -67.06 -33.06 74.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.142 0.496 . . . . 0.0 110.135 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.23 -44.8 12.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.012 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.81 HD21 HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -108.68 34.11 3.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.207 -173.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -23.47 63.84 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.258 -0.276 . . . . 0.0 110.656 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 69.01 -49.51 0.59 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -162.49 -38.2 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.387 178.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.702 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 60.2 pttt -179.86 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 110.751 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 135.31 2.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.699 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -119.05 151.85 37.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.017 0.437 . . . . 0.0 109.959 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -66.38 143.19 57.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.146 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.567 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 73.4 mtm180 -53.25 -50.01 84.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.652 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.5 Cg_endo -57.55 -30.06 87.14 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.196 1.931 . . . . 0.0 112.643 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.94 84.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.599 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.81 HD23 HD21 ' A' ' 58' ' ' LEU . 69.8 mt -63.38 -42.52 98.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.305 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 85.0 mttt -57.65 -42.48 83.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.318 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 65.8 tttp -65.34 -49.82 67.94 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.197 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 55.2 t80 -51.71 -45.69 63.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 69' ' ' LEU . 76.0 mt -65.13 -43.1 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.2 mttt -61.8 -42.36 98.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.1 mm-40 -64.84 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.259 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.64 -42.38 8.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.042 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -120.67 79.78 31.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.464 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.09 -22.15 68.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 112.273 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.838 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.7 mp -50.39 -61.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 122.04 0.924 . . . . 0.0 110.387 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 45' ' ' LYS . 1.1 t -79.85 -32.12 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.142 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.442 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -56.26 -45.83 87.51 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.701 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.2 m -100.96 33.04 2.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.791 0.329 . . . . 0.0 110.793 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 80' ' ' VAL . . . -80.1 32.69 0.27 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m 64.08 -72.65 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.56 0.744 . . . . 0.0 112.409 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 38.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 0.0 110.545 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -43.86 98.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.802 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -44.74 91.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.021 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.62 -48.05 82.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.222 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -60.97 -42.11 97.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.155 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 90.2 t80 -61.16 -49.62 76.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 74.6 m-20 -58.89 -42.97 90.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -65.77 -42.32 90.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.851 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.77 -42.76 89.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.749 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 29.4 mm -60.52 -53.74 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.688 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 91' ' ' ASN . 99.0 mttt -58.17 -46.54 85.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.55 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 18.3 tptm -65.78 -46.17 79.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.083 -175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.54 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -70.81 -34.03 66.2 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.063 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.749 ' HB ' ' O ' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -63.77 -34.7 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.57 0.7 . . . . 0.0 111.042 -178.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 20.8 pt-20 -86.55 -36.6 18.84 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.491 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.14 71.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.225 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.75 37.8 0.75 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.554 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.38 -34.12 5.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 4.2 m-85 -127.4 161.42 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.418 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 9.6 pt-20 -144.8 129.74 18.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.922 0.391 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.58 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 70.5 mt-30 -99.21 103.51 20.7 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -60.98 -32.38 92.33 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.115 2.543 . . . . 0.0 113.234 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.44 -47.87 10.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.798 0.332 . . . . 0.0 110.962 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.8 27.41 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.8 135.99 72.26 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.525 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.77 39.99 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.204 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.94 -143.75 5.88 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.03 135.6 33.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.58 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 2.5 p -114.0 141.23 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.116 0.484 . . . . 0.0 110.821 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.2 ttpp -122.53 152.73 40.07 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.774 HD21 ' HA ' ' A' ' 52' ' ' ILE . 16.2 mt -57.75 130.37 46.12 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.61 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.859 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.915 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.447 0.641 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -91.19 131.75 36.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.452 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 40.0 t -73.12 128.87 36.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.78 -18.76 62.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.825 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -58.73 -45.6 89.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 46' ' ' SER . 2.6 mt-10 -68.16 -50.71 52.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.227 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD23 HG11 ' A' ' 80' ' ' VAL . 4.7 mp -56.77 -55.84 29.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.328 -175.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 69' ' ' LEU . 67.8 mt -64.92 -54.44 29.62 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -176.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.617 HG13 ' HE1' ' A' ' 103' ' ' PHE . 90.4 mt -58.51 -41.42 81.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.7 -41.99 64.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.77 -53.52 3.52 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.127 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.635 HD11 ' HA ' ' A' ' 114' ' ' LYS . 34.7 tp -48.25 -37.39 16.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.387 0.675 . . . . 0.0 112.012 -172.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -72.0 -32.73 67.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.663 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.16 -42.32 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.09 12.1 33.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.871 -0.518 . . . . 0.0 111.834 -170.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -63.08 -27.54 69.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.702 0.286 . . . . 0.0 110.515 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 59.07 -111.76 0.57 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.908 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.51 -36.42 83.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.769 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.498 ' HD3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -175.41 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.498 ' N ' ' HD3' ' A' ' 62' ' ' LYS . . . -154.3 145.6 12.99 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.896 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 p -95.11 -117.13 0.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -167.36 152.61 7.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 52.8 mtp180 -54.45 -54.47 48.12 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.947 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 19.1 Cg_endo -59.55 -34.36 96.84 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.073 1.848 . . . . 0.0 112.083 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.31 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.866 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.47 HD11 HD13 ' A' ' 55' ' ' LEU . 44.7 mt -61.17 -45.94 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.577 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 45.5 mtmt -59.74 -34.66 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.647 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 85.0 tttt -63.84 -53.53 49.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.897 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -54.93 -43.16 73.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.98 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 69' ' ' LEU . 56.7 mt -62.57 -46.49 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.233 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 85.5 mttt -66.12 -34.12 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 111.484 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.8 mm-40 -66.07 -42.34 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.133 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.56 -44.5 7.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -119.8 71.52 15.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.69 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.79 -9.48 24.8 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.612 2.208 . . . . 0.0 113.315 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.826 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.3 mp -56.48 -58.49 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.054 0.93 . . . . 0.0 109.183 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -77.94 -30.74 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.735 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -57.03 -41.96 92.75 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.091 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.0 m -92.87 28.66 2.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.774 -0.251 . . . . 0.0 111.22 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -80.01 131.64 35.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -61.05 -39.92 91.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -102.46 26.85 7.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.464 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.769 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 31.9 t80 -59.2 -45.06 92.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.635 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.71 -47.59 79.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.66 -47.75 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.12 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -61.01 -43.27 99.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.484 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.37 -50.35 73.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.33 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.61 -36.28 82.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -66.88 -42.03 86.25 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.401 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 HG21 ' A' ' 113' ' ' VAL . 35.9 mm -60.12 -48.91 86.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 63.6 mttp -61.91 -43.04 99.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.252 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 23.7 tptm -68.22 -38.63 82.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.812 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -63.78 -43.28 97.94 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.194 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 27.1 m -64.82 -36.72 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.12 0.46 . . . . 0.0 111.362 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -76.25 -41.89 47.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.87 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.244 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 102.11 40.5 2.62 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.359 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -113.0 -43.6 3.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.812 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 6.1 m-85 -128.49 165.59 20.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.652 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -141.8 142.25 33.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.011 0.524 . . . . 0.0 109.715 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -115.21 117.71 40.88 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.46 -41.55 25.57 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.932 2.421 . . . . 0.0 112.659 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -83.64 -60.48 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.048 0.451 . . . . 0.0 110.746 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.04 -153.16 23.38 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.47 133.68 58.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.84 2.36 . . . . 0.0 112.8 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.5 28.87 18.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.21 -158.81 23.16 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.105 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.56 148.75 47.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.605 0.24 . . . . 0.0 110.512 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.653 HG21 HD12 ' A' ' 94' ' ' ILE . 34.2 t -117.78 152.97 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.887 0.375 . . . . 0.0 110.276 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.635 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -157.69 153.09 26.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.563 HD22 HD23 ' A' ' 55' ' ' LEU . 1.5 mm? -53.15 134.56 38.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.018 0.437 . . . . 0.0 111.861 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.968 174.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.932 0.396 . . . . 0.0 111.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 80' ' ' VAL . 71.8 mmtt -88.87 140.62 29.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.3 m -68.48 107.36 2.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 110.279 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 51' ' ' ILE . 19.7 m-85 -62.61 -36.25 82.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.3 ttm105 -54.86 -43.48 73.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.87 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.74 -49.63 67.7 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.503 ' HB3' HG12 ' A' ' 73' ' ' ILE . 2.4 mp -55.32 -49.59 71.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.535 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.83 HG23 HD13 ' A' ' 69' ' ' LEU . 76.1 mt -66.33 -50.67 66.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.236 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.7 ' HA ' HD21 ' A' ' 115' ' ' LEU . 39.7 mt -61.25 -47.21 94.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.526 0.203 . . . . 0.0 111.304 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -54.25 -42.41 69.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.675 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.667 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -73.53 -56.98 5.24 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.332 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD23 HD23 ' A' ' 115' ' ' LEU . 4.8 tp -58.07 -30.28 66.09 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -75.96 -32.83 59.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.76 -51.01 6.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.38 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.698 ' HG ' ' N ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -76.79 -53.71 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.006 -176.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.698 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 40.3 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.749 2.42 . . . . 0.0 117.057 175.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' LEU . 51.3 mt-10 64.16 -105.73 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.27 0.628 . . . . 0.0 109.414 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -77.87 -30.28 50.79 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.711 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 167.65 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.134 178.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . -142.1 150.87 22.43 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -133.57 156.3 48.07 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.863 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.8 t -62.68 157.17 21.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 82.9 mtm180 -48.87 -52.41 46.58 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.076 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 6.0 Cg_endo -49.63 -38.28 45.15 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 122.977 2.452 . . . . 0.0 112.979 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.85 90.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.983 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.83 HD13 HG23 ' A' ' 51' ' ' ILE . 58.7 mt -66.16 -44.25 84.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.887 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 57.1 mtpt -59.07 -35.38 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.828 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 45.3 tttm -68.79 -50.23 52.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.333 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.1 -43.87 64.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.554 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' A' ' 50' ' ' LEU . 80.6 mt -62.87 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.963 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.5 mttt -61.19 -37.4 82.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 52.4 mt-10 -67.92 -42.4 81.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.964 0.411 . . . . 0.0 111.197 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.12 -40.54 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.94 76.2 58.0 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.592 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -18.99 52.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.779 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.7 mp -51.96 -67.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.829 0.823 . . . . 0.0 110.29 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 86' ' ' PHE . 1.2 t -74.21 -35.78 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.02 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.64 -42.29 66.93 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.935 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -102.66 27.75 6.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.952 0.406 . . . . 0.0 110.34 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -72.97 140.24 47.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -61.77 -38.74 89.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.453 0.644 . . . . 0.0 110.468 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -102.87 22.43 13.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.421 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 31.7 t80 -58.38 -45.49 88.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.201 0.524 . . . . 0.0 110.877 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.47 -42.57 98.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.208 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.2 -49.41 61.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.617 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -61.93 -43.42 98.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.057 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.42 ' O ' HG12 ' A' ' 94' ' ' ILE . 87.7 t80 -58.47 -47.32 84.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.487 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -62.17 -43.2 99.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.473 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -64.08 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.877 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.62 98.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.641 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 51' ' ' ILE . 30.9 mm -61.17 -53.22 52.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.02 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 57.2 mttm -53.81 -49.71 67.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.083 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -72.22 -30.88 65.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.631 ' HA3' ' CD1' ' A' ' 103' ' ' PHE . . . -75.67 -39.3 34.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.855 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 29.6 m -69.06 -37.69 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.904 0.352 . . . . 0.0 111.317 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.1 pt-20 -66.89 -39.18 87.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.925 0.393 . . . . 0.0 110.675 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.3 36.56 5.89 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.754 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -112.67 -23.12 10.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.8 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -135.28 153.78 51.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 169.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 34.6 mm-40 -142.23 123.21 14.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.768 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 54.8 mt-30 -96.27 107.79 37.62 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.851 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -62.94 -34.27 71.88 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.233 1.955 . . . . 0.0 111.522 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -86.5 33.3 0.63 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.46 -138.17 19.31 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.151 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -91.04 -28.52 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.992 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.97 52.13 2.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.79 -140.76 4.02 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.234 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.863 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -80.13 142.79 34.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.768 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 6.1 p -120.43 143.15 33.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.038 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -119.46 143.22 47.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.7 HD21 ' HA ' ' A' ' 52' ' ' ILE . 10.7 mt -58.12 129.46 42.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.608 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.779 0 CA-C-O 121.464 0.65 . . . . 0.0 112.243 -176.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.87 0.367 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' HG21 ' A' ' 80' ' ' VAL . 34.4 mmtm -77.88 135.49 37.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.82 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 m -72.68 116.6 13.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.243 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.91 -31.52 72.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.71 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -58.22 -42.12 85.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.439 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.79 -53.95 18.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 80' ' ' VAL . 2.8 mp -53.71 -53.46 51.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.822 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.412 HG12 ' HE1' ' A' ' 90' ' ' PHE . 63.5 mt -65.59 -50.64 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.315 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.498 HG23 HD21 ' A' ' 115' ' ' LEU . 51.7 mt -62.31 -42.64 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.79 -40.75 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 110.934 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -75.34 -59.38 3.6 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.467 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.891 HD23 HD22 ' A' ' 115' ' ' LEU . 19.1 tp -46.17 -37.96 7.68 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.927 0.891 . . . . 0.0 112.401 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -72.12 -31.99 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.94 -41.44 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.764 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 54' ' ' GLY . 1.5 pt? -107.4 20.11 19.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.449 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -66.59 -26.14 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.482 -0.136 . . . . 0.0 110.844 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 67.92 -46.16 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -151.62 -46.08 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.22 -0.3 . . . . 0.0 110.73 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 23.4 pttm -174.63 26.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.534 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.03 133.31 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.763 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.503 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -126.27 141.22 52.0 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.391 0.277 . . . . 0.0 110.293 178.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 m -62.56 137.11 58.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.763 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.557 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 39.2 mtp180 -53.8 -49.32 89.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.146 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 17.7 Cg_endo -56.41 -34.27 94.04 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.977 1.785 . . . . 0.0 112.523 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.05 95.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 58' ' ' LEU . 5.2 mp -60.59 -40.44 91.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -61.11 -35.72 77.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.501 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 59.3 tttp -65.09 -50.3 66.68 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.913 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.22 -44.04 64.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.948 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.1 mt -65.19 -42.8 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.824 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 111.489 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.4 mm-40 -63.48 -41.8 98.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.19 -43.46 8.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.197 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -120.36 81.58 30.53 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.499 0.19 . . . . 0.0 110.882 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.01 -23.39 77.36 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.659 2.239 . . . . 0.0 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.852 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.5 mp -53.62 -63.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.868 0.842 . . . . 0.0 110.4 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 50' ' ' LEU . 1.2 t -77.23 -33.26 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.689 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -41.52 61.62 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.551 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -104.53 30.62 5.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.766 0.317 . . . . 0.0 110.856 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 80' ' ' VAL . . . -82.71 48.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.6 t 55.79 -103.39 0.18 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.303 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -81.05 39.64 0.51 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.245 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.412 ' CD1' HG13 ' A' ' 80' ' ' VAL . 10.8 t80 -58.57 -40.16 82.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.21 -45.02 88.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.555 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.33 -44.93 95.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.196 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -61.89 -43.3 99.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.795 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.412 ' HE1' HG12 ' A' ' 51' ' ' ILE . 86.2 t80 -60.5 -50.32 74.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.075 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -59.3 -43.32 92.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.345 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -64.41 -40.72 96.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.807 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.78 93.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.15 -48.82 85.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.512 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 60.2 mtpt -58.61 -49.2 78.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.027 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 17.0 tptm -66.45 -39.71 89.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.805 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.633 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -67.67 -43.67 84.21 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.398 -175.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -64.71 -39.03 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.996 0.398 . . . . 0.0 111.687 -175.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.5 pt-20 -72.0 -40.99 68.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.55 83.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.183 0.516 . . . . 0.0 111.048 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.2 40.34 0.59 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.703 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 -37.83 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.68 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 7.6 m-85 -129.03 160.09 33.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.916 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -126.69 144.68 50.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.965 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.57 HE21 HG11 ' A' ' 98' ' ' VAL . 54.7 mt-30 -128.16 105.67 19.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.918 0.389 . . . . 0.0 111.144 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 90.5 Cg_endo -78.61 39.67 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.151 2.567 . . . . 0.0 112.708 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -148.39 -56.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.761 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.85 -144.43 7.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.88 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.14 -38.31 2.85 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.735 2.29 . . . . 0.0 113.494 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.486 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -127.74 40.81 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.59 -145.11 18.43 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.969 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.616 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -84.93 141.19 30.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.64 HG12 HD21 ' A' ' 55' ' ' LEU . 14.5 t -104.42 154.12 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.789 0.328 . . . . 0.0 110.502 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 62' ' ' LYS . 78.0 tttt -148.58 144.54 27.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.891 HD22 HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -52.47 133.14 35.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.56 -178.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.498 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HE3' HD13 ' A' ' 79' ' ' ILE . 71.2 mmtt -88.17 120.76 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 m -67.55 121.9 16.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.118 0.485 . . . . 0.0 110.051 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -63.23 -23.59 67.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.188 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.61 -38.0 80.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.716 0.293 . . . . 0.0 110.735 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 46' ' ' SER . 4.2 mt-10 -72.18 -50.6 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' CD2' HG11 ' A' ' 80' ' ' VAL . 2.4 mp -54.0 -52.46 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.623 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD13 HD13 ' A' ' 94' ' ' ILE . 69.1 mt -64.09 -53.01 48.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.293 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.514 HG13 ' HE1' ' A' ' 103' ' ' PHE . 60.4 mt -61.89 -44.62 99.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.738 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -54.52 -44.36 72.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.516 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 58' ' ' LEU . . . -69.54 -63.38 3.4 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.2 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.877 ' HG ' HD22 ' A' ' 115' ' ' LEU . 15.0 tp -40.72 -44.83 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.444 1.097 . . . . 0.0 112.757 -175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.443 ' N ' HD21 ' A' ' 115' ' ' LEU . 4.6 t -73.03 -26.38 61.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.512 0.672 . . . . 0.0 110.922 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.01 -39.62 14.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.644 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 54' ' ' GLY . 1.2 pt? -113.8 20.98 15.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.959 -0.463 . . . . 0.0 111.934 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 46.2 pttt -61.17 -31.57 71.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.737 0.304 . . . . 0.0 111.266 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 56.51 -102.63 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.113 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -65.8 -34.29 77.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.363 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.577 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 9.6 ptpp? 173.76 -37.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.821 0.448 . . . . 0.0 110.079 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.95 26.29 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.711 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -124.01 141.6 51.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.726 0.298 . . . . 0.0 111.348 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 5.7 m -63.74 148.3 49.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.372 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.566 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.8 -50.9 58.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.0 Cg_endo -50.84 -33.18 40.18 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.76 2.307 . . . . 0.0 112.865 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.05 -48.22 74.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.948 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 73' ' ' ILE . 6.6 mp -65.56 -38.6 90.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.844 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 92.6 mttt -57.78 -39.96 78.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.58 -51.39 62.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.172 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -52.76 -44.22 66.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.847 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 69' ' ' LEU . 81.5 mt -67.56 -45.87 84.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.459 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.1 mttt -58.7 -43.32 90.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.86 0.362 . . . . 0.0 111.221 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.4 -39.68 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.818 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -94.45 -36.35 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -125.68 72.98 68.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 -23.36 42.93 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.959 2.439 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.1 mp -53.34 -68.06 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.542 0.687 . . . . 0.0 110.598 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG11 ' CD2' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -70.9 -35.41 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.88 177.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -42.14 62.58 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.8 m -107.16 38.95 1.98 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.791 0.329 . . . . 0.0 110.844 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.61 3.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.82 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t 70.8 -58.91 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.808 0.843 . . . . 0.0 111.806 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -96.73 23.88 6.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CD1' HG13 ' A' ' 80' ' ' VAL . 20.6 t80 -56.36 -44.88 80.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.681 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.24 -40.59 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.57 -48.7 76.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.173 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.213 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 51' ' ' ILE . 82.5 t80 -62.06 -48.52 79.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.785 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -61.74 -41.6 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -60.58 -42.04 95.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.787 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.815 HD12 HG21 ' A' ' 113' ' ' VAL . 40.5 mm -60.53 -53.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.62 -45.01 92.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.696 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -67.71 -38.51 83.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.145 0.498 . . . . 0.0 110.149 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.608 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -66.43 -43.49 92.41 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.17 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 26.8 m -66.34 -37.89 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.101 0.451 . . . . 0.0 111.602 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.82 -42.62 66.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.553 0.216 . . . . 0.0 110.908 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.51 93.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.98 35.88 1.09 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.31 -36.11 5.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.9 m-85 -130.64 162.09 30.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.832 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -135.49 149.01 49.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.552 ' HG3' HG11 ' A' ' 98' ' ' VAL . 47.4 mt-30 -124.69 113.34 27.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.974 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 61.4 Cg_endo -76.81 -33.83 2.7 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.954 2.436 . . . . 0.0 113.031 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.88 -46.62 12.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.173 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.02 -174.02 45.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.729 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.51 -29.33 89.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.273 2.648 . . . . 0.0 112.639 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . -135.39 39.81 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 110.105 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.36 -56.59 0.87 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.866 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -173.57 143.03 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.617 0.367 . . . . 0.0 110.131 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.815 HG21 HD12 ' A' ' 94' ' ' ILE . 21.4 t -99.48 150.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 0.0 110.988 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -143.31 141.54 31.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.877 HD22 ' HG ' ' A' ' 55' ' ' LEU . 2.7 mm? -52.84 131.02 34.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.124 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.56 174.205 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.1 pttm . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.84 0.352 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -151.35 -51.39 0.12 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -66.8 147.75 52.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.291 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.36 41.9 0.72 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.933 0.397 . . . . 0.0 110.942 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.9 p -170.73 -142.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.201 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t 57.15 35.91 26.85 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.082 0.553 . . . . 0.0 111.374 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 72.1 mmtt -98.33 126.94 44.04 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 169.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.466 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 40.4 t -71.84 124.58 25.14 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.407 ' O ' HG13 ' A' ' 51' ' ' ILE . 1.8 m-85 -64.42 -26.11 68.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.289 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.07 -43.47 70.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.355 175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 3.1 mm-40 -73.08 -46.07 53.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.337 0.589 . . . . 0.0 110.28 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 HG11 ' A' ' 80' ' ' VAL . 1.4 mp -61.35 -49.85 75.3 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.434 -175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.521 HD13 HD13 ' A' ' 94' ' ' ILE . 70.7 mt -62.91 -51.36 72.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.671 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.71 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.807 HG13 ' HE1' ' A' ' 103' ' ' PHE . 47.6 mt -60.14 -43.41 92.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -50.8 -43.98 58.9 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.412 0.445 . . . . 0.0 110.485 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.571 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -80.8 -55.88 3.24 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.547 176.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.697 HD13 HD11 ' A' ' 69' ' ' LEU . 24.2 tp -51.29 -31.08 20.1 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.326 0.651 . . . . 0.0 111.953 -171.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -75.89 -31.04 59.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.299 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.19 -51.19 5.91 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.6 OUTLIER -89.31 21.42 3.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.139 0.495 . . . . 0.0 111.007 -173.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.694 ' HB2' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -59.75 -32.09 70.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.992 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 56.2 -109.36 0.49 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.634 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.689 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 16.2 ptm180 -65.86 -34.78 78.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.189 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.737 ' O ' ' HD3' ' A' ' 114' ' ' LYS . 21.0 ptmt -175.2 -48.2 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.062 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.2 29.78 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.5 m -141.41 152.64 44.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.159 0.504 . . . . 0.0 111.494 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.85 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 7.7 t -66.42 159.99 25.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.724 -174.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.556 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.8 OUTLIER -50.29 -50.14 72.38 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.6 Cg_endo -50.85 -38.98 58.73 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.599 2.199 . . . . 0.0 112.84 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.43 81.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.756 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.697 HD11 HD13 ' A' ' 55' ' ' LEU . 18.1 mt -63.6 -41.64 98.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.244 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 94.9 mttt -60.1 -38.78 83.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 88.1 tttt -68.29 -47.69 66.95 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.121 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -50.7 -47.06 59.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.752 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.3 mt -67.63 -40.56 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.071 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 97.3 mttt -63.31 -40.11 96.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.634 0.254 . . . . 0.0 111.664 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 4.8 mm-40 -73.59 -39.45 64.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.317 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -93.96 -41.44 9.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -119.87 73.51 18.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.13 -23.68 54.36 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.994 2.463 . . . . 0.0 113.585 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.855 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.1 mp -50.06 -56.42 3.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.857 0.837 . . . . 0.0 110.456 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -91.55 -32.37 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.666 178.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -55.31 -41.43 79.61 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.348 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.1 t -100.92 33.2 2.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.227 0.537 . . . . 0.0 109.994 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.32 145.49 25.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.078 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.5 m -65.13 125.19 24.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.33 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m120 65.44 29.88 11.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.61 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -60.98 -43.42 98.85 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.321 0.581 . . . . 0.0 110.07 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -54.01 -42.35 68.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.962 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -72.05 -49.17 38.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -56.51 -37.81 70.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.597 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.501 ' CE1' HG12 ' A' ' 51' ' ' ILE . 69.6 t80 -58.65 -41.29 85.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.181 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -61.09 -45.54 94.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -64.09 -36.16 83.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.639 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.65 -42.95 99.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.95 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.54 HD12 HG21 ' A' ' 113' ' ' VAL . 42.6 mm -60.73 -47.62 92.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.268 176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 97.3 mttt -59.72 -42.49 93.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.963 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 1.4 tmtp? -65.61 -39.66 91.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.242 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.804 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -69.56 -40.82 77.67 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.106 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.6 m -70.26 -36.81 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.022 0.411 . . . . 0.0 111.29 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 1.5 pt-20 -67.85 -35.64 78.92 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.928 0.394 . . . . 0.0 110.361 175.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.874 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.16 37.84 41.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.964 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -113.38 -32.47 6.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.807 ' HE1' HG13 ' A' ' 52' ' ' ILE . 8.4 m-85 -121.41 158.41 28.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.161 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -143.59 143.6 31.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.458 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 67.8 mt-30 -111.5 104.2 55.86 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-O 120.971 0.415 . . . . 0.0 111.034 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 21.0 Cg_endo -62.03 -35.28 77.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.229 2.619 . . . . 0.0 112.512 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -96.04 28.99 2.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.288 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.834 ' HA2' ' HA ' ' A' ' 126' ' ' GLU . . . 74.93 174.82 34.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.915 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 129' ' ' VAL . 21.8 Cg_exo -63.51 140.27 74.77 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.706 2.271 . . . . 0.0 111.442 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 68.09 41.34 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.6 -176.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.47 -138.64 3.9 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.658 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.85 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -85.94 134.95 33.85 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.641 HG12 HD21 ' A' ' 55' ' ' LEU . 39.7 t -97.99 154.0 3.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.737 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 44.1 tptt -144.47 133.12 22.24 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.77 HD12 ' HE3' ' A' ' 117' ' ' LYS . 0.2 OUTLIER -55.35 118.8 4.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.54 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.37 129.28 34.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.206 0.527 . . . . 0.0 110.933 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.77 ' HE3' HD12 ' A' ' 115' ' ' LEU . 35.3 mmtp -131.53 -40.72 1.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.522 177.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -139.63 136.99 34.91 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.878 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -77.12 58.6 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.323 0.582 . . . . 0.0 110.494 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.1 p -70.37 156.97 91.07 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.442 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.23 -178.61 1.47 Allowed 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.771 2.314 . . . . 0.0 112.583 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 63.05 37.7 11.45 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.661 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 t -132.9 55.02 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.126 171.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -111.74 44.7 1.33 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.563 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -130.2 24.62 5.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.448 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.834 ' HA ' ' HA2' ' A' ' 108' ' ' GLY . 24.3 pt-20 -100.5 -4.56 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.451 -175.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt 68.34 -74.13 0.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.223 0.609 . . . . 0.0 111.655 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -158.13 54.29 0.46 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.678 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.565 HG22 ' HG3' ' A' ' 109' ' ' PRO . 29.9 t -82.12 58.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.441 0.639 . . . . 0.0 109.743 174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.169 -176.342 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 57.79 -136.04 1.01 Allowed 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.567 0.542 . . . . 0.0 110.898 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -164.84 142.96 6.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.26 -146.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.833 0.349 . . . . 0.0 110.506 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -79.53 28.65 0.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.783 0.325 . . . . 0.0 110.981 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.8 m -77.33 38.87 0.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.134 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 80' ' ' VAL . 30.6 mmtm -91.49 147.0 23.34 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 174.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 49' ' ' GLU . 15.3 t -70.21 -17.16 63.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.826 0.346 . . . . 0.0 111.368 -175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 71.49 -44.35 0.59 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.191 -175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' HG3' HD12 ' A' ' 52' ' ' ILE . 4.7 ttm105 -54.51 -45.55 73.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.057 0.456 . . . . 0.0 110.58 176.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.591 ' HG3' HD13 ' A' ' 50' ' ' LEU . 13.6 pt-20 -59.73 -46.01 90.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.13 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.591 HD13 ' HG3' ' A' ' 49' ' ' GLU . 5.1 mp -62.75 -52.52 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.664 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.95 -52.14 63.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.535 -176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.625 HD11 ' OD2' ' A' ' 102' ' ' ASP . 74.7 mt -63.45 -41.29 92.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -56.57 -37.47 70.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.638 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -78.17 -58.62 3.12 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.421 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 115' ' ' LEU . 32.1 tp -49.71 -32.65 13.95 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.454 0.702 . . . . 0.0 112.381 -172.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 t -73.75 -31.75 63.49 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 110.773 177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.05 -50.27 6.51 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.8 OUTLIER -92.2 17.39 9.7 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.825 -171.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 17.2 pttp -68.43 -29.04 67.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 58.76 -113.35 0.68 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.738 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.611 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.2 ptp85 -67.34 -27.48 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 59.3 pttt -173.29 -43.03 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 114' ' ' LYS . . . -150.83 158.38 27.65 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 119.714 -1.232 . . . . 0.0 114.004 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.432 ' OG ' ' HG ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER -106.25 144.06 33.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.403 . . . . 0.0 111.169 -177.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -64.19 141.93 58.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.3 mtp-105 -55.43 -49.59 91.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.1 Cg_endo -58.32 -29.02 86.72 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.944 1.763 . . . . 0.0 112.107 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.02 83.99 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.83 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 55' ' ' LEU . 39.3 mt -62.58 -43.82 97.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.408 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 98.4 mttt -57.15 -40.69 77.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.703 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 53.4 tttp -67.97 -47.34 68.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.564 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.16 -46.02 65.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.374 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.411 HG23 HD23 ' A' ' 50' ' ' LEU . 53.4 mt -63.65 -44.28 98.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.992 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.2 mttt -64.13 -37.5 87.69 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 67.2 mm-40 -69.68 -39.51 76.94 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.365 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -94.29 -41.45 9.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -123.16 77.16 51.94 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.618 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.03 -17.6 45.85 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.398 . . . . 0.0 112.824 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.743 ' H ' HD12 ' A' ' 79' ' ' ILE . 2.8 mp -55.71 -64.95 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 122.049 0.928 . . . . 0.0 110.016 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 45' ' ' LYS . 1.2 t -76.16 -33.05 23.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.206 177.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -51.55 -42.35 51.19 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.679 -177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -101.67 31.12 3.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.857 0.36 . . . . 0.0 110.914 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -74.87 148.68 39.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.711 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -47.63 80.59 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -113.39 34.85 4.27 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 46.4 t80 -54.71 -46.17 74.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.591 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -58.46 -47.45 83.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.836 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.58 -48.33 75.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.726 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -58.97 -45.05 91.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.245 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.44 ' O ' HG12 ' A' ' 94' ' ' ILE . 90.5 t80 -56.77 -47.11 80.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.947 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -62.13 -44.1 97.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.736 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.604 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 78.6 m-20 -66.01 -38.81 89.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.751 0.31 . . . . 0.0 110.769 177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.94 88.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.383 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 90' ' ' PHE . 36.5 mm -61.73 -51.69 69.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.991 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.604 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -62.29 -41.07 98.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -173.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 46.6 tptt -71.73 -34.59 69.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 0.0 110.265 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.747 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -67.73 -40.37 90.02 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.964 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 17.2 m -65.2 -42.13 93.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.166 0.483 . . . . 0.0 111.246 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -67.81 -41.25 83.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.721 0.296 . . . . 0.0 111.414 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.87 -28.37 68.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.626 -178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.09 36.63 4.89 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.55 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.625 ' OD2' HD11 ' A' ' 52' ' ' ILE . 35.2 t70 -113.83 -41.99 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.027 -0.586 . . . . 0.0 109.495 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.747 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 21.1 m-85 -114.44 171.82 7.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.957 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 114' ' ' LYS . 0.7 OUTLIER -153.47 136.33 15.38 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -176.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 80.7 mt-30 -122.39 105.84 36.03 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 25.5 Cg_endo -62.14 -36.05 71.81 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.896 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.47 ' HB2' ' HA3' ' A' ' 111' ' ' GLY . 98.9 mttt -91.76 16.37 10.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.069 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.15 -146.59 49.28 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.955 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.71 133.88 57.02 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.15 2.567 . . . . 0.0 112.482 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 61.76 30.7 18.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.108 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.47 ' HA3' ' HB2' ' A' ' 107' ' ' LYS . . . -114.89 160.1 13.38 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.566 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.61 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -55.12 130.83 43.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.577 HG12 HD21 ' A' ' 55' ' ' LEU . 17.7 t -90.17 155.66 3.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.486 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.634 ' HD3' ' HB3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -152.16 136.8 16.96 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.687 177.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -51.15 127.32 18.92 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.801 -174.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.13 127.76 33.93 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 43.7 tptt -76.16 92.63 3.26 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.884 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.9 pttm 62.23 170.63 0.13 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.148 0.979 . . . . 0.0 111.513 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -60.24 -53.47 57.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.45 -172.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.595 ' OG ' ' HE2' ' A' ' 118' ' ' LYS . 33.7 p -73.28 135.85 79.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.185 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -47.0 134.34 18.25 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.729 2.953 . . . . 0.0 113.892 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -149.47 49.56 0.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.476 177.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 32.8 t -93.98 133.39 35.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.064 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.625 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 2.7 mptp? -72.17 -32.67 67.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.06 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -72.38 151.74 42.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.368 171.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -71.84 53.87 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.175 0.512 . . . . 0.0 110.991 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 129' ' ' VAL . 51.2 tptt -73.78 -48.96 27.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.225 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 75.37 -35.31 0.27 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.11 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 127' ' ' LYS . 99.1 t 74.82 -50.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.963 0.905 . . . . 0.0 111.328 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.545 -0.74 . . . . 0.0 110.842 175.15 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.5 pttm . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.93 0.395 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 60.8 58.2 2.44 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.567 0.699 . . . . 0.0 109.367 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.82 144.58 54.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.929 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.03 -29.19 27.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.4 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HA ' HG22 ' A' ' 79' ' ' ILE . 8.2 p -156.9 -7.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.708 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.0 m -80.0 55.26 2.08 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HB2' ' CG2' ' A' ' 80' ' ' VAL . 71.5 mmtt -83.16 138.23 33.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.473 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 48.2 m -72.41 115.74 12.03 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 51' ' ' ILE . 8.1 m-85 -62.29 -30.45 71.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.544 -178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -52.5 -48.55 65.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.988 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 19.2 mm-40 -62.53 -46.65 87.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.173 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 HG11 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -60.06 -48.53 81.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.834 -178.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.696 HG12 ' HE1' ' A' ' 90' ' ' PHE . 68.7 mt -64.29 -53.85 38.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.06 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.78 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.9 mt -60.44 -45.52 96.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -54.48 -39.2 67.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 110.504 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -80.42 -59.88 2.46 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.451 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.68 ' HB3' HD23 ' A' ' 115' ' ' LEU . 18.3 tp -46.04 -36.06 5.38 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.185 0.994 . . . . 0.0 112.543 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.1 t -68.78 -34.21 75.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.122 0.486 . . . . 0.0 110.412 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.55 -53.44 4.8 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.614 ' O ' ' HB3' ' A' ' 64' ' ' SER . 1.7 pt? -91.52 20.34 5.45 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.923 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HE3' ' O ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -60.43 -19.89 57.86 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.683 179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 43.9 mt-10 63.29 -115.13 0.46 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.982 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -73.06 -48.2 38.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.688 0.28 . . . . 0.0 111.142 178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -179.18 27.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.233 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.48 125.94 0.88 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.583 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.614 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 2.3 p -113.22 133.46 55.06 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 13.7 m -57.92 135.65 56.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.936 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.585 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 35.5 ptt180 -53.92 -41.11 86.3 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 21.5 Cg_endo -57.94 -28.52 83.21 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 121.672 1.582 . . . . 0.0 112.703 177.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.24 88.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.717 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.53 ' HG ' HD21 ' A' ' 58' ' ' LEU . 6.7 mp -59.42 -33.43 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.434 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.582 ' HG3' ' HA ' ' A' ' 67' ' ' PRO . 8.6 mtmm -56.97 -38.49 73.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.2 tttp -67.1 -52.35 42.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.099 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.42 -43.47 64.85 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.817 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.45 HG12 ' HB3' ' A' ' 50' ' ' LEU . 79.7 mt -65.87 -46.8 87.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.164 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.3 mttt -60.48 -43.38 97.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.694 0.283 . . . . 0.0 111.437 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.2 mt-10 -66.46 -36.68 83.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -93.96 -33.72 13.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.823 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -130.24 76.04 78.38 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.525 -178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -56.48 -21.29 37.08 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.036 2.491 . . . . 0.0 112.469 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.842 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.7 mp -52.37 -68.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.721 0.772 . . . . 0.0 110.52 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.555 HG11 HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -73.23 -30.51 31.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.223 177.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -34.46 36.68 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.82 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -114.94 42.31 2.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.106 0.479 . . . . 0.0 110.208 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.08 15.25 1.94 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.775 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m 69.75 -62.35 0.42 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.832 0.853 . . . . 0.0 112.468 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -98.4 29.56 3.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.035 0.445 . . . . 0.0 110.127 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -56.47 -46.18 80.53 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.472 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.404 ' CB ' ' HE3' ' A' ' 70' ' ' LYS . 6.5 p-10 -62.24 -42.15 99.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.744 0.307 . . . . 0.0 110.847 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.95 -48.54 65.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.344 0.593 . . . . 0.0 110.166 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -61.09 -41.01 95.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.852 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.696 ' HE1' HG12 ' A' ' 51' ' ' ILE . 60.1 t80 -59.34 -43.85 92.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -61.26 -43.74 98.38 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.4 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -64.48 -38.23 90.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.876 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.21 -41.86 98.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.788 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD13 HD13 ' A' ' 51' ' ' ILE . 46.4 mm -59.85 -48.99 85.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.273 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' NZ ' ' HB3' ' A' ' 95' ' ' LYS . 9.9 mtpm? -57.33 -48.18 79.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.224 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' OE2' ' A' ' 99' ' ' GLU . 13.3 tmtt? -62.92 -41.08 99.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.239 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.794 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -65.72 -43.67 93.77 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.101 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 25.3 m -69.69 -35.47 65.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 122.365 -0.491 . . . . 0.0 111.651 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.421 ' OE2' ' HA ' ' A' ' 96' ' ' LYS . 22.4 pt-20 -74.09 -33.76 63.75 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.952 0.406 . . . . 0.0 110.804 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.74 -19.0 59.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.343 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.66 42.31 6.91 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.78 -177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -117.03 -37.85 3.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.794 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 8.6 m-85 -118.14 161.65 19.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.953 171.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' CD ' ' HB ' ' A' ' 123' ' ' VAL . 26.3 pt-20 -142.06 130.79 22.8 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HG2' HG22 ' A' ' 113' ' ' VAL . 83.0 mt-30 -106.39 110.43 63.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 105' ' ' GLN . 11.2 Cg_exo -71.39 -37.04 6.08 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 123.005 2.47 . . . . 0.0 112.754 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -86.73 -48.85 7.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.462 -174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.84 170.84 37.01 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.784 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.551 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 20.9 Cg_endo -61.65 -34.03 85.07 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.029 2.486 . . . . 0.0 112.561 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.5 43.8 1.07 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.68 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -145.08 -144.61 4.17 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.1 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -74.64 137.84 42.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.87 0.367 . . . . 0.0 111.523 -177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 55' ' ' LEU . 11.4 t -108.27 158.71 8.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.644 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -139.79 140.93 36.78 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -56.34 119.78 6.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.99 134.28 38.89 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.051 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.16 123.01 19.52 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 118' ' ' LYS . 21.2 tptt -68.17 -37.4 80.95 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 120' ' ' SER . 11.9 mptt -83.75 79.0 9.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.711 175.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 66.3 m 72.04 120.19 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 123.911 0.757 . . . . 0.0 112.309 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 130' ' ' SER . 23.6 Cg_exo -65.88 158.4 54.14 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.838 3.025 . . . . 0.0 112.555 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -151.61 42.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.721 0.772 . . . . 0.0 110.044 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.477 ' HB ' ' CD ' ' A' ' 104' ' ' GLU . 7.5 p -94.84 135.25 29.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.909 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HG2' HG22 ' A' ' 123' ' ' VAL . 58.9 pttt 40.04 66.86 0.54 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.549 0.74 . . . . 0.0 111.993 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -70.67 51.32 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.381 0.61 . . . . 0.0 111.536 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.652 ' HG3' ' HG2' ' A' ' 127' ' ' LYS . 22.3 pt-20 -73.0 -27.82 62.01 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.354 178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.652 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 21.0 pttm -163.46 -142.95 0.07 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.07 123.18 19.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.0 110.584 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.5 p -165.96 47.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 122.538 1.161 . . . . 0.0 109.512 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 121' ' ' PRO . 48.1 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.23 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.049 0.452 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -78.69 60.32 2.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.413 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -132.53 153.05 51.33 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 134.15 53.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.851 0.357 . . . . 0.0 111.299 -177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.512 ' HA ' HG22 ' A' ' 79' ' ' ILE . 72.8 p 52.71 50.24 18.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.747 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -85.66 20.72 2.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.256 0.55 . . . . 0.0 110.436 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -84.14 122.38 28.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.58 ' HB2' ' HG2' ' A' ' 49' ' ' GLU . 4.8 m -70.16 121.09 16.86 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -58.65 -33.64 70.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.913 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -54.95 -40.07 69.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.636 176.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.58 ' HG2' ' HB2' ' A' ' 46' ' ' SER . 3.4 mm-40 -69.93 -52.35 25.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.349 0.595 . . . . 0.0 110.087 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD23 HG11 ' A' ' 80' ' ' VAL . 2.5 mp -57.17 -49.02 77.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.71 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.543 HG12 ' HE1' ' A' ' 90' ' ' PHE . 82.9 mt -63.38 -52.64 55.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.746 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.972 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.533 HG13 ' HE1' ' A' ' 103' ' ' PHE . 54.2 mt -63.76 -44.99 98.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -58.59 -41.07 84.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.462 0.649 . . . . 0.0 109.898 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.636 ' O ' ' HG ' ' A' ' 58' ' ' LEU . . . -71.28 -53.34 10.55 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.627 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.906 HD23 HD13 ' A' ' 115' ' ' LEU . 46.0 tp -54.07 -37.77 64.56 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.662 0.785 . . . . 0.0 111.916 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.423 ' N ' HD21 ' A' ' 115' ' ' LEU . 5.8 t -74.9 -31.11 61.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.781 0.324 . . . . 0.0 110.647 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.39 -53.5 10.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.274 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.684 HD13 ' HB3' ' A' ' 64' ' ' SER . 1.2 pp -89.16 30.97 0.91 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.612 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -54.78 -33.67 61.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.031 -177.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 58' ' ' LEU . 90.5 mt-10 66.63 -48.82 0.45 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.927 0.891 . . . . 0.0 111.932 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -155.59 -28.26 0.1 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.231 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 26.0 pttm -168.05 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.057 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 113' ' ' VAL . . . -160.38 159.9 31.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 121.306 -0.473 . . . . 0.0 112.085 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.684 ' HB3' HD13 ' A' ' 58' ' ' LEU . 6.7 t -124.54 162.49 23.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 110.83 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.987 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 11.8 m -64.59 159.65 21.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.635 -178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 110' ' ' ALA . 99.4 mtt180 -53.99 -48.49 93.75 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 7.9 Cg_endo -51.24 -41.16 59.5 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 122.407 2.071 . . . . 0.0 112.614 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.34 -43.27 99.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.882 0.372 . . . . 0.0 110.699 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.499 HD11 HD13 ' A' ' 55' ' ' LEU . 40.1 mt -63.27 -47.27 83.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.698 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 90' ' ' PHE . 25.5 mtmm -61.41 -36.5 80.5 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.112 0.482 . . . . 0.0 110.574 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.634 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 37.1 tttm -65.23 -50.36 66.13 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.271 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -53.7 -44.33 69.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.072 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.3 mt -66.13 -41.09 88.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.46 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . 99.5 mttt -68.21 -31.81 71.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 49.3 mt-10 -70.28 -47.91 59.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 111.182 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -94.69 -35.29 12.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.403 -170.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -122.43 73.01 39.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 O-C-N 122.384 -0.198 . . . . 0.0 110.704 -178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.49 -23.69 57.45 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 2.78 . . . . 0.0 112.937 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.806 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.1 mp -52.11 -59.21 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.068 0.937 . . . . 0.0 110.679 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.513 HG11 HD23 ' A' ' 50' ' ' LEU . 1.2 t -86.99 -34.34 7.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.582 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.94 -42.4 70.07 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.297 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.1 m -102.22 32.29 3.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.085 0.469 . . . . 0.0 110.831 177.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.73 149.62 27.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.3 120.96 13.17 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 63.68 33.29 13.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.22 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -58.16 -46.23 86.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.19 0.519 . . . . 0.0 110.309 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.96 -45.25 78.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.706 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -65.89 -45.9 80.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-30 -61.45 -41.47 97.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.543 ' HE1' HG12 ' A' ' 51' ' ' ILE . 90.4 t80 -59.7 -47.33 86.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -59.3 -42.15 90.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.364 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.52 -39.35 93.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.054 175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.62 -44.61 96.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.681 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.526 HD12 HG21 ' A' ' 113' ' ' VAL . 47.8 mm -60.98 -46.64 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.537 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 86.3 mttt -57.77 -45.74 85.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.074 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 5.3 tppp? -67.18 -41.45 85.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.186 0.517 . . . . 0.0 110.747 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.646 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -65.08 -42.59 96.54 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.129 -176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -66.96 -31.42 53.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 117.065 0.433 . . . . 0.0 111.672 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 2.1 pt-20 -81.13 -36.57 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.093 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.21 73.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.874 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.35 46.33 1.08 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.528 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.415 ' C ' ' HB3' ' A' ' 116' ' ' ALA . 7.6 t0 -124.02 -33.29 3.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.982 0.42 . . . . 0.0 109.972 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 2.5 m-85 -135.59 160.72 37.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.819 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.733 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 78.1 mt-10 -126.94 143.38 51.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 175.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.579 ' HG3' HG11 ' A' ' 98' ' ' VAL . 63.8 mt-30 -108.42 110.17 61.63 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.802 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.642 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . 19.2 Cg_exo -69.07 -39.8 7.31 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.059 2.506 . . . . 0.0 112.765 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -84.03 -47.1 11.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.322 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.645 ' HA2' HG22 ' A' ' 129' ' ' VAL . . . 148.82 -165.89 29.26 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.235 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.06 131.19 44.44 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.124 2.549 . . . . 0.0 112.226 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . 60.07 25.38 14.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.555 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.35 -149.95 11.62 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.941 177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.987 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -64.41 150.46 46.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.481 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.526 HG21 HD12 ' A' ' 94' ' ' ILE . 44.0 t -117.68 151.41 19.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -140.12 137.42 34.46 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.906 HD13 HD23 ' A' ' 55' ' ' LEU . 2.7 mm? -56.77 121.55 10.09 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.847 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.733 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . . . -90.03 122.0 32.62 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.134 172.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -83.38 -28.84 28.64 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.746 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.606 ' HD3' ' HB3' ' A' ' 122' ' ' GLU . 17.8 ptpt -71.79 134.83 46.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.533 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.03 41.72 1.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 72.8 m -161.85 149.26 11.72 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.951 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -61.47 126.27 18.81 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.209 1.939 . . . . 0.0 111.21 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.606 ' HB3' ' HD3' ' A' ' 118' ' ' LYS . 26.8 tt0 -174.73 57.85 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.346 0.593 . . . . 0.0 109.965 -177.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.85 129.44 43.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.81 45.88 0.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.336 0.588 . . . . 0.0 111.202 -173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.642 ' HD2' ' HA ' ' A' ' 106' ' ' PRO . 56.1 mttm -84.54 143.43 29.33 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 175.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 63.86 -126.46 0.5 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.917 -173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -72.62 -40.13 66.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.105 0.479 . . . . 0.0 111.008 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -171.34 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.69 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.645 HG22 ' HA2' ' A' ' 108' ' ' GLY . 14.8 p -165.96 -32.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.887 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.329 -0.844 . . . . 0.0 109.941 177.087 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 56.36 50.63 12.84 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.654 0.596 . . . . 0.0 110.504 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 56.63 -167.5 0.11 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.712 1.205 . . . . 0.0 111.446 -175.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 44' ' ' SER . . . -70.9 147.17 49.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.2 m -78.3 35.98 0.23 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.105 0.478 . . . . 0.0 110.829 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 42' ' ' ALA . 16.6 t -87.81 38.5 0.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.546 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HE3' HD13 ' A' ' 79' ' ' ILE . 72.5 mmtt -75.54 127.6 33.44 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.593 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 26.8 t -70.74 116.94 11.63 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' HE2' ' HD1' ' A' ' 86' ' ' PHE . 19.0 m-85 -63.53 -33.9 76.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' A' ' 46' ' ' SER . 54.3 ttt180 -55.27 -48.47 73.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.786 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 46' ' ' SER . 24.0 tp10 -68.41 -46.59 69.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.18 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.447 ' CD2' HG11 ' A' ' 80' ' ' VAL . 1.3 mp -54.48 -48.66 71.56 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.261 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.566 HD13 HD13 ' A' ' 94' ' ' ILE . 81.0 mt -65.6 -46.75 88.64 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.717 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' HE1' ' A' ' 103' ' ' PHE . 36.7 mt -61.4 -50.18 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.595 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -55.07 -40.24 70.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.202 0.525 . . . . 0.0 110.539 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -76.91 -59.69 3.11 Favored Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.844 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.829 HD23 HD21 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -55.6 -34.56 64.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.113 -0.543 . . . . 0.0 111.841 -171.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.496 ' O ' ' HD2' ' A' ' 59' ' ' LYS . 4.7 t -65.79 -28.81 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.162 0.506 . . . . 0.0 110.182 175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.55 -49.19 7.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 54' ' ' GLY . 0.3 OUTLIER -93.59 14.4 19.02 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -170.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -60.8 -26.58 67.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 57.44 -106.87 0.34 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.059 0.456 . . . . 0.0 110.466 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 62' ' ' LYS . 2.6 ptp85 -69.22 -35.12 75.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.788 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HD2' HG21 ' A' ' 129' ' ' VAL . 14.2 ptpt -179.61 -40.35 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.93 167.0 26.9 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 m -135.19 144.68 47.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.289 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -66.2 160.55 24.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.16 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 67.3 mtm180 -54.4 -52.45 69.19 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.7 Cg_endo -55.34 -33.22 84.54 Favored 'Trans proline' 0 C--N 1.359 1.131 0 C-N-CA 122.271 1.981 . . . . 0.0 112.501 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.06 -43.99 97.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.593 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.829 HD21 HD23 ' A' ' 55' ' ' LEU . 30.7 mt -67.07 -47.14 72.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.393 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 9.2 mtmp? -61.32 -39.13 89.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.157 -176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 63.8 tttm -67.09 -49.53 64.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.033 0.444 . . . . 0.0 109.844 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -51.09 -44.89 61.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.76 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.7 mt -64.44 -43.88 97.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.948 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 90.4 mttt -63.9 -34.41 77.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.619 0.247 . . . . 0.0 111.547 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.5 mm-40 -69.91 -41.86 74.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -100.28 -33.28 10.47 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.9 67.51 79.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.598 0.237 . . . . 0.0 110.819 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.83 -19.73 40.46 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.221 2.614 . . . . 0.0 112.973 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.825 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.0 mp -51.37 -57.18 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 122.252 1.025 . . . . 0.0 109.865 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 50' ' ' LEU . 1.2 t -85.02 -35.78 10.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.916 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.11 -40.5 59.24 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -102.42 30.09 4.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 110.437 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.97 145.96 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.1 m -59.49 -37.13 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.132 -174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -116.13 32.7 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.915 0.388 . . . . 0.0 110.151 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.516 ' HD1' ' HE2' ' A' ' 47' ' ' TYR . 34.9 t80 -56.01 -48.39 76.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.397 -178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.28 -44.24 97.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.34 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -66.01 -46.38 78.14 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.075 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -62.36 -40.14 95.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.207 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -59.38 -50.65 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.884 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -61.52 -38.58 87.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.549 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -67.14 -37.28 83.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.126 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.86 97.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 113' ' ' VAL . 45.2 mm -58.85 -51.04 76.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.215 0.531 . . . . 0.0 110.203 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -43.3 89.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.752 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.677 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 0.4 OUTLIER -68.04 -44.36 76.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.238 0.542 . . . . 0.0 109.735 178.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.726 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -60.88 -45.69 96.04 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.857 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 35.2 m -65.81 -33.59 64.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.897 0.348 . . . . 0.0 111.871 -177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.677 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 1.6 pp20? -77.68 -41.32 38.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 110.657 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.35 -42.84 74.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.735 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 121.96 40.01 0.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HB2' ' CA ' ' A' ' 97' ' ' GLY . 87.8 m-20 -113.03 -41.71 3.68 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.726 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 2.0 m-85 -132.75 169.85 16.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.102 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 116' ' ' ALA . 32.0 mt-10 -134.8 146.3 49.19 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.596 ' HG3' HG11 ' A' ' 98' ' ' VAL . 88.9 mt-30 -120.53 83.64 34.77 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.586 ' HB2' ' HB ' ' A' ' 129' ' ' VAL . 85.7 Cg_endo -78.48 42.08 1.17 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.656 2.238 . . . . 0.0 112.902 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -145.8 -48.34 0.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.903 0.382 . . . . 0.0 110.167 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.22 -145.71 14.51 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.748 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -66.38 125.42 13.93 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.753 2.302 . . . . 0.0 112.396 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 54.02 35.0 21.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.105 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.79 -148.71 11.45 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.373 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.45 135.23 34.75 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 94' ' ' ILE . 57.5 t -93.13 132.4 37.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 1.1 tmtp? -117.94 129.37 55.57 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -72.22 112.24 8.13 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.261 0.553 . . . . 0.0 111.372 -173.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 104' ' ' GLU . . . -68.07 132.07 46.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.854 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -146.14 66.0 1.2 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.095 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -165.25 -151.89 0.15 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.334 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 119' ' ' LYS . 13.0 mptt -87.22 -48.08 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.156 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 51.0 m -155.04 144.14 15.04 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.509 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 7.4 Cg_exo -70.19 132.15 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.024 1.816 . . . . 0.0 112.003 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -91.06 40.37 1.02 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.863 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.636 HG23 ' HB2' ' A' ' 127' ' ' LYS . 13.4 p -144.76 140.82 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.739 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -165.95 -59.45 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -111.3 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.662 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.79 -127.37 1.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.383 0.427 . . . . 0.0 110.302 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.636 ' HB2' HG23 ' A' ' 123' ' ' VAL . 47.8 mmtm 57.02 42.9 25.36 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.428 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -74.16 132.22 42.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.87 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 106' ' ' PRO . 13.0 p -65.48 135.23 28.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.371 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.832 -0.604 . . . . 0.0 109.506 -177.485 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.712 0.291 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -165.85 131.94 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 64.31 107.9 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 O-C-N 123.838 0.711 . . . . 0.0 111.133 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.06 24.76 10.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.328 0.585 . . . . 0.0 109.873 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.2 m -167.23 -141.2 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.954 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.6 m 57.83 35.56 25.56 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 80' ' ' VAL . 75.3 mmtt -94.14 127.91 40.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.6 OUTLIER -75.24 114.69 14.06 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.573 ' HA ' HD12 ' A' ' 50' ' ' LEU . 5.4 m-85 -62.59 -32.7 73.74 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -55.82 -46.31 78.12 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.978 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 46' ' ' SER . 10.9 pt-20 -72.46 -39.98 67.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.608 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 47' ' ' TYR . 66.2 mt -60.46 -51.68 68.45 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.135 0.493 . . . . 0.0 111.745 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 69' ' ' LEU . 65.4 mt -65.12 -42.03 93.35 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.792 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.774 ' HA ' HD21 ' A' ' 115' ' ' LEU . 35.6 mt -64.32 -46.11 94.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.278 178.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.13 -36.74 71.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.353 0.597 . . . . 0.0 110.119 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -77.15 -59.67 3.07 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.616 176.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD23 HD23 ' A' ' 115' ' ' LEU . 4.0 tp -54.08 -30.37 48.0 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.086 0.555 . . . . 0.0 112.442 -171.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -67.06 -33.06 74.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.142 0.496 . . . . 0.0 110.135 175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.23 -44.8 12.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.012 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.81 HD21 HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -108.68 34.11 3.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.369 -0.533 . . . . 0.0 112.207 -173.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -23.47 63.84 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.258 -0.276 . . . . 0.0 110.656 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 69.01 -49.51 0.59 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.278 1.031 . . . . 0.0 112.491 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.702 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -162.49 -38.2 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.387 178.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.702 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 60.2 pttt -179.86 33.79 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 110.751 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.32 135.31 2.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.699 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -119.05 151.85 37.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.017 0.437 . . . . 0.0 109.959 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.1 m -66.38 143.19 57.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.146 177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 73.4 mtm180 -53.25 -50.01 84.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.652 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 18.5 Cg_endo -57.55 -30.06 87.14 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.196 1.931 . . . . 0.0 112.643 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.74 -44.94 84.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.599 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.81 HD23 HD21 ' A' ' 58' ' ' LEU . 69.8 mt -63.38 -42.52 98.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.305 176.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 85.0 mttt -57.65 -42.48 83.58 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.318 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 65.8 tttp -65.34 -49.82 67.94 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.197 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.476 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 55.2 t80 -51.71 -45.69 63.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 69' ' ' LEU . 76.0 mt -65.13 -43.1 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.587 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.2 mttt -61.8 -42.36 98.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.707 0.289 . . . . 0.0 111.713 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.1 mm-40 -64.84 -37.15 86.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.259 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -95.64 -42.38 8.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.042 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -120.67 79.78 31.07 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.464 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.09 -22.15 68.55 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 112.273 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.838 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.7 mp -50.39 -61.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 122.04 0.924 . . . . 0.0 110.387 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG21 ' HB2' ' A' ' 45' ' ' LYS . 1.1 t -79.85 -32.12 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.142 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.442 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -56.26 -45.83 87.51 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.701 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.2 m -100.96 33.04 2.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.791 0.329 . . . . 0.0 110.793 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 80' ' ' VAL . . . -80.1 32.69 0.27 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m 64.08 -72.65 0.06 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.56 0.744 . . . . 0.0 112.409 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.2 38.3 1.6 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.503 0.668 . . . . 0.0 110.545 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -61.08 -43.86 98.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.802 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -44.74 91.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.021 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.62 -48.05 82.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.173 0.511 . . . . 0.0 110.222 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -60.97 -42.11 97.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.155 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 90.2 t80 -61.16 -49.62 76.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.209 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.405 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 74.6 m-20 -58.89 -42.97 90.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.043 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -65.77 -42.32 90.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.851 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.77 -42.76 89.68 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.749 ' O ' ' HB ' ' A' ' 98' ' ' VAL . 29.4 mm -60.52 -53.74 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.688 176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 91' ' ' ASN . 99.0 mttt -58.17 -46.54 85.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.55 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 18.3 tptm -65.78 -46.17 79.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 0.0 111.083 -175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.54 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -70.81 -34.03 66.2 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.063 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.749 ' HB ' ' O ' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -63.77 -34.7 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.57 0.7 . . . . 0.0 111.042 -178.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 20.8 pt-20 -86.55 -36.6 18.84 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.491 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.28 -40.14 71.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.225 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.71 ' HA2' ' HG3' ' A' ' 121' ' ' PRO . . . 119.75 37.8 0.75 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.554 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -114.38 -34.12 5.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.703 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 4.2 m-85 -127.4 161.42 28.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.418 171.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.532 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 9.6 pt-20 -144.8 129.74 18.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.922 0.391 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.58 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 70.5 mt-30 -99.21 103.51 20.7 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 104' ' ' GLU . 52.3 Cg_exo -60.98 -32.38 92.33 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.115 2.543 . . . . 0.0 113.234 -174.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -83.44 -47.87 10.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.798 0.332 . . . . 0.0 110.962 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 154.75 176.8 27.41 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.8 135.99 72.26 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.609 2.206 . . . . 0.0 112.525 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.77 39.99 3.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.204 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -126.94 -143.75 5.88 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -88.03 135.6 33.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.58 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 2.5 p -114.0 141.23 30.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.116 0.484 . . . . 0.0 110.821 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.2 ttpp -122.53 152.73 40.07 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.774 HD21 ' HA ' ' A' ' 52' ' ' ILE . 16.2 mt -57.75 130.37 46.12 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.61 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.43 159.94 32.5 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.915 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -67.53 80.63 0.17 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.469 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 118' ' ' LYS . 12.8 mptt 61.79 -114.71 0.55 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.462 -176.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -103.99 43.52 1.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.807 0.336 . . . . 0.0 111.061 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 56.5 p -166.79 130.3 1.51 Allowed Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-O 120.932 0.396 . . . . 0.0 111.564 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.71 ' HG3' ' HA2' ' A' ' 101' ' ' GLY . 2.9 Cg_exo -77.23 137.09 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.179 2.586 . . . . 0.0 112.31 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 129' ' ' VAL . 48.6 mt-10 -98.85 44.49 1.03 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.152 173.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 105' ' ' GLN . 55.0 t -143.93 117.13 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.867 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm 64.2 -50.81 0.28 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 172.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 121' ' ' PRO . 39.5 mtpt -58.94 125.85 25.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.947 0.403 . . . . 0.0 111.919 -172.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . 84.9 mt-10 57.35 -150.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.936 177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.863 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.6 OUTLIER -83.18 -154.97 0.15 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.755 -178.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.658 ' HG2' ' HG2' ' A' ' 127' ' ' LYS . 65.7 mm-40 60.16 -134.05 0.79 Allowed 'General case' 0 C--O 1.234 0.252 0 C-N-CA 122.476 0.311 . . . . 0.0 111.367 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 122' ' ' GLU . 21.7 t 60.79 53.69 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.59 0.71 . . . . 0.0 110.041 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.147 -177.502 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.1 tttp . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -72.93 -50.9 20.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.247 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' OE2' ' HB3' ' A' ' 44' ' ' SER . 88.5 tt0 -172.75 129.62 0.52 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.249 173.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.17 -133.59 0.14 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.844 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.9 m -80.58 41.77 0.57 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.905 0.383 . . . . 0.0 111.907 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.418 ' HB3' ' OE2' ' A' ' 41' ' ' GLU . 14.5 t -84.3 42.36 0.88 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.447 0.641 . . . . 0.0 110.101 176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -91.19 131.75 36.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.525 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.452 ' HB3' ' HG3' ' A' ' 49' ' ' GLU . 40.0 t -73.12 128.87 36.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.78 -18.76 62.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.825 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -58.73 -45.6 89.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 46' ' ' SER . 2.6 mt-10 -68.16 -50.71 52.72 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.227 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD23 HG11 ' A' ' 80' ' ' VAL . 4.7 mp -56.77 -55.84 29.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.328 -175.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 69' ' ' LEU . 67.8 mt -64.92 -54.44 29.62 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.053 -176.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.617 HG13 ' HE1' ' A' ' 103' ' ' PHE . 90.4 mt -58.51 -41.42 81.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.7 -41.99 64.4 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.77 -53.52 3.52 Favored Glycine 0 CA--C 1.493 -1.327 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.127 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.635 HD11 ' HA ' ' A' ' 114' ' ' LYS . 34.7 tp -48.25 -37.39 16.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 123.387 0.675 . . . . 0.0 112.012 -172.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 t -72.0 -32.73 67.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.663 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.16 -42.32 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.09 12.1 33.86 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.871 -0.518 . . . . 0.0 111.834 -170.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -63.08 -27.54 69.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.702 0.286 . . . . 0.0 110.515 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 59.07 -111.76 0.57 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.908 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -63.51 -36.42 83.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.769 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.498 ' HD3' ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -175.41 -38.9 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.498 ' N ' ' HD3' ' A' ' 62' ' ' LYS . . . -154.3 145.6 12.99 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.896 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 p -95.11 -117.13 0.11 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -167.36 152.61 7.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 52.8 mtp180 -54.45 -54.47 48.12 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.947 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 19.1 Cg_endo -59.55 -34.36 96.84 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.073 1.848 . . . . 0.0 112.083 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.31 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.866 177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.47 HD11 HD13 ' A' ' 55' ' ' LEU . 44.7 mt -61.17 -45.94 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.577 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 45.5 mtmt -59.74 -34.66 73.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.647 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 85.0 tttt -63.84 -53.53 49.15 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.897 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -54.93 -43.16 73.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.98 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 69' ' ' LEU . 56.7 mt -62.57 -46.49 96.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.233 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 85.5 mttt -66.12 -34.12 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 111.484 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.8 mm-40 -66.07 -42.34 89.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.133 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -94.56 -44.5 7.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -119.8 71.52 15.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.69 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.79 -9.48 24.8 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.612 2.208 . . . . 0.0 113.315 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.826 ' H ' HD12 ' A' ' 79' ' ' ILE . 4.3 mp -56.48 -58.49 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.054 0.93 . . . . 0.0 109.183 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 86' ' ' PHE . 1.0 OUTLIER -77.94 -30.74 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 113.443 -1.708 . . . . 0.0 109.735 173.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' CA ' ' HG2' ' A' ' 74' ' ' LYS . . . -57.03 -41.96 92.75 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.091 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.0 m -92.87 28.66 2.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.774 -0.251 . . . . 0.0 111.22 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -80.01 131.64 35.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 174.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -61.05 -39.92 91.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.97 0.414 . . . . 0.0 110.899 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -102.46 26.85 7.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.464 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.769 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 31.9 t80 -59.2 -45.06 92.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.635 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -56.71 -47.59 79.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.66 -47.75 82.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.12 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -61.01 -43.27 99.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.484 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.37 -50.35 73.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.33 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -62.61 -36.28 82.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.149 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -66.88 -42.03 86.25 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.401 175.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.11 95.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 HG21 ' A' ' 113' ' ' VAL . 35.9 mm -60.12 -48.91 86.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.497 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 63.6 mttp -61.91 -43.04 99.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.252 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 23.7 tptm -68.22 -38.63 82.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.036 0.446 . . . . 0.0 110.563 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.812 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -63.78 -43.28 97.94 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.194 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.672 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 27.1 m -64.82 -36.72 78.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 117.12 0.46 . . . . 0.0 111.362 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 3.1 pt-20 -76.25 -41.89 47.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.14 -28.87 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.812 0.339 . . . . 0.0 111.244 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.689 ' HA3' ' HA ' ' A' ' 119' ' ' LYS . . . 102.11 40.5 2.62 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.359 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -113.0 -43.6 3.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.812 ' CD2' ' HA3' ' A' ' 97' ' ' GLY . 6.1 m-85 -128.49 165.59 20.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.652 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' OE2' ' HG3' ' A' ' 117' ' ' LYS . 16.5 mt-10 -141.8 142.25 33.19 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.011 0.524 . . . . 0.0 109.715 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -115.21 117.71 40.88 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.508 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -63.46 -41.55 25.57 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.932 2.421 . . . . 0.0 112.659 -177.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -83.64 -60.48 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.048 0.451 . . . . 0.0 110.746 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.04 -153.16 23.38 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.47 133.68 58.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.84 2.36 . . . . 0.0 112.8 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.5 28.87 18.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.272 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.21 -158.81 23.16 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.105 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.56 148.75 47.98 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.605 0.24 . . . . 0.0 110.512 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.653 HG21 HD12 ' A' ' 94' ' ' ILE . 34.2 t -117.78 152.97 19.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 120.887 0.375 . . . . 0.0 110.276 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.635 ' HA ' HD11 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -157.69 153.09 26.12 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 174.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.563 HD22 HD23 ' A' ' 55' ' ' LEU . 1.5 mm? -53.15 134.56 38.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.018 0.437 . . . . 0.0 111.861 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.43 142.51 56.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.968 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.48 ' HG3' ' OE2' ' A' ' 104' ' ' GLU . 41.7 mttp -60.08 -36.8 78.16 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.903 -177.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . 33.1 ttmt -165.1 159.92 18.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.472 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.689 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 0.0 OUTLIER -63.76 -49.16 74.07 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.625 ' H ' ' HG2' ' A' ' 119' ' ' LYS . 67.9 m 61.06 156.28 0.11 Allowed Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.376 173.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.47 170.19 8.55 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.539 2.159 . . . . 0.0 111.584 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -60.35 116.39 4.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.442 0.639 . . . . 0.0 111.083 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.4 t -97.85 131.93 43.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.821 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? 47.51 -135.72 0.97 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.912 0.757 . . . . 0.0 112.255 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -147.73 -52.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.681 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -79.24 132.65 36.56 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.551 ' HG3' ' HB3' ' A' ' 99' ' ' GLU . 3.4 mptp? -80.82 57.38 3.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 111.674 -176.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.425 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.6 mt-10 -78.86 61.22 3.04 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 128' ' ' GLU . 65.5 t 79.16 -44.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.361 -166.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.3 p . . . . . 0 C--N 1.321 -0.642 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.63 172.765 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 39' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.757 0.313 . . . . 0.0 111.105 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -59.57 135.09 57.56 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.34 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 29.1 tt0 -80.09 54.07 1.85 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.096 0.474 . . . . 0.0 110.232 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.19 -46.46 67.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.158 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -136.32 23.82 3.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.501 ' HB2' ' HG3' ' A' ' 41' ' ' GLU . 67.0 m -92.29 34.09 1.06 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.491 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 80' ' ' VAL . 71.8 mmtt -88.87 140.62 29.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.3 m -68.48 107.36 2.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 110.279 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 51' ' ' ILE . 19.7 m-85 -62.61 -36.25 82.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.3 ttm105 -54.86 -43.48 73.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.87 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -65.74 -49.63 67.7 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.362 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.503 ' HB3' HG12 ' A' ' 73' ' ' ILE . 2.4 mp -55.32 -49.59 71.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.535 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.83 HG23 HD13 ' A' ' 69' ' ' LEU . 76.1 mt -66.33 -50.67 66.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.236 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.7 ' HA ' HD21 ' A' ' 115' ' ' LEU . 39.7 mt -61.25 -47.21 94.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.526 0.203 . . . . 0.0 111.304 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -54.25 -42.41 69.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.675 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.667 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -73.53 -56.98 5.24 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 120.157 -1.021 . . . . 0.0 112.332 176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD23 HD23 ' A' ' 115' ' ' LEU . 4.8 tp -58.07 -30.28 66.09 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 t -75.96 -32.83 59.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.08 0.466 . . . . 0.0 110.182 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.76 -51.01 6.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.38 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.698 ' HG ' ' N ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -76.79 -53.71 7.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.006 -176.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.698 ' N ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER 40.3 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 127.749 2.42 . . . . 0.0 117.057 175.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 58' ' ' LEU . 51.3 mt-10 64.16 -105.73 0.14 Allowed 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.27 0.628 . . . . 0.0 109.414 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -77.87 -30.28 50.79 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.711 176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 167.65 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.134 178.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . -142.1 150.87 22.43 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.242 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.4 t -133.57 156.3 48.07 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.863 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 10.8 t -62.68 157.17 21.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.941 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 82.9 mtm180 -48.87 -52.41 46.58 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.076 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 6.0 Cg_endo -49.63 -38.28 45.15 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 122.977 2.452 . . . . 0.0 112.979 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.85 90.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.658 0.266 . . . . 0.0 110.983 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.83 HD13 HG23 ' A' ' 51' ' ' ILE . 58.7 mt -66.16 -44.25 84.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.887 176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 57.1 mtpt -59.07 -35.38 73.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.828 178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 45.3 tttm -68.79 -50.23 52.01 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.333 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.1 -43.87 64.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.554 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.503 HG12 ' HB3' ' A' ' 50' ' ' LEU . 80.6 mt -62.87 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.963 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 97.5 mttt -61.19 -37.4 82.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 71' ' ' LYS . 52.4 mt-10 -67.92 -42.4 81.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.964 0.411 . . . . 0.0 111.197 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.12 -40.54 9.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.94 76.2 58.0 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.592 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.8 -18.99 52.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.779 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.7 mp -51.96 -67.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-O 121.829 0.823 . . . . 0.0 110.29 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 86' ' ' PHE . 1.2 t -74.21 -35.78 41.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.084 -1.417 . . . . 0.0 110.02 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -53.64 -42.29 66.93 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.935 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -102.66 27.75 6.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.952 0.406 . . . . 0.0 110.34 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.628 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . . . -72.97 140.24 47.26 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 m -61.77 -38.74 89.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.453 0.644 . . . . 0.0 110.468 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -102.87 22.43 13.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.421 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.628 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 31.7 t80 -58.38 -45.49 88.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.201 0.524 . . . . 0.0 110.877 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -61.47 -42.57 98.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.208 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -68.2 -49.41 61.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.617 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -61.93 -43.42 98.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.057 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.42 ' O ' HG12 ' A' ' 94' ' ' ILE . 87.7 t80 -58.47 -47.32 84.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.487 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -62.17 -43.2 99.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.473 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -64.08 -38.6 91.66 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.034 -0.266 . . . . 0.0 110.877 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.62 98.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.641 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.442 HD13 HD13 ' A' ' 51' ' ' ILE . 30.9 mm -61.17 -53.22 52.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.02 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 57.2 mttm -53.81 -49.71 67.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.083 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -72.22 -30.88 65.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.631 ' HA3' ' CD1' ' A' ' 103' ' ' PHE . . . -75.67 -39.3 34.82 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.855 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 29.6 m -69.06 -37.69 77.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.904 0.352 . . . . 0.0 111.317 -177.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.1 pt-20 -66.89 -39.18 87.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.925 0.393 . . . . 0.0 110.675 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.35 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.847 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.3 36.56 5.89 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.754 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -112.67 -23.12 10.38 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.8 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -135.28 153.78 51.77 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 169.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 34.6 mm-40 -142.23 123.21 14.48 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.768 ' HG2' ' HB ' ' A' ' 113' ' ' VAL . 54.8 mt-30 -96.27 107.79 37.62 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.851 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 36.3 Cg_endo -62.94 -34.27 71.88 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.233 1.955 . . . . 0.0 111.522 175.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -86.5 33.3 0.63 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.46 -138.17 19.31 Favored Glycine 0 C--O 1.225 -0.428 0 C-N-CA 120.838 -0.696 . . . . 0.0 113.151 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -91.04 -28.52 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.93 2.42 . . . . 0.0 113.992 -174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -129.97 52.13 2.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -138.79 -140.76 4.02 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.234 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.863 ' HA ' ' HA ' ' A' ' 65' ' ' SER . . . -80.13 142.79 34.47 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.768 ' HB ' ' HG2' ' A' ' 105' ' ' GLN . 6.1 p -120.43 143.15 33.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.038 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -119.46 143.22 47.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.7 HD21 ' HA ' ' A' ' 52' ' ' ILE . 10.7 mt -58.12 129.46 42.07 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.608 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.12 121.62 42.57 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.464 0.65 . . . . 0.0 112.243 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -137.34 36.9 2.5 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -162.72 118.13 1.82 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 113.272 -1.786 . . . . 0.0 107.929 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.26 -55.4 18.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.185 0.517 . . . . 0.0 110.699 -175.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 73.9 m -63.63 131.57 94.91 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.17 177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 120' ' ' SER . 21.4 Cg_exo -60.76 138.21 77.96 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.013 1.809 . . . . 0.0 111.167 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -147.89 41.28 1.01 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.804 0.811 . . . . 0.0 110.059 -174.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 106' ' ' PRO . 4.4 t -95.21 51.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.683 173.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.673 ' HG3' ' HG2' ' A' ' 128' ' ' GLU . 7.9 ttpm? -117.97 -34.29 4.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.732 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.628 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 4.0 ttmp? -70.94 140.78 51.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.231 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.628 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 85.5 mt-10 67.17 51.72 0.9 Allowed 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.637 0.586 . . . . 0.0 109.921 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 61.6 mttp 73.65 132.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.349 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.673 ' HG2' ' HG3' ' A' ' 124' ' ' LYS . 83.2 mt-10 -72.29 167.76 19.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.082 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.4 t -65.89 114.46 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.767 -0.635 . . . . 0.0 109.741 -177.029 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 42.1 ttmt . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.611 0.243 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -84.97 -168.76 2.34 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.541 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 57.53 50.56 10.92 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.339 0.59 . . . . 0.0 110.061 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.21 -10.57 42.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.552 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 m -72.82 7.02 2.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.004 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 m -78.41 41.8 0.4 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.87 0.367 . . . . 0.0 111.665 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HB2' HG21 ' A' ' 80' ' ' VAL . 34.4 mmtm -77.88 135.49 37.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.82 175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.4 m -72.68 116.6 13.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.243 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -66.91 -31.52 72.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.71 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -58.22 -42.12 85.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.439 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.79 -53.95 18.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.717 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 80' ' ' VAL . 2.8 mp -53.71 -53.46 51.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.822 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.412 HG12 ' HE1' ' A' ' 90' ' ' PHE . 63.5 mt -65.59 -50.64 70.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.315 -177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.498 HG23 HD21 ' A' ' 115' ' ' LEU . 51.7 mt -62.31 -42.64 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -54.79 -40.75 69.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 110.934 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' O ' HD23 ' A' ' 58' ' ' LEU . . . -75.34 -59.38 3.6 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.467 174.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.891 HD23 HD22 ' A' ' 115' ' ' LEU . 19.1 tp -46.17 -37.96 7.68 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 123.927 0.891 . . . . 0.0 112.401 -174.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -72.12 -31.99 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.236 0.541 . . . . 0.0 110.76 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.94 -41.44 13.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.764 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 54' ' ' GLY . 1.5 pt? -107.4 20.11 19.37 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.449 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -66.59 -26.14 66.96 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.482 -0.136 . . . . 0.0 110.844 179.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 67.92 -46.16 0.51 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -151.62 -46.08 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.22 -0.3 . . . . 0.0 110.73 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.645 ' HA ' ' HD2' ' A' ' 114' ' ' LYS . 23.4 pttm -174.63 26.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.534 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.03 133.31 1.65 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 119.902 -1.142 . . . . 0.0 112.763 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.503 ' HB3' ' O ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -126.27 141.22 52.0 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.391 0.277 . . . . 0.0 110.293 178.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.3 m -62.56 137.11 58.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.763 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.557 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 39.2 mtp180 -53.8 -49.32 89.93 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.146 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 17.7 Cg_endo -56.41 -34.27 94.04 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.977 1.785 . . . . 0.0 112.523 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.23 -45.05 95.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 58' ' ' LEU . 5.2 mp -60.59 -40.44 91.77 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 177.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -61.11 -35.72 77.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.501 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 75' ' ' GLU . 59.3 tttp -65.09 -50.3 66.68 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.913 175.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.22 -44.04 64.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.948 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.1 mt -65.19 -42.8 95.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.824 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.261 . . . . 0.0 111.489 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 71' ' ' LYS . 5.4 mm-40 -63.48 -41.8 98.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -94.19 -43.46 8.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.197 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -120.36 81.58 30.53 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.499 0.19 . . . . 0.0 110.882 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.01 -23.39 77.36 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.659 2.239 . . . . 0.0 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.852 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.5 mp -53.62 -63.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.868 0.842 . . . . 0.0 110.4 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 50' ' ' LEU . 1.2 t -77.23 -33.26 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.689 178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -41.52 61.62 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.551 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.4 m -104.53 30.62 5.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.766 0.317 . . . . 0.0 110.856 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 80' ' ' VAL . . . -82.71 48.84 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.6 t 55.79 -103.39 0.18 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.303 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -81.05 39.64 0.51 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.939 0.399 . . . . 0.0 111.245 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.412 ' CD1' HG13 ' A' ' 80' ' ' VAL . 10.8 t80 -58.57 -40.16 82.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 175.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.21 -45.02 88.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.555 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.33 -44.93 95.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.196 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -61.89 -43.3 99.13 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.795 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.412 ' HE1' HG12 ' A' ' 51' ' ' ILE . 86.2 t80 -60.5 -50.32 74.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.075 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -59.3 -43.32 92.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.345 -176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -64.41 -40.72 96.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.807 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.78 93.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.025 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.15 -48.82 85.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.512 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.626 ' O ' ' HG2' ' A' ' 99' ' ' GLU . 60.2 mtpt -58.61 -49.2 78.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.027 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 99' ' ' GLU . 17.0 tptm -66.45 -39.71 89.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.805 -177.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.633 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -67.67 -43.67 84.21 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.703 -0.68 . . . . 0.0 113.398 -175.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.0 m -64.71 -39.03 84.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.996 0.398 . . . . 0.0 111.687 -175.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.626 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 4.5 pt-20 -72.0 -40.99 68.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.55 83.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.183 0.516 . . . . 0.0 111.048 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.2 40.34 0.59 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.703 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 -37.83 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.68 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 7.6 m-85 -129.03 160.09 33.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.916 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.549 ' OE2' ' HA ' ' A' ' 121' ' ' PRO . 29.7 mm-40 -126.69 144.68 50.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.965 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.57 HE21 HG11 ' A' ' 98' ' ' VAL . 54.7 mt-30 -128.16 105.67 19.93 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.918 0.389 . . . . 0.0 111.144 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 90.5 Cg_endo -78.61 39.67 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.151 2.567 . . . . 0.0 112.708 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -148.39 -56.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.761 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 172.85 -144.43 7.86 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.88 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.14 -38.31 2.85 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.735 2.29 . . . . 0.0 113.494 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.486 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -127.74 40.81 3.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -176.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.59 -145.11 18.43 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.969 175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.616 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -84.93 141.19 30.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.64 HG12 HD21 ' A' ' 55' ' ' LEU . 14.5 t -104.42 154.12 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.789 0.328 . . . . 0.0 110.502 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.645 ' HD2' ' HA ' ' A' ' 62' ' ' LYS . 78.0 tttt -148.58 144.54 27.32 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.891 HD22 HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -52.47 133.14 35.56 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.56 -178.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.62 130.59 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 173.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -63.41 -54.59 34.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.934 -172.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 119' ' ' LYS . 2.8 mmmp? -130.75 35.41 4.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 118' ' ' LYS . 1.6 mptm? 70.63 -52.92 0.66 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.031 0.832 . . . . 0.0 110.921 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.0 m -69.69 148.68 96.76 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.549 ' HA ' ' OE2' ' A' ' 104' ' ' GLU . 5.9 Cg_endo -49.96 135.92 36.49 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.312 2.675 . . . . 0.0 112.613 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.11 48.62 0.38 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.849 -175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.8 t -133.82 67.08 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.974 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -81.1 61.0 4.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.646 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -69.44 -17.37 63.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.794 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -165.0 156.54 15.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.466 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -62.01 -43.01 99.75 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -86.3 31.93 0.64 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.951 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.6 p -74.04 -34.93 40.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.0 0.429 . . . . 0.0 110.27 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.401 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.844 0.354 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -110.61 -46.81 3.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.647 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -156.28 143.11 18.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.242 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.59 141.59 30.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.495 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.469 ' HA ' HG22 ' A' ' 79' ' ' ILE . 13.9 m 64.08 46.23 3.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -85.06 41.74 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.955 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HE3' HD13 ' A' ' 79' ' ' ILE . 71.2 mmtt -88.17 120.76 29.84 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 55.7 m -67.55 121.9 16.85 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.118 0.485 . . . . 0.0 110.051 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -63.23 -23.59 67.5 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.188 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -59.61 -38.0 80.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.716 0.293 . . . . 0.0 110.735 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 46' ' ' SER . 4.2 mt-10 -72.18 -50.6 26.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' CD2' HG11 ' A' ' 80' ' ' VAL . 2.4 mp -54.0 -52.46 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.014 -0.993 . . . . 0.0 111.623 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD13 HD13 ' A' ' 94' ' ' ILE . 69.1 mt -64.09 -53.01 48.98 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.293 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.514 HG13 ' HE1' ' A' ' 103' ' ' PHE . 60.4 mt -61.89 -44.62 99.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.738 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -54.52 -44.36 72.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.516 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.487 ' C ' HD22 ' A' ' 58' ' ' LEU . . . -69.54 -63.38 3.4 Favored Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.2 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.877 ' HG ' HD22 ' A' ' 115' ' ' LEU . 15.0 tp -40.72 -44.83 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.444 1.097 . . . . 0.0 112.757 -175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.443 ' N ' HD21 ' A' ' 115' ' ' LEU . 4.6 t -73.03 -26.38 61.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.512 0.672 . . . . 0.0 110.922 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.01 -39.62 14.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.644 -176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.487 HD22 ' C ' ' A' ' 54' ' ' GLY . 1.2 pt? -113.8 20.98 15.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.959 -0.463 . . . . 0.0 111.934 -170.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 46.2 pttt -61.17 -31.57 71.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.737 0.304 . . . . 0.0 111.266 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 56.51 -102.63 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.113 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -65.8 -34.29 77.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.363 -177.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.577 ' HG2' ' HG2' ' A' ' 61' ' ' ARG . 9.6 ptpp? 173.76 -37.85 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.821 0.448 . . . . 0.0 110.079 178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.1 156.95 26.29 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.711 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -124.01 141.6 51.9 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.726 0.298 . . . . 0.0 111.348 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' ALA . 5.7 m -63.74 148.3 49.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.372 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.566 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -48.8 -50.9 58.32 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 66' ' ' ARG . 10.0 Cg_endo -50.84 -33.18 40.18 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.76 2.307 . . . . 0.0 112.865 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.05 -48.22 74.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.948 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 73' ' ' ILE . 6.6 mp -65.56 -38.6 90.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.844 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 66' ' ' ARG . 92.6 mttt -57.78 -39.96 78.72 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.137 0.494 . . . . 0.0 110.108 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.58 -51.39 62.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.172 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -52.76 -44.22 66.34 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.847 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 69' ' ' LEU . 81.5 mt -67.56 -45.87 84.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.459 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 99.1 mttt -58.7 -43.32 90.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.86 0.362 . . . . 0.0 111.221 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.4 -39.68 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.818 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -94.45 -36.35 11.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -125.68 72.98 68.94 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.497 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.98 -23.36 42.93 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.959 2.439 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.781 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.1 mp -53.34 -68.06 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.542 0.687 . . . . 0.0 110.598 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG11 ' CD2' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -70.9 -35.41 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.88 177.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.22 -42.14 62.58 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.432 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.8 m -107.16 38.95 1.98 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 120.791 0.329 . . . . 0.0 110.844 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.61 3.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.82 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t 70.8 -58.91 0.55 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.808 0.843 . . . . 0.0 111.806 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -96.73 23.88 6.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 110.825 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.444 ' CD1' HG13 ' A' ' 80' ' ' VAL . 20.6 t80 -56.36 -44.88 80.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.681 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.24 -40.59 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -63.57 -48.7 76.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.173 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -61.94 -38.88 90.14 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.213 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.431 ' CE1' HG12 ' A' ' 51' ' ' ILE . 82.5 t80 -62.06 -48.52 79.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.785 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -61.74 -41.6 97.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -60.58 -42.04 95.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.787 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.28 99.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.924 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.815 HD12 HG21 ' A' ' 113' ' ' VAL . 40.5 mm -60.53 -53.08 53.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -63.62 -45.01 92.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.696 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 96' ' ' LYS . 0.7 OUTLIER -67.71 -38.51 83.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.145 0.498 . . . . 0.0 110.149 -179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.608 ' HA3' ' CD2' ' A' ' 103' ' ' PHE . . . -66.43 -43.49 92.41 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.17 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 26.8 m -66.34 -37.89 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 117.101 0.451 . . . . 0.0 111.602 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -71.82 -42.62 66.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.553 0.216 . . . . 0.0 110.908 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.24 -39.51 93.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.252 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 116.98 35.88 1.09 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.966 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.31 -36.11 5.4 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.656 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 3.9 m-85 -130.64 162.09 30.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.832 176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -135.49 149.01 49.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.552 ' HG3' HG11 ' A' ' 98' ' ' VAL . 47.4 mt-30 -124.69 113.34 27.16 Favored Pre-proline 0 C--N 1.322 -0.612 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.974 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 112' ' ' ALA . 61.4 Cg_endo -76.81 -33.83 2.7 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.954 2.436 . . . . 0.0 113.031 -177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -82.88 -46.62 12.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.173 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.02 -174.02 45.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.729 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.51 -29.33 89.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.273 2.648 . . . . 0.0 112.639 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 66' ' ' ARG . . . -135.39 39.81 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.32 0.581 . . . . 0.0 110.105 177.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -101.36 -56.59 0.87 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.866 -177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 106' ' ' PRO . . . -173.57 143.03 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.617 0.367 . . . . 0.0 110.131 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.815 HG21 HD12 ' A' ' 94' ' ' ILE . 21.4 t -99.48 150.53 5.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.112 0.482 . . . . 0.0 110.988 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -143.31 141.54 31.02 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.877 HD22 ' HG ' ' A' ' 55' ' ' LEU . 2.7 mm? -52.84 131.02 34.85 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.124 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.55 117.55 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.56 174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 117' ' ' LYS . 26.3 ttmt -149.4 22.22 0.93 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.382 -176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 8.1 mmpt? -151.83 135.03 15.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.944 -1.48 . . . . 0.0 108.56 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 119' ' ' LYS . 3.3 mppt? -75.15 -54.53 6.97 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 13.4 p -86.46 147.48 44.37 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.931 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 120' ' ' SER . 28.2 Cg_exo -60.35 145.99 97.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.342 2.028 . . . . 0.0 111.889 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -137.82 54.89 1.8 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.514 0.673 . . . . 0.0 109.733 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 32.0 t -93.62 133.78 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.433 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.09 107.14 9.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.868 0.366 . . . . 0.0 111.572 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 48.04 45.94 19.29 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.358 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.27 -46.83 66.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.463 0.649 . . . . 0.0 109.345 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -163.07 29.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.819 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 54.83 42.76 30.89 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.429 -176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.86 132.4 37.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.284 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.741 -178.115 . . . . . . . . 0 0 . 1 stop_ save_